Edgar Filing: Colfax CORP

Unassociated Document

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K/A

Amendment No. 1

(Mark One)

x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2009

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-34045

Colfax Corporation

(Exact name of registrant as specified in its charter)

Delaware		54-1887631
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

8730 Stony Point Parkway, Suite 150 Richmond, Virginia		23235
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: 804-560-4070

Securities Registered Pursuant to Section 12(b) of the Act:

Title of Each Class		Name of Each Exchange On Which Registered
Common Stock, $.001 par value		New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

NONE

(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ¨ No x

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ¨ No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨		Accelerated filer x		Non-accelerated filer ¨		Smaller reporting company ¨
		(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ¨ No x

The aggregate market value of common shares held by non-affiliates of the Registrant on July 3, 2009 was $178,598,119 based upon the closing price of the registrant's common shares as quoted on the New York Stock Exchange composite tape on such date.

As of January 31, 2010, the number of shares of registrant’s common stock outstanding was 43,243,554.

EXHIBIT INDEX APPEARS ON PAGE 88

DOCUMENTS INCORPORATED BY REFERENCE

Part III incorporates certain information by reference from the registrant’s definitive proxy statement for its 2010 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after the end of the registrant’s fiscal year covered by this report. With the exception of the sections of the 2010 proxy statement specifically incorporated herein by reference, the 2010 proxy statement is not deemed to be filed as part of this Form 10-K/A.

EXPLANATORY NOTE

Overview

Colfax Corporation (the “Company”) is filing this Amendment No. 1 on Form 10-K/A to our annual report on Form 10-K for the year ended December 31, 2009, originally filed on February 25, 2010 (the “Original Form 10-K”), to restate our financial statements and corresponding financial information for the year ended December 31, 2009 for the effect of an overstatement of our pension liability. The amendment also restates the quarterly financial information included in Note 20 to the consolidated financial statements with respect to each fiscal quarter in the years ended December 31, 2008 and 2009. The Company does not intend to amend its Quarterly Reports on Form 10-Q for these fiscal quarters.

Restatement

While preparing the 2010 census data for our defined benefit pension plan actuarial valuations, the Company determined that previous actuarial valuations for the plans of a U.S. subsidiary contained errors in participant data. The errors largely originated in census data compiled by the subsidiary’s former actuaries prior to our acquisition of the subsidiary in 1997. Because these errors affected the valuation of pension liabilities at the date of the acquisition, goodwill was also overstated.

As a result of the errors, the pension liability was overstated by $21.7 million as of December 31, 2009 and $20.0 million as of December 31, 2008. Additionally, goodwill was overstated by $3.8 million as of December 31, 2009 and 2008 and shareholder’s equity was understated by $18.0 million as of December 31, 2009 and $14.4 million as of December 31, 2008. Net income was understated by $2.1 million for the year ended December 31, 2009, $1.1 million for the year ended December 31, 2008, and $0.8 million for the year ended December 31, 2007. There is no cash flow impact from these errors. The errors increased other comprehensive income by $1.5 million for the year ended December 31, 2009, had a less than $0.1 million impact on the year ended December 31, 2008, and decreased other comprehensive income by $0.5 million for the year ended December 31, 2007.

This amendment also contains balance sheet reclassifications at December 31, 2009 to reclassify a portion of the asbestos insurance asset from long term to current and to reflect certain property previously recorded in other assets as property, plant and equipment.

The Company is filing amended Quarterly Reports on Form 10-Q/A for the quarter ended April 2, 2010 and the quarter ended July 2, 2010, to correct the errors described above. Please refer to those amended reports for further discussion of the restatement of those respective periods.

All of the information in this Form 10-K/A is as of February 25, 2010, the date the Company filed the Original Form 10-K with the Securities and Exchange Commission. This Form 10-K/A continues to speak as of the date of the Original Form 10-K and does not reflect any subsequent information or events other than the restatement discussed in Note 2 to the Consolidated Financial Statements appearing in this Form 10-K/A. Accordingly, this Form 10-K/A should be read in conjunction with our filings made with the Securities and Exchange Commission subsequent to the filing of the Original Form 10-K, including any amendments to those filings. Among other things, forward-looking statements made in the Original Form 10-K have not been revised to reflect events, results or developments that occurred or facts that became known to us after the date of the Original Form 10-K, other than the restatement.

For the convenience of the reader, this Form 10-K/A sets forth the Original Form 10-K in its entirety. No attempt has been made in this Form 10-K/A to modify or update the disclosures in the Original Form 10-K except as required to reflect the effects of the restatement discussed in Note 2 to the Consolidated Financial Statements. However, changes have been made to the following items solely as a result of, and to reflect, the restatement, and no other information in the Form 10-K/A is amended hereby as a result of the restatement:

Part I, Item 1A - Risk Factors

Part II, Item 6 - Selected Financial Data

Part II, Item 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations

Part II, Item 8 - Financial Statements and Supplementary Data

Part II, Item 9A - Controls and Procedures

Part IV, Item 15 - Exhibits and Financial Statement Schedules

In the Original Form 10-K, the Company reported under Item 9A “Controls and Procedures,” that its disclosure controls and procedures were effective. Management, in consultation with the Audit Committee, has concluded that the errors set forth herein constituted a material weakness in the Company’s internal controls over financial reporting as of the date of the Original Form 10-K. The revised assessment is included under Part II, Item 9A in this document.

The Company is including currently dated Sarbanes-Oxley Act Section 302 and Section 906 certifications of the Chief Executive Officer and Chief Financial Officer that are attached to this Form 10-K/A as Exhibits 31.1, 31.2, 32.1 and 32.2.

TABLE OF CONTENTS

			PAGE
PART I
	Item 1.	Business	2
	Item 1A.	Risk Factors	10
	Item 1B.	Unresolved Staff Comments	19
	Item 2.	Properties	19
	Item 3.	Legal Proceedings	19
	Item 4.	Submission of Matters to a Vote of Security Holders	19
		Executive Officers of the Registrant	19

PART II
	Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	20
	Item 6.	Selected Financial Data	22
	Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	41
	Item 8.	Financial Statements and Supplementary Data	42
	Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	83
	Item 9A.	Controls and Procedures	83
	Item 9B.	Other Information	84

PART III
	Item 10.	Directors, Executive Officers and Corporate Governance	84
	Item 11.	Executive Compensation	84
	Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	84
	Item 13.	Certain Relationships and Related Transactions, and Director Independence	85
	Item 14.	Principal Accountant Fees and Services	85

PART IV
	Item 15.	Exhibits and Financial Statement Schedules	85

Unless otherwise indicated, references in this Form 10-K/A to “Colfax”, “the Company”, “we”, “our” and “us” refer to Colfax Corporation and its subsidiaries.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Annual Report that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Annual Report is filed with the SEC. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding: projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of management for future operations including statements relating to potential acquisitions, compensation plans, purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance; the outcome of outstanding claims or legal proceedings including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” and similar expressions. These statements are based on assumptions and assessments made by our management in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the following:

•

risks associated with our international operations;

•

significant movements in foreign currency exchange rates;

•

changes in the general economy, including the current global economic downturn, as well as the cyclical nature of our markets;

•

our ability to accurately estimate the cost of or realize savings from our restructuring programs;

•

availability and cost of raw materials, parts and components used in our products;

•

the competitive environment in our industry;

•

our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;

•

the amount of and our ability to estimate our asbestos-related liabilities;

•

material disruption at any of our significant manufacturing facilities;

•

the solvency of our insurers and the likelihood of their payment for asbestos-related claims;

•

our ability to manage and grow our business and execution of our business and growth strategies;

•

loss of key management;

•

our ability and the ability of customers to access required capital at a reasonable cost;

•

our ability to expand our business in our targeted markets;

•

our ability to cross-sell our product portfolio to existing customers;

•

the level of capital investment and expenditures by our customers in our strategic markets;

•

our financial performance;

•

our ability to identify, address and remediate any material weaknesses in our internal control over financial reporting; and

•

others risks and factors, listed in Item 1A. Risk Factors in Part I of this Form 10-K/A.

Any such forward-looking statements are not guarantees of future performance and actual results, developments and business decisions may differ materially from those envisaged by such forward-looking statements. These forward-looking statements speak only as of the date the Original Form 10-K was filed with the SEC. We do not assume any obligation and do not intend to update any forward-looking statement except as required by law. See Item IA. Risk Factors in Part I of this Form 10-K/A for a further discussion regarding some of the reasons that actual results may be materially different from those that we anticipate.

PART I

ITEM 1.

BUSINESS

General

Colfax Corporation is a global supplier of a broad range of fluid handling products, including pumps, fluid handling systems and controls, and specialty valves. We believe that we are a leading manufacturer of rotary positive displacement pumps, which include screw pumps, gear pumps and progressive cavity pumps. We design and engineer our products to high quality and reliability standards for use in critical fluid handling applications where performance is paramount. We also offer customized fluid handling solutions to meet individual customer needs based on our in-depth technical knowledge of the applications in which our products are used.

Our products are marketed principally under the Allweiler, Fairmount, Houttuin, Imo, LSC, Portland Valve, Tushaco, Warren and Zenith brand names. We believe that our brands are widely known and have a premium position in our industry. Allweiler, Houttuin, Imo and Warren are among the oldest and most recognized brands in the markets in which we participate, with Allweiler dating back to 1860. We have a global manufacturing footprint, with production facilities in Europe, North America and Asia, as well as worldwide sales and distribution channels.

We employ a comprehensive set of tools that we refer to as the Colfax Business System, or CBS. CBS is a disciplined strategic planning and execution methodology designed to achieve excellence and world-class financial performance in all aspects of our business by focusing on the Voice of the Customer and continuously improving quality, delivery and cost. Modeled on the Danaher Business System, CBS focuses on conducting root-cause analysis, developing process improvements and implementing sustainable systems. Our approach addresses the entire business, not just manufacturing operations.

We currently serve markets that have a need for highly engineered, critical fluid handling solutions and are global in scope. Our strategic markets include:

Strategic Markets		Applications
Commercial Marine		Fuel oil transfer; oil transport; water and wastewater handling; cargo handling

Oil and Gas		Crude oil gathering; pipeline services; unloading and loading; rotating equipment lubrication; lube oil purification

Power Generation		Fuel unloading, transfer, burner and injection; rotating equipment lubrication

Global Navy		Fuel oil transfer; oil transport; water and wastewater handling; firefighting; fluid control

General Industrial		Machinery lubrication; hydraulic elevators; chemical processing; pulp and paper processing; food and beverage processing; distribution

We serve a global customer base across multiple markets through a combination of direct sales and marketing associates and third-party distribution channels. Our customer base is highly diversified and includes commercial, industrial and government customers such as Alfa Laval Group, General Dynamics Corporation, General Electric Company, Northrup Grumman Corporation, Siemens AG, Rolls-Royce Group plc, the U.S. Navy and various sovereign navies around the world. Our business is not dependent on any single customer or a few customers. In 2009, no single customer represented more than 4% of sales.

Our business began with an initial investment by our founders in 1995 with the intention to acquire, manage and create a world-class industrial manufacturing company. We seek to acquire businesses with leading market positions and brands that exhibit strong cash flow generation potential. With our management expertise and the introduction of CBS into our acquired businesses, we pursue growth in revenues and improvements in operating margins.

Since our platform acquisitions of Imo and Allweiler in 1997 and 1998, respectively, we have completed additional acquisitions that have broadened our fluid handling product portfolio and geographic footprint. A summary of recent acquisition activity follows:

In June 2004, we acquired the net assets of Zenith, a leading manufacturer of precision metering pumps for the general industrial market.

In August 2004, we acquired the net assets of Portland Valve, a manufacturer of specialty valves used primarily for naval applications.

In August 2005, we acquired Tushaco, a leading manufacturer of rotary positive displacement pumps in India.

In January 2007, we acquired LSC, a manufacturer of fluid handling systems. LSC designs, manufactures, installs and maintains oil mist lubrication and oil purification systems in refineries, petrochemical plants and other processing facilities.

In November 2007, we acquired Fairmount, an original equipment manufacturer of mission critical programmable automation controllers in fluid handling applications primarily for the U.S. Navy.

In August 2009, we acquired PD-Technik, a provider of marine aftermarket related products and services.

In addition to our acquisitions, in 2005 we opened a greenfield production facility in Wuxi, China to manufacture and assemble complete products and systems for our customers in China and other Asian markets and to supply low cost components and parts for our existing operations.

Our Industry

Based on industry data supplied by The Freedonia Group and European Industrial Forecasting, we estimate the worldwide fluid handling market, which we define as industrial pumps, valves, and gaskets and seals, to have been $139 billion in 2008. Within this market, we primarily compete in the estimated $3 billion global rotary positive displacement pump market, a sub-section of the estimated $12 billion positive displacement pump market. We are also a competitor in the estimated $19 billion centrifugal pump market and the estimated $68 billion valve market.

We believe that there are over 10,000 companies competing in the worldwide fluid handling industry. The fluid handling industry’s customer base is broadly diversified across many sectors of the economy, and we believe customers place a premium on quality, reliability, availability, design and application engineering support. Because products in the fluid handling industry often are used as components in critical applications, we believe the most successful industry participants are those that have the technical capabilities to meet customer specifications, offer products with reputations for quality and reliability, and can provide timely delivery and strong aftermarket support.

Competitive Strengths

Strong Market Positions, Broad Product Portfolio and Leading Brands. We believe that we are a leading manufacturer of rotary positive displacement pumps, which include screw pumps, gear pumps and progressive cavity pumps. We offer a broad portfolio of fluid handling products that fulfill critical needs of customers across numerous industries. Our brands are among the oldest and most recognized in the markets in which we participate.

Strong Application Expertise. We believe that our reputation for quality and technical expertise positions us as a premium supplier of fluid handling products. With 150 years of experience, we have significant expertise in designing and manufacturing fluid handling products that are used in critical applications, such as lubricating power generation turbines, transporting crude oil through pipelines, and transferring heavy fuel oil in commercial marine vessels.

Extensive Global Sales, Distribution and Manufacturing Network. We sell our products through more than 300 direct sales and marketing associates and approximately 250 authorized distributors in more than 100 countries. We believe that our global reach within the highly fragmented, worldwide fluid handling industry provides us with an ability to better serve our customers. Our European, North American and Asian manufacturing capabilities provide us with the ability to optimize material sourcing, transportation and production costs and reduce foreign currency risk.

We Use CBS to Continuously Improve Our Business. CBS is our business system designed to encourage a culture of continuous improvement in all aspects of our operations and strategic planning. Modeled on the Danaher Business System, CBS focuses on conducting root-cause analysis, developing process improvements and implementing sustainable systems. Our approach addresses the entire business, not just manufacturing operations.

Large Installed Base Generating Aftermarket Sales and Service. With a history dating back to 1860, we have a significant installed base across numerous industries. Because of the critical applications in which our products are used and the high quality and reliability of our products, we believe there is a tendency to replace “like for like” products. This tendency leads to significant aftermarket demand for replacement products as well as for spare parts and service. In the year ended December 31, 2009, approximately 24% of our revenues were derived from aftermarket sales and services.

Broad and Diverse Customer Base. Our customer base spans numerous industries and is geographically diverse. Approximately 76% of our sales in 2009 were delivered to customers outside of the U.S. In addition, no single customer represented more than 4% of our sales during this period.

Management Team with Extensive Industry Experience and Focus on Strategic Development. We are led by a senior management team with an average of over 20 years of experience in industrial manufacturing. Since 1995, we have acquired 13 companies and divested businesses that do not fit within our long-term growth strategy. We believe that we have extensive experience in acquiring and effectively integrating attractive acquisition targets.

Growth Strategy

We intend to continue to increase our sales, expand our geographic reach, broaden our product offerings, and improve our profitability through the following strategies:

Apply CBS to Drive Profitable Sales Growth and Increase Shareholder Value. The core element of our management philosophy is CBS, which we implement in each of our businesses. CBS focuses our organization on continuous improvement and performance goals by empowering our associates to develop innovative strategies to meet customer needs. Rather than a static process, CBS continues to evolve as we benchmark ourselves against best-in-class industrial companies.

Beyond the traditional application of cost control, overhead rationalization, global process optimization, and implementation of lean manufacturing techniques, we utilize CBS to identify strategic opportunities to enhance future sales growth. The foremost principle of CBS is the Voice of the Customer, which drives our activities to continuously improve customer service, product quality, delivery and cost. The Voice of the Customer is instrumental in the development of new products, services and solutions by utilizing a formal interview process with the end users of our products to identify “pain points” or customer needs. By engaging end users in the discussion, rather than solely relying on salespeople or channel partners for anecdotal input, we see the real issues and opportunities. We then prioritize these opportunities with the intention of implementing novel or breakthrough ideas that uniquely solve end-user needs. As we continue to apply the methodology of CBS to our existing businesses as well as to future acquisitions, we believe that we will be able to continue to introduce innovative new products and solutions, improve operating margins and increase the asset utilization of our businesses. As a result, we believe we can create profitable sales growth, generate excess cash flow to fund future acquisitions and increase shareholder value.

Execute Market Focused Strategies. We have aligned our marketing and sales organization into market focused teams designed to coordinate global activity around five strategic markets: commercial marine, oil and gas, power generation, global navy and general industrial. These markets have a need for highly engineered, critical fluid handling solutions and are attractive due to their ongoing capital expenditure requirements, long term growth rates and global nature. We intend to continue to use our application expertise, highly engineered and specialized products, broad product portfolio and recognized product brands to generate high margin incremental revenue.

Commercial Marine— We provide complete fluid handling packages to shipbuilders throughout the world primarily for use in engine room applications. Our products are widely recognized for their superior reliability and lower total cost of ownership. The increased rate of commercial marine vessel construction in recent years has expanded our installed base of fluid handling products and has generated increased aftermarket revenues. In addition to supplying our products for new vessels, we intend to continue to grow our aftermarket sales and services by optimizing our channels to improve market coverage. We are also addressing changing environmental requirements with our products. We also intend to continue to expand our global reach by utilizing our Chinese operations to offer locally manufactured products, to reduce production costs and to provide local customer service and support for the Asia Pacific region, an area where the majority of the commercial marine vessels are constructed.

Oil and Gas— We provide a broad portfolio of fluid handling products for many oil and gas applications around the world. In particular, we have a strong presence in oil field tank farms, pipelines and refineries and also in Floating Production Storage and Offloading (FPSO) installations. We intend to continue to execute our strategy in the global crude oil transport market by targeting applications where our products can replace less efficient fluid handling alternatives. We also intend to leverage our position as a leading supplier of 2-screw pumps by developing complex turnkey systems to capture the growing need for fluid handling solutions that can undertake the difficult task of handling varying mixtures of heavy crude oil, natural gas and water at the same time. Additionally, we expect to continue to extend LSC’s presence within the refinery market through increased market coverage and intend to broaden LSC’s core lubrication offerings for new applications. We are also adding resources to the growing oil and gas markets around the world, including Asia, the Middle East and developing nations.

Power Generation— We provide fluid handling products used in critical lubrication and fuel injection services for fossil fuel, hydro and nuclear power plants around the world. We believe that we have in-depth knowledge of fuel injection and lubrication applications, strong product brand names and a reputation for reliability in the power generation industry. Within this market we intend to continue our growth as a provider of turnkey systems by utilizing our expertise in power generation applications to develop innovative solutions. We also plan to continue to leverage our global presence to strengthen our relationships with large original equipment manufacturers of power generation equipment to establish us as a critical supplier.

Global Navy— For over 90 years we have supplied our specialty centrifugal and screw pumps to sovereign navies around the world, including the U.S. Navy and most of the major navies in Europe. With the acquisitions of Portland Valve and Fairmount, we have broadened our offering to include specialty valves and advanced control systems, respectively. We intend to continue to design, manufacture and sell high value fluid handling systems in order to meet the evolving requirements and standards of the navies around the world. Our engineers are also working with the U.S. Navy to incorporate electronics and advanced control algorithms into our products. We are also focused on expanding our repair and service capabilities as work is outsourced to private shipyards. As part of this strategy, we have established a waterfront repair and service facility in San Diego, California to complement our Portland, Maine facility in order to provide more responsive aftermarket support to the U.S. Navy.

General Industrial— We provide fluid handling solutions for a broad array of general industrial applications, including machinery lubrication, commercial construction, chemical processing, pulp and paper processing and food and beverage processing, among others. We intend to continue to apply our application and engineering expertise to supply our customers with a portfolio of products that can solve their most critical fluid handling needs. We also intend to continue to expand our presence in the general industrial market by targeting new applications for our existing products, deploying regionally focused strategies and leveraging our global presence and sales channels to sell our solutions worldwide.

Target Faster Growing Regions by Leveraging Our Global Manufacturing, Sales and Distribution Network. We intend to continue to leverage our strong global presence and worldwide network of distributors to capitalize on growth opportunities by selling regionally developed and marketed products and solutions throughout the world. As our customers have become increasingly global in scope, we have likewise increased our global reach to serve our customers by maintaining a local presence in numerous markets and investing in sales, marketing and manufacturing capabilities globally.

To further enhance our focus on serving our customers, we have developed and are in the process of implementing the Colfax Sales Office (“CSO”), a web-based selection, configuration, quotation, order entry and aftermarket tool to streamline the quote-to-order process. We believe that CSO, when fully installed, will significantly increase the speed of supplying quotes to our customers and will reduce our selling costs and increase our manufacturing efficiency. This is expected to be accomplished by eliminating many manual front-end processes and establishing an integrated, automated platform across brands to capture sales that otherwise would be lost due to increased response times.

Develop New Products, Applications and Technologies. We will continue to engineer our key products to meet the needs of new and existing customers and also to improve our existing product offerings to strengthen our market position. We plan to continue to develop technological, or “SMART,” solutions, which incorporate advanced electronics, sensors and controls, through the use of our Voice of the Customer process to solve specific customer needs. We believe our SMART solutions will reduce our customers’ total cost of ownership by providing real-time diagnostic capabilities to minimize downtime, increase operational efficiency and avoid unnecessary costs. We also intend to leverage Fairmount’s portfolio of advanced controls into our broader industrial offerings to develop innovative SMART fluid handling solutions.

To further align our product innovation efforts across our operations, we have established a global engineering center of excellence located at our office in Mumbai, India, which collaborates with our global operations to design new products, modify existing solutions, identify opportunities to reduce manufacturing costs and increase the efficiency of our existing product lines. We believe that we will be able to reallocate select engineering functions to our engineering centers, thereby freeing resources to spend time on higher value work.

Grow Our Offerings of Systems and Solutions. We will continue to provide high value added fluid handling solutions by utilizing our engineering and application expertise and our brand recognition and sales channels to drive incremental revenue. We intend to establish regional system manufacturing capabilities to address our customers’ desire to purchase turnkey modules and their preference for outsourced assembly.

Continue to Pursue Strategic Acquisitions that Complement our Platform. We believe that the fragmented nature of the fluid handling industry presents substantial consolidation and growth opportunities for companies with access to capital and the management expertise to execute a disciplined acquisition and integration program. We have successfully applied this strategy since our inception and plan to continue to seek companies that:

enhance our position in our strategic markets;

have recognized, leading brands and strong industry positions;

present opportunities to expand our product lines and services;

have a reputation for high quality products;

will broaden our global manufacturing footprint;

complement or augment our existing worldwide sales and distribution networks; or

present opportunities to provide operational synergies and improve the combined business operations by implementing CBS.

We believe that we can identify attractive acquisition candidates in the future and that strategic acquisition growth will give us the opportunity to gain a competitive advantage relative to smaller operators through greater purchasing power, a larger international sales and distribution network, and a broader portfolio of products and services.

Products

We design, manufacture and distribute fluid handling products that transfer or control liquids in a variety of applications. We also sell replacement parts and perform repair services for our manufactured products.

Our primary products, brands and their end uses include:

Fluid Handling Products	Primary Brands	Primary End Uses
Pumps	Allweiler, Houttuin, Imo, Warren, Tushaco and Zenith	Commercial marine, oil and gas, machinery lubrication, power generation, global navy and commercial construction

Fluid Handling Systems	Allweiler, Fairmount, Houttuin, Imo, LSC and Warren	Commercial marine, oil and gas, power generation and global navy

Specialty Valves	Portland Valve	Global navy

Pumps

Rotary Positive Displacement Pumps —We believe that we are a leading manufacturer of rotary positive displacement pumps with a broad product portfolio and globally recognized brands. Rotary positive displacement pumps consist of a casing containing screws, gears, vanes or similar components that are actuated by the relative rotation of that component to the casing, which results in the physical movement of the liquid from the inlet to the discharge at a constant rate. Positive displacement pumps generally offer precise, quiet and highly efficient transport of viscous fluids. The U.S. Hydraulic Institute accredits 11 basic types of rotary positive displacement pumps, of which we manufacture five (3-screw, 2-screw, progressive cavity, gear and peristaltic).

Specialty Centrifugal Pumps— Centrifugal pumps use the kinetic energy imparted by rotating an impeller inside a configured casing to create pressure. While traditionally used to transport large quantities of thin liquids, our centrifugal pumps use specialty designs and materials to offer customers high quality, reliability and customized solutions for a wide range of viscosities, temperatures and applications. We position our specialty centrifugal pumps for applications where customers clearly recognize our brand value or in markets where centrifugal and rotary pumps are complimentary.

Fluid Handling Systems

We manufacture complete fluid handling systems used primarily in the oil and gas, power generation, commercial marine and global navy markets. We offer turnkey systems and support, including design, manufacture, installation, commission and service. Our systems include:

oil mist lubrication systems, which are used in rotating equipment in oil refineries and other process industries;

custom designed packages used in crude oil pipeline applications;

lubrication and fuel forwarding systems used in power generation turbines;

complete packages for commercial marine engine rooms; and

fire suppression systems for navy applications.

Specialty Valves

Our specialty valves are used primarily in naval applications. Our valve business has specialized machining, welding and fabrication capabilities that enable it to serve as a supplier to the U.S. Navy. In addition to designing and manufacturing valves, we also offer repair and retrofit services for products manufactured by other valve suppliers through our aftermarket support centers located in Portland, Maine and San Diego, California.

Manufacturing

We manufacture and assemble our products at 14 locations in Europe, North America and Asia. This global manufacturing reach enables us to serve our customers wherever they choose to do business. Each of our manufacturing sites offers machining, fabrication and assembly capabilities that gives us the flexibility to source some of our products from multiple facilities. We believe that this flexibility enables us to minimize the impact of a manufacturing disruption if one of our facilities was to be damaged as a result of a natural disaster or otherwise. Our manufacturing facilities also benefit from the use of shared technology and collaboration across production lines, enabling us to increase operational efficiencies through the use of common suppliers and the duplication of production processes.

Competition

Our products and services are marketed on a worldwide basis. We believe that the principal elements of competition in our markets are:

the ability to meet customer specifications;

application expertise and design and engineering capabilities;

product quality and brand name;

timeliness of delivery;

price; and

quality of aftermarket sales and support.

The markets we serve are highly fragmented and competitive. Because we compete in selected niches of the fluid handling industry, there is not any single company that competes directly with us across all of our markets. As a result, we have many different competitors in each of our strategic markets. In the commercial marine market, we compete primarily with Naniwa Pump Manufacturing Co., Ltd., Shinko Industries, Ltd., Shin Shin Machinery Group Co., Ltd. and Taiko Kikai Industries Co., Ltd. In the oil and gas market, we compete primarily with Joh. Heinr. Bornemann GmbH and Leistritz Pumpen GmbH. In the power generation market, we compete primarily with Buffalo Pumps, a subsidiary of Ampco-Pittsburgh Corporation. In the global navy market, we compete primarily with Buffalo Pumps, Carver Pump Company, Curtiss-Wright Corporation and Tyco International, Inc.

Research and Development

We closely integrate research and development with marketing, manufacturing and product engineering in meeting the needs of our customers. Our business product engineering teams are continuously enhancing our existing products and developing new product applications for our growing base of customers that require custom solutions. We believe these capabilities provide a significant competitive advantage in the development of high quality fluid handling systems. Our product engineering teams focus on:

lowering the cost of manufacturing our existing products;

redesigning existing product lines to increase their efficiency or enhance their performance; and

developing new product applications.

Expenditures for research and development for the years ended December 31, 2009, 2008 and 2007 were $5.9 million, $5.9 million and $4.2 million, respectively.

Intellectual Property

We rely on a combination of intellectual property rights, including patents, trademarks, copyrights, trade secrets and contractual provisions to protect our intellectual property. Although we highlight recent additions to our patent portfolio as part of our marketing efforts, we do not consider any one patent or trademark or any group thereof essential to our business as a whole or to any of our business operations. We also rely on proprietary product knowledge and manufacturing processes in our operations.

International Operations

Our products and services are available worldwide. We believe this geographic diversity allows us to draw on the skills of a worldwide workforce, provides stability to our operations, allows us to drive economies of scale, provides revenue streams that may offset economic trends in individual economies, and offers us an opportunity to access new markets for products. In addition, we believe that future growth is dependent in part on our ability to develop products and sales models that target developing countries. Our principal markets outside the United States are in Europe, Asia, the Middle East and South America.

The manner in which our products and services are sold differs by region. Most of our sales in non-U.S. markets are made by subsidiaries located outside the United States, though we also sell into non-U.S. markets through various representatives and distributors and directly from the U.S. In countries with low sales volumes, we generally sell through representatives and distributors.

Financial information about our international operations is contained in Note 18 of the Consolidated Financial Statements included in Item 8. Financial Statements and Supplementary Data, and information about the possible effects of foreign currency fluctuations on our business is set forth in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. For a discussion of risks related to our non-U.S. operations and foreign currency exchange, please refer to Item 1A. Risk Factors.

Raw Materials and Backlog

We obtain raw materials, component parts and supplies from a variety of sources, generally each from more than one supplier. Our principal raw materials are metals, castings, motors, seals and bearings. Our suppliers and sources of raw materials are based in both the United States and other countries, and we believe that our sources of raw materials are adequate for our needs for the foreseeable future. We believe that the loss of any one supplier would not have a material adverse effect on our business or results of operations.

Manufacturing turnaround time is generally sufficiently short to allow us to manufacture to order for most of our products, which helps to limit inventory levels. Backlog generally is a function of requested customer delivery dates and may range from days to several years based on the actual requested delivery dates. Backlog of orders as of December 31, 2009 was $290.9 million, compared with $349.0 million as of December 31, 2008. We expect to ship approximately 70% of our December 31, 2009 backlog during 2010; however, orders are subject to postponement or cancellation.

Seasonality

Our fluid handling business is seasonal. As our customers seek to fully utilize capital spending budgets before the end of the year, historically our shipments have peaked during the fourth quarter; however, the global economic downturn has disrupted this pattern. Also, our European operations typically experience a slowdown during the July and August holiday season.

Working Capital

We maintain an adequate level of working capital to support our business needs. There are no unusual industry practices or requirements related to working capital items.

Associates

The following table presents our worldwide associate base as of the periods indicated:

	December 31,
	2009		2008		2007
United States		598		739		701
Europe		1,189		1,276		1,219
Asia		254		299		262
Total		2,041		2,314		2,182

There are 42 associates in the United States covered by a collective bargaining agreement with the International Union of Electronic, Electrical, Salaried, Machine and Furniture Workers-Communications Workers of America (IUE-CWA). The contract with the union expires December 4, 2011 and provides for wage increases ranging from 3.5% to a maximum of 3.8% per year. In addition, approximately 48% of our associates are represented by foreign trade unions, by law, in Germany, Sweden and the Netherlands, which subjects us to arrangements very similar to collective bargaining agreements. We have not experienced any work stoppages or strikes that have had a material adverse impact on operations. We consider our relations with our associates to be good.

Government Contracts

Sales to U.S. government defense agencies and government contractors constituted approximately 4% of our revenue in 2009. We are subject to business and cost accounting regulations associated with our U.S. government defense contracts. Violations can result in civil, criminal or administrative proceedings involving fines, compensatory and treble damages, restitution, forfeitures, and suspension or debarment from U.S. government defense contracts.

Company Information and Access to SEC Reports

We were organized as a Delaware corporation in 1998. Our principal executive offices are located at 8730 Stony Point Parkway, Suite 150, Richmond, Virginia 23235, and our main telephone number at that address is (804) 560-4070. Our corporate website address is www.colfaxcorp.com.

We make available, free of charge through our website, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports as soon as practicable after filing or furnishing the material to the SEC. You may also request a copy of these filings, at no cost, by writing or telephoning us at: Investor Relations, Colfax Corporation, 8730 Stony Point Parkway, Suite 150, Richmond, VA 23235, telephone (804) 560-4070. Information contained on our website is not incorporated by reference in this report.

ITEM 1A.

RISK FACTORS

An investment in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with the information included elsewhere in this Annual Report on Form 10-K/A and other documents we file with the SEC. If any of the following risks actually occur, our business, financial condition or operating results could suffer. As a result, the trading price of our common stock could decline and you could lose all or part of your investment in our common stock. The risks and uncertainties described below are those that we have identified as material, but are not the only risks and uncertainties facing us and we caution that this list of risk factors may not be exhaustive. Our business is also subject to general risks and uncertainties that affect many other companies, such as overall U.S. and non-U.S. economic and industry conditions, a global economic slowdown, geopolitical events, changes in laws or accounting rules, fluctuations in interest rates, terrorism, international conflicts, natural disasters or other disruptions of expected economic or business conditions. We operate in a continually changing business environment, and new risk factors emerge from time to time which we cannot predict. Additional risks and uncertainties not currently known to us or that we currently believe are immaterial also may impair our business, including our results of operations, liquidity and financial condition.

Risks Related to Our Business

Changes in the general economy, including the current global economic downturn, and the cyclical nature of our markets could harm our operations and financial performance.

Our financial performance depends, in large part, on conditions in the markets we serve and on the general condition of the global economy. Any sustained weakness in demand, downturn or uncertainty in the global economy could continue to reduce our sales and profitability, and result in restructuring efforts. Restructuring efforts are inherently risky and we may not be able to predict the cost and timing of such actions accurately or properly estimate the impact on demand, if any. We also may not be able to realize the anticipated savings we expected from restructuring activities. The current global economic downturn may continue to materially affect demand for our products and we may not be able to predict the effect on our results. In addition, our products are sold in many industries, some of which are cyclical and may experience periodic downturns. Cyclical weakness in the industries we serve could lead to reduced demand for our products and affect our profitability and financial performance.

We believe that many of our customers and suppliers are reliant on liquidity from global credit markets and in some cases, require external financing to purchase products or finance operations. If the current conditions impacting the credit markets and general economy continue, demand for our products may continue to be negatively affected and orders may be canceled or delayed, which could materially impact our financial position, results of operations and cash flow. Further, lack of liquidity by our customers could impact our ability to collect amounts owed to us and lack of liquidity by financial institutions could impact our ability to fully access our existing credit facility.

The majority of our sales are derived from international operations. We are subject to specific risks associated with international operations.

In the year ended December 31, 2009, we derived approximately 66% of our sales from operations outside of the U.S. and have manufacturing facilities in seven countries. Sales from international operations, export sales and the use of manufacturing facilities outside of the U.S. are subject to risks inherent in doing business outside the U.S. These risks include:

	Ÿ	economic instability;

partial or total expropriation of our international assets;

trade protection measures, including tariffs or import-export restrictions;

	Ÿ	currency exchange rate fluctuations and restrictions on currency repatriation;

significant adverse changes in taxation policies or other laws or regulations; and

the disruption of operations from political disturbances, terrorist activities, insurrection or war.

Significant movements in foreign currency exchange rates may harm our financial results.

We are exposed to fluctuations in currency exchange rates. In the year ended December 31, 2009, approximately 66% of our sales were derived from operations outside the U.S. A significant portion of our revenues and income are denominated in Euros, Swedish Kronor and Norwegian Kroner. Consequently, depreciation of the Euro, Krona or Krone against the U.S. dollar has a negative impact on the income from operations of our European operations. Large fluctuations in the rate of exchange between the Euro, the Krona, the Krone and the U.S. dollar could have a material adverse effect on our results of operations and financial condition.

In addition, we do not engage to a material extent in hedging activities intended to offset the risk of exchange rate fluctuations. Any significant change in the value of the currencies of the countries in which we do business against the U.S. dollar could affect our ability to sell products competitively and control our cost structure, which, in turn, could adversely affect our results of operations and financial condition.

We are dependent on the availability of raw materials, as well as parts and components used in our products.

While we manufacture many of the parts and components used in our products, we require substantial amounts of raw materials and purchase parts and components from suppliers. The availability and prices for raw materials, parts and components may be subject to curtailment or change due to, among other things, suppliers’ allocations to other purchasers, interruptions in production by suppliers, changes in exchange rates and prevailing price levels. Any significant change in the supply of, or price for, these raw materials or parts and components could materially affect our business, financial condition, results of operations and cash flow. In addition, delays in delivery of components or raw materials by our suppliers could cause delays in our delivery of products to our customers.

The markets we serve are highly competitive and some of our competitors may have resources superior to ours. Responding to this competition could reduce our sales and operating margins.

We sell most of our products in highly fragmented and competitive markets. We believe that the principal elements of competition in our markets are:

	Ÿ	the ability to meet customer specifications;

	Ÿ	application expertise and design and engineering capabilities;

	Ÿ	product quality and brand name;

	Ÿ	timeliness of delivery;

	Ÿ	price; and

quality of aftermarket sales and support.

In order to maintain and enhance our competitive position, we intend to continue our investment in manufacturing quality, marketing, customer service and support, and distribution networks. We may not have sufficient resources to continue to make these investments and we may not be able to maintain our competitive position. Our competitors may develop products that are superior to our products, develop methods of more efficiently and effectively providing products and services, or adapt more quickly than we do to new technologies or evolving customer requirements. Some of our competitors may have greater financial, marketing and research and development resources than we have. As a result, those competitors may be better able to withstand the effects of periodic economic downturns. In addition, pricing pressures could cause us to lower the prices of some of our products to stay competitive. We may not be able to compete successfully with our existing competitors or with new competitors. If we fail to compete successfully, the failure would have a material adverse effect on our business and results of operations.

Acquisitions have formed a significant part of our growth strategy in the past and are expected to continue to do so. If we are unable to identify suitable acquisition candidates or successfully integrate the businesses we acquire or realize the intended benefits, our growth strategy may not succeed. Acquisitions involve numerous risks, including risks related to integration and undisclosed or underestimated liabilities.

Historically, our business strategy has relied on acquisitions. We expect to derive a significant portion of our growth by acquiring businesses and integrating those businesses into our existing operations. We intend to seek acquisition opportunities both to expand into new markets and to enhance our position in our existing markets. However, our ability to do so will depend on a number of steps, including our ability to:

	Ÿ	identify suitable acquisition candidates;

	Ÿ	negotiate appropriate acquisition terms;

	Ÿ	obtain debt or equity financing that we may need to complete proposed acquisitions;

	Ÿ	complete the proposed acquisitions; and

integrate the acquired business into our existing operations.

If we fail to achieve any of these steps, our growth strategy may not be successful.

In addition, acquisitions involve numerous risks, including difficulties in the assimilation of the operations, technologies, services and products of the acquired company, the potential loss of key employees of the acquired company and the diversion of our management’s attention from other business concerns. This is the case particularly in the fiscal quarters immediately following the completion of an acquisition because the operations of the acquired business are integrated into the acquiring businesses’ operations during this period. We cannot be sure that we will accurately anticipate all of the changing demands that any future acquisition may impose on our management, our operational and management information systems and our financial systems.

Once integrated, acquired operations may not achieve levels of revenue, profitability or productivity comparable with those that our existing operations achieve, or may otherwise not perform as we expected.

We may underestimate or fail to discover liabilities relating to a future acquisition during the due diligence investigation and we, as the successor owner, might be responsible for those liabilities. For example, two of our acquired subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured with components that are alleged to have contained asbestos. Although our due diligence investigations in connection with these acquisitions uncovered the existence of potential asbestos-related liabilities, the scope of such liabilities were greater than we had originally estimated. Although we seek to minimize the impact of underestimated or potential undiscovered liabilities by structuring acquisitions to minimize liabilities and obtaining indemnities and warranties from the selling party, these methods may not fully protect us from the impact of undiscovered liabilities. Indemnities or warranties are often limited in scope, amount or duration, and may not fully cover the liabilities for which they were intended. The liabilities that are not covered by the limited indemnities or warranties could have a material adverse effect on our business and financial condition.

We may require additional capital to finance our operating needs and to finance our growth. If the terms on which the additional capital is available are unsatisfactory, if the additional capital is not available at all or we are not able to fully access our existing credit facility, we may not be able to pursue our growth strategy.

Our growth strategy will require additional capital investment to complete acquisitions, integrate the completed acquisitions into our existing operations, and to expand into new markets.

We intend to pay for future acquisitions using a combination of cash, capital stock, notes and assumption of indebtedness. To the extent that we do not generate sufficient cash internally to provide the capital we require to fund our growth strategy and future operations, we will require additional debt or equity financing. We cannot be sure that this additional financing will be available or, if available, will be on terms acceptable to us. Further, high volatility in the equity markets and in our stock price may make it difficult for us to access the equity markets for additional capital at attractive prices, if at all. If we are unable to obtain sufficient additional capital in the future, it will limit our ability to implement our business strategy. Continued issues resulting from the current global economic downturn involving liquidity and capital adequacy affecting lenders could affect our ability to fully access our existing credit facilities. In addition, even if future debt financing is available, it may result in (1) increased interest expense, (2) increased term loan payments, (3) increased leverage, and (4) decreased income available to fund further acquisitions and expansion. It may also limit our ability to withstand competitive pressures and make us more vulnerable to economic downturns. If future equity financing is available, it may dilute the equity interests of our existing stockholders.

In addition, our credit facility agreement includes restrictive covenants which could limit our financial flexibility. If we do not maintain compliance with these covenants, our creditors could declare a default. Our ability to comply with the provisions of our indebtedness may be affected by changes in economic or business conditions beyond our control.

A material disruption at any of our manufacturing facilities could adversely affect our ability to generate sales and meet customer demand.

If operations at our manufacturing facilities were to be disrupted as a result of significant equipment failures, natural disasters, power outages, fires, explosions, terrorism, adverse weather conditions, labor disputes or other reasons, our financial performance could be adversely affected as a result of our inability to meet customer demand for our products. Interruptions in production could increase our costs and reduce our sales. Any interruption in production capability could require us to make substantial capital expenditures to remedy the situation, which could negatively affect our profitability and financial condition. We maintain property damage insurance which we believe to be adequate to provide for reconstruction of facilities and equipment, as well as business interruption insurance to mitigate losses resulting from any production interruption or shutdown caused by an insured loss. However, any recovery under our insurance policies may not offset the lost sales or increased costs that may be experienced during the disruption of operations, which could adversely affect our financial performance.

The loss of key management could have a material adverse effect on our ability to run our business.

We may be adversely affected if we lose members of our senior management. We are highly dependent on our senior management team as a result of their extensive experience. The loss of key management or the inability to attract, retain and motivate sufficient numbers of qualified management personnel could have a material adverse effect on us and our business.

Available insurance coverage, the number of future asbestos-related claims and the average settlement value of current and future asbestos-related claims of two of our subsidiaries could be different than we have estimated, which could materially and adversely affect our financial condition, results of operations and cash flow.

Two of our subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers and were not manufactured by any of our subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. For purposes of our financial statements, we have estimated the future claims exposure and the amount of insurance available based upon certain assumptions with respect to future claims and liability costs. We estimate the liability costs to be incurred in resolving pending and forecasted claims for the next 15-year period.

Our decision to use a 15-year period is based on our belief that this is the extent of our ability to forecast liability costs. We also estimate the amount of insurance proceeds available for such claims based on the current financial strength of the various insurers, our estimate of the likelihood of payment and applicable current law. We reevaluate these estimates regularly. Although we believe our current estimates are reasonable, a change in the time period used for forecasting our liability costs, the actual number of future claims brought against us, the cost of resolving these claims, the likelihood of payment by, and the solvency of, insurers and the amount of remaining insurance available could be substantially different than our estimates, and future revaluation of our liabilities and insurance recoverables could result in material adjustments to these estimates, any of which could materially and adversely affect our financial condition, results of operations and cash flow. In addition, the company incurs defense costs related to those claims, a portion of which has historically been reimbursed by our insurers. We also incur litigation costs in connection with actions against certain of the subsidiaries’ insurers relating to insurance coverage. While these costs may be significant, we may not be able to predict the amount or duration of such costs. Additionally, we may experience delays in receiving reimbursement from insurers, during which time we may be required to pay cash for settlement or legal defense costs. Any increase in the actual number of future claims brought against us, the defense costs of resolving these claims, the cost of pursuing claims against our insurers, the likelihood and timing of payment by, and the solvency of, insurers and the amount of remaining insurance available, could materially and adversely affect our financial condition, results of operations and cash flow.

Our international operations are subject to the laws and regulations of the United States and many foreign countries. Failure to comply with these laws may affect our ability to conduct business in certain countries and may affect our financial performance.

We are subject to a variety of laws regarding our international operations, including the Foreign Corrupt Practices Act and regulations issued by U.S. Customs and Border Protection, the Bureau of Industry and Security, and the regulations of various foreign governmental agencies. We cannot predict the nature, scope or effect of future regulatory requirements to which our international sales and manufacturing operations might be subject or the manner in which existing laws might be administered or interpreted. Future regulations could limit the countries in which some of our products may be manufactured or sold, or could restrict our access to, and increase the cost of obtaining, products from foreign sources. In addition, actual or alleged violations of these laws could result in enforcement actions and financial penalties that could result in substantial costs.

Our foreign subsidiaries have done and may continue to do business in countries subject to U.S. sanctions and embargoes, including Iran and Syria, and we have limited managerial oversight over those activities. Failure to comply with these sanctions and embargoes may result in enforcement or other regulatory actions.

From time to time, certain of our foreign subsidiaries sell products to companies and entities located in, or controlled by the governments of, certain countries that are or have previously been subject to sanctions and embargoes imposed by the U.S. government and/or the United Nations, such as Iran and Syria. With the exception of the U.S. sanctions against Cuba, the applicable sanctions and embargoes generally do not prohibit our foreign subsidiaries from selling non-U.S.-origin products and services in those countries. However, Colfax Corporation, its U.S. personnel and its domestic subsidiaries, as well as employees of our foreign subsidiaries who are U.S. citizens, are prohibited from participating in, approving or otherwise facilitating any aspect of the business activities in those countries. These constraints may negatively affect the financial or operating performance of such business activities. We cannot be certain that our attempts to comply with U.S. sanction laws and embargoes will be effective, and as a consequence we may face enforcement or other actions if our compliance efforts are not effective. Actual or alleged violations of these laws could result in substantial fines or other sanctions which could result in substantial costs. In addition, Iran and Syria currently are identified by the State Department as state sponsors of terrorism, and may be subject to increasingly restrictive sanctions. Because certain of our foreign subsidiaries have contact with and transact business in such countries, including sales to enterprises controlled by agencies of the governments of such countries, our reputation may suffer due to our association with these countries, which may have a material adverse effect on the price of our common stock. Further, certain U.S. states and municipalities have recently enacted legislation regarding investments by pension funds and other retirement systems in companies that have business activities or contacts with countries that have been identified as state sponsors of terrorism and similar legislation may be pending in other states. As a result, pension funds and other retirement systems may be subject to reporting requirements with respect to investments in companies such as ours or may be subject to limits or prohibitions with respect to those investments that may have a material adverse effect on the price of our shares.

In addition, one of our foreign subsidiaries made a small number of sales from 2003 through 2007 totaling approximately $60,000 in the aggregate to two customers in Cuba which may have been made in violation of regulations of the U.S. Treasury Department’s Office of Foreign Assets Control, or OFAC. Cuba is also identified by the U.S. State Department as a state sponsor of terrorism. We have submitted a disclosure report to OFAC regarding these transactions. On December 5, 2008, the Company executed a tolling agreement with the OFAC extending the statute of limitations for the investigation until May 1, 2010. As a result of these sales, we may be subject to fines or other sanctions.

If we fail to comply with export control regulations, we could be subject to substantial fines or other sanctions.

Some of our products manufactured or assembled in the United States are subject to the U.S. Export Administration Regulations, administered by the U.S. Department of Commerce, Bureau of Industry and Security, which require that we obtain an export license before we can export such products to specified countries. Additionally, some of our products are subject to the International Traffic in Arms Regulations, which restrict the export of certain military or intelligence-related items, technologies and services to non-U.S. persons. Failure to comply with these laws could harm our business by subjecting us to sanctions by the U.S. government, including substantial monetary penalties, denial of export privileges and debarment from U.S. government contracts.

Approximately 48% of our employees are represented by foreign trade unions. If the representation committees responsible for negotiating with these unions on our behalf are unsuccessful in negotiating new and acceptable agreements when the existing agreements with our employees covered by the unions expire or if the foreign trade unions chose not to support our restructuring programs, we could experience business disruptions or increased costs.

As of December 31, 2009, we had 1,365 employees in foreign locations. In certain countries, labor and employment laws are more restrictive than in the U.S. and, in many cases, grant significant job protection to employees, including rights on termination of employment. In Germany, Sweden and the Netherlands, by law, some of our employees are represented by trade unions in these jurisdictions, which subjects us to employment arrangements very similar to collective bargaining agreements. If our employees represented by foreign trade unions were to engage in a strike, work stoppage or other slowdown in the future, we could experience a significant disruption of our operations. Such disruption could interfere with our business operations and could lead to decreased productivity, increased labor costs and lost revenue.

Although we have not experienced any material recent strikes or work stoppages, we cannot offer any assurance that the representation committees that negotiate with the foreign trade unions on our behalf will be successful in negotiating new collective bargaining agreements or other employment arrangements when the current ones expire. Furthermore, future labor negotiations could result in significant increases in our labor costs.

Our manufacturing business is subject to the possibility of product liability lawsuits, which could harm our business.

In addition to the asbestos-related liability claims described above, as the manufacturer of equipment for use in industrial markets, we face an inherent risk of exposure to other product liability claims. Although we maintain quality controls and procedures, we cannot be sure that our products will be free from defects. In addition, some of our products contain components manufactured by third parties, which may also have defects. We maintain insurance coverage for product liability claims. Our insurance policies have limits, however, that may not be sufficient to cover claims made against us. In addition, this insurance may not continue to be available to us at a reasonable cost. With respect to components manufactured by third-party suppliers, the contractual indemnification that we seek from our third-party suppliers may be limited and thus insufficient to cover claims made against us. If our insurance coverage or contractual indemnification is insufficient to satisfy product liability claims made against us, the claims could have an adverse effect on our business and financial condition. Even claims without merit could harm our reputation, reduce demand for our products, cause us to incur substantial legal costs and distract the attention of our management.

As a manufacturer, we are subject to a variety of environmental and health and safety laws for which compliance could be costly. In addition, if we fail to comply with such laws, we could incur liability that could result in penalties and costs to correct any non-compliance.

Our business is subject to international, federal, state and local environmental and safety laws and regulations, including laws and regulations governing emissions of: regulated air pollutants; discharges of wastewater and storm water; storage and handling of raw materials; generation, storage, transportation and disposal of regulated wastes; and worker safety. These requirements impose on our business certain responsibilities, including the obligation to obtain and maintain various environmental permits. If we were to fail to comply with these requirements or fail to obtain or maintain a required permit, we could be subject to penalties and be required to undertake corrective action measures to achieve compliance. In addition, if our noncompliance with such regulations were to result in a release of hazardous materials to the environment, such as soil or groundwater, we could be required to remediate such contamination, which could be costly. Moreover, noncompliance could subject us to private claims for property damage or personal injury based on exposure to hazardous materials or unsafe working conditions. Changes in applicable requirements or stricter interpretation of existing requirements may result in costly compliance requirements or otherwise subject us to future liabilities.

As the present or former owner or operator of real property, or generator of waste, we could become subject to liability for environmental contamination, regardless of whether we caused such contamination.

Under various federal, state and local laws, regulations and ordinances, and, in some instances, international laws, relating to the protection of the environment, a current or former owner or operator of real property may be liable for the cost to remove or remediate contamination on, under, or released from such property and for any damage to natural resources resulting from such contamination. Similarly, a generator of waste can be held responsible for contamination resulting from the treatment or disposal of such waste at any off-site location (such as a landfill), regardless of whether the generator arranged for the treatment or disposal of the waste in compliance with applicable laws. Costs associated with liability for removal or remediation of contamination or damage to natural resources could be substantial and liability under these laws may attach without regard to whether the responsible party knew of, or was responsible for, the presence of the contaminants. In addition, the liability may be joint and several. Moreover, the presence of contamination or the failure to remediate contamination at our properties, or properties for which we are deemed responsible, may expose us to liability for property damage or personal injury, or materially adversely affect our ability to sell our real property interests or to borrow using the real property as collateral. We cannot be sure that we will not be subject to environmental liabilities in the future as a result of historic or current operations that have resulted or will result in contamination.

Failure to maintain and protect our trademarks, trade names and technology may affect our operations and financial performance.

The market for many of our products is, in part, dependent upon the goodwill engendered by our trademarks and trade names. Trademark protection is therefore material to a portion of our business. The failure to protect our trademarks and trade names may have a material adverse effect on our business, financial condition and operating results. Litigation may be required to enforce our intellectual property rights, protect our trade secrets or determine the validity and scope of proprietary rights of others. Any action we take to protect our intellectual property rights could be costly and could absorb significant management time and attention. As a result of any such litigation, we could lose any proprietary rights we have. In addition, it is possible that others will independently develop technology that will compete with our patented or unpatented technology. The development of new technologies by competitors that may compete with our technologies could reduce demand for our products and affect our financial performance.

Some of our stockholders may exert significant influence over us.

Currently, two of our stockholders, Mitchell P. Rales and Steven M. Rales, together, and through an entity wholly owned by them, hold approximately 42% of our outstanding common stock. The level of ownership of these stockholders, and the service of Mitchell Rales as chairman of our board of directors, enables them to exert significant influence over all matters involving us, including matters presented to our stockholders for approval, such as election and removal of our directors and change of control transactions. This concentration of ownership and voting power may also have the effect of delaying or preventing a change in control of our company and could prevent stockholders from receiving a premium over the market price if a change in control is proposed. The interests of these persons may not coincide with the interests of the other holders of our common stock with respect to our operations or strategy.

The market price of our common stock may experience a high level of volatility.

The market price for our common stock has experienced a high level of volatility and may continue to do so in the future. During the period from our initial public offering (IPO) to December 31, 2009, our common stock traded between $5.33 and $28.35 per share. At any given time, you may not be able to sell your shares at a price that you think is acceptable. The market liquidity for our stock is relatively low. As of December 31, 2009, we had 43,229,104 shares of common stock outstanding. The average daily trading volume in our common stock during the period from January 1, 2009 to December 31, 2009 was approximately 210,000 shares. Although a more active trading market may develop in the future, the limited market liquidity for our stock may affect your ability to sell at a price that is satisfactory to you. Stock markets in general have experienced extreme volatility that has often been unrelated to the operating performance of a particular company. These broad fluctuations may adversely affect the trading price of our common stock, regardless of our operating performance.

Provisions in our charter documents and Delaware law may delay or prevent an acquisition of our company, which could decrease the value of your shares.

Our amended and restated certificate of incorporation, amended and restated bylaws, and Delaware law contain provisions that may make it difficult for a third-party to acquire us without the consent of our board of directors. These provisions include prohibiting stockholders from taking action by written consent, prohibiting special meetings of stockholders called by stockholders and prohibiting stockholder nominations and approvals without complying with specific advance notice requirements. In addition, our board of directors has the right to issue preferred stock without stockholder approval, which our board of directors could use to effect a rights plan or “poison pill” that could dilute the stock ownership of a potential hostile acquirer and may have the effect of delaying, discouraging or preventing an acquisition of our company. Delaware law also imposes some restrictions on mergers and other business combinations between us and any holder of 15% or more of our outstanding voting stock. Although Mitchell Rales and Steven Rales, both individually and in the aggregate, hold more than 15% of our outstanding voting stock, this provision of Delaware law does not apply to them.

There may be limitations on our ability to fully utilize our net operating loss carryforwards and other U.S. deferred tax assets in future periods.

If the recent global economic decline persists for a prolonged period of time, we may not be able to generate sufficient future U.S. taxable income to utilize our U.S. net operating loss carryforwards (NOLs) and/or other net U.S. deferred tax assets. Our net U.S. deferred tax assets, including U.S. NOLs and net of valuation allowances, are $54.4 million as of December 31, 2009. If sufficient future taxable income and/or available tax planning strategies are not available to utilize some or all of these deferred tax assets, additional valuation allowances may be recorded which would negatively affect our results of operations.

In addition, we believe we experienced an “ownership change” within the meaning of Section 382 of the Internal Revenue Code of 1986, as amended, as a result of our May 2008 IPO. Our ability to use our NOLs existing at the time of the ownership change to offset any taxable income generated in taxable periods after the ownership change is subject to an annual limitation. The amount of NOLs that we may utilize on an annual basis under Section 382 would generally be equal to the product of the value of our outstanding stock immediately prior to the ownership change (less certain capital contributions during the preceding two years) and the “long term tax exempt rate” which was 4.71% for May 2008. The amount of NOLs existing as of the time of the ownership change is estimated to be $65.3 million and will begin to expire in 2021.

Our results of operations could vary as a result of the methods, estimates and judgments we use in applying our accounting policies.

The methods, estimates and judgments we use in applying our accounting policies have a significant impact on our results of operations (see “Critical Accounting Policies and Estimates” in Part II, Item 7 of this Form 10-K). Such methods, estimates and judgments are, by their nature, subject to substantial risks, uncertainties and assumptions, and factors may arise over time that lead us to change our methods, estimates and judgments. Changes in those methods, estimates and judgments could significantly affect our results of operations.

Any impairment in the value of our intangible assets, including goodwill, would negatively affect our operating results and total capitalization.

Our total assets reflect substantial intangible assets, primarily goodwill. The goodwill results from our acquisitions, representing the excess of cost over the fair value of the net assets we have acquired. We assess at least annually whether there has been impairment in the value of our intangible assets. If future operating performance at one or more of our business units were to fall significantly below current levels, if competing or alternative technologies emerge, or if market conditions for businesses acquired declines, we could incur, under current applicable accounting rules, a non-cash charge to operating earnings for goodwill impairment. Any determination requiring the write-off of a significant portion of unamortized intangible assets would negatively affect our results of operations and total capitalization, the effect of which could be material.

Our defined benefit pension plans are subject to financial market risks that could adversely affect our operating results, financial condition and cash flow.

Our defined benefit pension plan obligations are affected by changes in market interest rates and the majority of plan assets are invested in publicly traded debt and equity securities, which are affected by market risks. Significant changes in market interest rates, decreases in the fair value of plan assets and investment losses or lack of expected investment gains on plan assets may adversely impact our future operating results, financial condition and cash flow.

We have identified a material weakness in our internal control over financial reporting. If our internal controls are not effective, investors could lose confidence in our financial reporting.

Our management had previously concluded that our internal control over financial reporting was effective as of December 31, 2009. In connection with the restatement to correct our financial statements for the effects of an overstatement of our pension liability, discussed in Note 2 to the consolidated financial statements included in Part II of this report, management determined a material weakness in internal control over financial reporting existed as of December 31, 2009. Accordingly, management has now concluded that our internal control over financial reporting was not effective as of December 31, 2009. Also, as described in “Part II—Item 9A. Controls and Procedures” of this report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2009.

Subsequent to the period covered by this report, management has implemented measures to remediate the material weakness set forth above. Specifically, we have implemented procedures to enhance review of participant data for benefit plans. As part of the Company’s 2010 assessment of internal control over financial reporting, management will conduct sufficient testing and evaluation of the implemented controls to ascertain whether they are designed and operating effectively. We believe the implemented controls will remediate the above identified material weakness.

Although we believe we have taken appropriate actions to remediate the material weakness discussed above, we cannot assure you that we will not discover other material weaknesses in the future. Any failure to maintain or implement required new or improved controls, or any difficulties we encounter in implementation, could cause us to fail to meet our periodic reporting obligations or result in material misstatements in our financial statements. In addition, substantial costs and resources may be required to rectify any internal control deficiencies. If we cannot produce reliable financial reports, investors could lose confidence in our reported financial information, the market price of our common stock could decline significantly, and our business and financial condition could be harmed.

ITEM 1B.

UNRESOLVED STAFF COMMENTS

None

ITEM 2.

PROPERTIES

We have 14 principal production facilities in seven countries. The following table lists our primary facilities at December 31, 2009, indicating the location, square footage, whether the facilities are owned or leased, and principal use.

Location	Sq. Footage	Owned/Leased	Principal Use
Richmond, Virginia	10,200	Leased	Corporate headquarters
Hamilton, New Jersey	2,200	Leased	Subsidiary headquarters
Columbia, Kentucky	75,000	Owned	Production
Warren, Massachusetts	147,000	Owned	Production
Monroe, North Carolina	170,000	Owned	Production
Houston, Texas	25,000	Leased	Production
Portland, Maine	61,000	Leased	Production
Tours, France	33,000	Leased	Production
Bottrop, Germany	55,000	Owned	Production
Gottmadingen, Germany	38,000	Leased	Production
Radolfzell, Germany	350,000	Owned	Production
Utrecht, Netherlands	50,000	Owned	Production
Stockholm, Sweden	130,000	Owned	Production
Daman, India	32,000	Owned	Production
Vapi, India	16,000	Leased	Production
Wuxi, China	60,000	Leased	Production

ITEM 3.

LEGAL PROCEEDINGS

Discussion of legal matters is incorporated by reference to Part II, Item 8, Note 19, “Commitments and Contingencies,” in the Notes to the Consolidated Financial Statements.

ITEM 4.

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No matters were submitted to a vote of security holders during the fourth quarter of 2009.

EXECUTIVE OFFICERS OF THE REGISTRANT

Set forth below are the names, ages, positions and experience of our executive officers. All of our executive officers hold office at the pleasure of our Board of Directors.

Name	Age	Position
Clay H. Kiefaber	54	President and Chief Executive Officer and Director
Mario E. DiDomenico	58	Senior Vice President, General Manager—Engineered Solutions
G. Scott Faison	48	Senior Vice President, Finance and Chief Financial Officer
Dr. Michael Matros	44	Senior Vice President, General Manager—Allweiler
Joseph B. Niemann	48	Senior Vice President, Marketing and Strategic Planning
Thomas M. O’Brien	59	Senior Vice President, General Counsel and Secretary
William E. Roller	47	Senior Vice President, General Manager—Americas
Steven W. Weidenmuller	46	Senior Vice President, Human Resources

Clay H. Kiefaber became the President and Chief Executive Officer in January 2010. Mr. Kiefaber has served on the Colfax Board of Directors since the Company’s IPO in 2008. Before joining Colfax in January 2010, he spent nearly 20 years in increasingly senior executive positions at Masco Corporation (“Masco”). Most recently, he was a Group President from 2006 to 2007, where he was responsible for a $2.8 billion group of building construction components. Prior to becoming a Group President at Masco, Mr. Kiefaber was Group Vice President of Masco Builder Cabinet Group. He previously spent 14 years in increasingly senior positions in Masco’s Merillat Industries subsidiary.

Mario E. DiDomenico joined our company in 1998 with the acquisition of Imo. Since that time he has served as the Manager of Operations for Warren Pump, Vice President—2 Screw Pumps and subsequently as Senior Vice President, General Manager—Engineered Solutions, which also includes Portland Valve, Fairmount and Tushaco following the acquisitions of those businesses.

G. Scott Faison has been the Senior Vice President, Finance and Chief Financial Officer since January 2005.

Dr. Michael Matros joined Allweiler in 1996 as a project manager in Research and Development. From 1996 until 2006, Dr. Matros has held several positions at Allweiler with increasing responsibilities, including Director of Research and Development and the Plant Manager of our Allweiler facility in Radolfzell, Germany. In April 2006, Dr. Matros was appointed to his current position as Senior Vice President, General Manager—Allweiler. In November 2006, Dr. Matros was appointed as a member of the management board at our German subsidiary, Allweiler AG.

Joseph B. Niemann joined us in 2006 as Senior Vice President of Marketing and Strategic Planning. Prior to joining our company, Mr. Niemann was Vice President, Marketing & eBusiness of Emerson Climate Technologies, a subsidiary of Emerson Electric Company, where he was employed from 1990 to 2005.

Thomas M. O’Brien has served as our Senior Vice President, General Counsel and Secretary since January 1998.

William E. Roller has served as our Senior Vice President, General Manager—Americas since June 1999. Colfax Americas includes Imo as well as Zenith and LSC following the acquisitions of those businesses.

Steven W. Weidenmuller has served as Senior Vice President, Human Resources since 2002.

PART II

ITEM 5.

MARKET FOR THE REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Our common stock began trading on the New York Stock Exchange under the symbol CFX on May 8, 2008. As of January 31, 2010, there were approximately 7,300 holders of record of our common stock. The high and low sales prices per share of our common stock, as reported on the New York Stock Exchange, for the fiscal periods presented are as follows:

	2009				2008
	High		Low		High		Low
First Quarter	$	13.22	$	5.33		N/A		N/A
Second Quarter	$	9.48	$	6.05	$	25.76	$	20.01
Third Quarter	$	12.66	$	7.21	$	28.35	$	14.73
Fourth Quarter	$	13.91	$	10.22	$	18.16	$	5.58

We have not paid any dividends on our common stock since inception, and we do not anticipate the declaration or payment of dividends at any time in the foreseeable future. Our credit agreement limits the amount of cash dividends and common stock repurchases the Company may make to a total of $10 million annually.

Performance Graph

Issuer Purchase of Equity Securities

On November 4, 2008, the Company’s board of directors authorized the repurchase of up to $20 million (up to $10 million per year in 2008 and 2009) of the Company’s common stock on the open market or in privately negotiated transactions. The repurchase program was to be conducted pursuant to SEC Rule 10b5-1. The timing and amount of shares repurchased was determined by the Share Repurchase Committee, constituting three members of the Company’s board of directors, based on its evaluation of market conditions and other factors. There were no common stock repurchases during 2009.

ITEM 6.

SELECTED FINANCIAL DATA

(in thousands, except per share information)

	Year ended December 31,
	2009 Restated			2008 Restated			2007 Restated			2006 Restated		2005 Restated
Statement of Operations Data:
Net sales	$	525,024		$	604,854		$	506,305		$	393,604	$	345,478
Cost of sales		339,237			387,667			330,714			256,806		222,353
Gross profit		185,787			217,187			175,591			136,798		123,125
Initial public offering-related costs		-			57,017			-			-		-
Selling, general and administrative expenses		112,503			124,105			97,426			78,964		73,542
Research and development expenses		5,930			5,856			4,162			3,336		2,855
Restructuring and other related charges		18,175			-			-			-		-
Asbestos liability and defense (income) costs		(2,193	)		(4,771	)		(63,978	)		21,783		14,272
Asbestos coverage litigation expenses		11,742			17,162			13,632			12,033		3,840
Operating income		39,630			17,818			124,349			20,682		28,616
Interest expense		7,212			11,822			19,246			14,186		9,026
Provision for income taxes		8,621			5,465			39,457			4,298		6,666
Income from continuing operations		23,797			531			65,646			2,198		12,924
Net income (1)	$	23,797		$	531		$	65,646		$	801	$	13,540

Net income (loss) per share from continuing operations — basic and diluted	$	0.55		$	(0.08	)	$	1.82		$	0.10	$	(0.03	)

	December 31,
	2009 Restated		2008 Restated		2007 Restated		2006 Restated		2005 Restated
Balance Sheet Data:
Cash and cash equivalents	$	49,963	$	28,762	$	48,093	$	7,608	$	7,821
Goodwill and intangibles, net		175,370		175,210		181,517		150,395		145,957
Asbestos insurance asset, including current portion		389,449		304,015		305,228		297,106		261,941
Total assets		999,401		907,550		899,522		792,018		696,738
Asbestos liability, including current portion		443,769		357,258		376,233		388,920		338,535
Total debt, including current portion (2)		91,485		97,121		206,493		188,720		158,454

(1)	Includes net (loss) income from discontinued operations of $(1.4) million and $0.6 million in the years ended December 31, 2006 and 2005, respectively.

(2)	See Note 13 to our Consolidated Financial Statements for information regarding the refinancing of the Company’s debt in conjunction with the IPO in May 2008.

We completed the acquisitions of PD-Technik in 2009, Fairmount and LSC in 2007 and Tushaco in 2005. See Item 1. Business and Note 5 to our Consolidated Financial Statements for further information.

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is designed to provide a reader of the Company’s financial statements with a narrative from the perspective of Company management. The Company’s MD&A is divided into four main sections:

•

Overview

•

Results of Operations

•

Liquidity and Capital Resources

•

Critical Accounting Policies

The following discussion of our financial condition and results of operations should be read together with “Selected Financial and Data,” “Risk Factors” and the financial statements and related notes included elsewhere in this Form 10-K/A. The following discussion includes forward-looking statements. For a discussion of important factors that could cause actual results to differ materially from the results referred to in the forward-looking statements, see “Special Note Regarding Forward-Looking Statements.”

The following discussion gives effect to the restatement of the Company's consolidated financial statements as discussed in Note 2 to the Company's consolidated financial statements in Part II, Item 8.

Overview

We currently serve markets that have a need for highly engineered, critical fluid handling solutions and are global in scope. Our strategic markets include:

Strategic Markets		Applications
Commercial Marine		Fuel oil transfer; oil transport; water and wastewater handling; cargo handling

Oil and Gas		Crude oil gathering; pipeline services; unloading and loading; rotating equipment lubrication; lube oil purification

Power Generation		Fuel unloading, transfer, burner and injection; rotating equipment lubrication

Global Navy		Fuel oil transfer; oil transport; water and wastewater handling; firefighting; fluid control

General Industrial		Machinery lubrication; hydraulic elevators; chemical processing; pulp and paper processing; food and beverage processing

Our business began in 1995 with the intention to acquire, manage and create a world-class industrial manufacturing company. We seek to acquire businesses with leading market positions and brands that exhibit strong cash flow generation potential. With our management expertise and the introduction of CBS into our acquired businesses, we pursue growth in revenues and improvements in operating margins.

Outlook

We believe that we are well positioned to grow our business organically over the long term by enhancing our product offerings and expanding our customer base in our strategic markets. The current global economic downturn had a significant impact on our sales and operating profit in 2009 when compared to 2008. Our order rates declined significantly in 2009 and if current economic conditions continue, our business results will continue to be negatively affected. In addition, we have had project delivery push-outs as well as order cancellations that may continue in 2010. We will continue to monitor general global economic conditions and expect the following market conditions:

•

In the commercial marine industry, we expect international trade and demand for crude oil and other commodities as well as the age of the global merchant fleet to continue to create demand for new ship construction over the long term. We also believe the increase in the size of the global fleet will create an opportunity to supply aftermarket parts and service. In addition, we believe pending and future environmental regulations will enhance the demand for our products. Based on the decline in orders in 2009 and our current backlog, we expect sales to decline in 2010 from 2009 levels. We are also likely to have additional order cancellations as well as delivery date extensions in the near term.

•

In the crude oil industry, we expect long term activity to remain favorable as capacity constraints and global demand drive further development of heavy oil fields. In pipeline applications, we expect demand for our highly efficient products to remain strong as our customers continue to focus on total cost of ownership. In refinery applications, a reduction in capital investment by our customers due to recent weak economic conditions and volatile oil prices has been negatively impacting sales and orders. Projects that were delayed in 2009 are being restarted and we expect sales to be at levels in 2010, while we expect growth in orders.

•

In the power generation industry, we expect activity in Asia and the Middle East to remain solid as economic growth and fundamental undersupply of power generation capacity continue to drive investment in energy infrastructure projects. In the world’s developed economies, we expect efficiency improvements will continue to drive demand. In 2010, we expect both sales and orders to be at similar levels versus 2009.

•

In the U.S., we expect Congress to continue to appropriate funds for new ship construction as older naval vessels are decommissioned. We also expect increased demand for integrated fluid handling systems for both new ship platforms and existing ship classes that reduce operating costs and improve efficiency as the U.S. Navy seeks to man vessels with fewer personnel. Outside of the U.S., we expect other sovereign nations will continue to expand their fleets as they address national security concerns. We expect modest growth in sales during 2010 and expect orders to decline as a result of the significant growth in orders in 2009 and the timing of projects.

•

In the general industrial market, we expect long-term demand to be driven by capital investment. While this market is very diverse, orders in 2009 declined compared to 2008 in all submarkets and most significantly in the chemical, distribution, machinery support and building products markets and in portions of the general industrial market, primarily in Europe and North America. We expect growth in both orders and sales in 2010.

Our global manufacturing sales and distribution network allows us to target fast growing regions throughout the world. We have production and distribution facilities in India and China and opened a Middle East sales and engineering office in Bahrain in 2009. We intend to leverage these investments to grow our market share in these emerging markets and plan to continue to invest in sales and marketing resources to increase our overall coverage.

We will also continue to target aftermarket opportunities in our strategic markets as we generally are able to generate higher margins on aftermarket parts and service than on foremarket opportunities. For the year ended December 31, 2009, aftermarket sales and services represented approximately 24% of our revenues.

We also expect to continue to grow as a result of strategic acquisitions. We believe that the extensive experience of our management team in acquiring and effectively integrating acquisition targets should enable us to capitalize on opportunities in the future.

Based on declining orders and our culture of continuous improvement, we initiated a series of restructuring actions during 2009 to better position the Company’s cost structure for future periods. We continue to monitor order rates and will adjust our manufacturing capacity and cost structure as demand warrants.

Results of Operations

Key Performance Measures

The discussion of our results of operations that follows focuses on some of the key financial measures that we use to evaluate our business. We evaluate our business using several measures, including net sales, orders and order backlog. Our sales, orders and backlog are affected by many factors, particularly the impact of acquisitions, the impact of fluctuating foreign exchange rates and change from our existing businesses which may be driven by market conditions and other factors. To facilitate the comparison between reporting periods, we describe the impact of each of these three factors, to the extent they impact the periods presented, on our sales, orders and backlog in tabular format under the heading “Sales and Orders.”

Orders and order backlog are highly indicative of our future revenue and thus are key measures of anticipated performance. Orders consist of contracts for products or services from our customers, net of cancellations. Order backlog consists of unfilled orders.

Items Affecting the Comparability of Our Reported Results

Our financial performance and growth are driven by many factors, principally our ability to serve increasingly global markets, fluctuations in the relationship of foreign currencies to the U.S. dollar, the general economic conditions within our five strategic markets, the global economy and capital spending levels, the availability of capital, our estimates concerning the availability of insurance proceeds to cover asbestos litigation expenses and liabilities, the amounts of asbestos litigation expenses and liabilities, the impact of restructuring initiatives, our ability to pass through cost increases through pricing, the impact of sales mix, and our ability to continue to grow through acquisitions. These key factors have impacted our results of operations in the past and are likely to affect them in the future.

Global Operations

Our products and services are available worldwide. The manner in which our products and services are sold differs by region. Most of our sales in non-U.S. markets are made by subsidiaries located outside the United States, though we also sell into non-U.S. markets through various representatives and distributors and directly from the U.S. In countries with low sales volumes, we generally sell through representatives and distributors. For the year ended December 31, 2009, approximately 76% of our sales were shipped to locations outside of the U.S. Accordingly, we are affected by levels of industrial activity and economic and political factors in countries throughout the world. Our ability to grow and our financial performance will be affected by our ability to address a variety of challenges and opportunities that are a consequence of our global operations, including efficiently utilizing our global sales, manufacturing and distribution capabilities, the expansion of market opportunities in Asia, successfully completing global strategic acquisitions, and engineering innovative new product applications for end users in a variety of geographic markets. However, we believe that our geographic, end market and product diversification may limit the impact that any one country or economy could have on our consolidated results.

Foreign Currency Fluctuations

A significant portion of our sales, approximately 66% for the year ended December 31, 2009, are derived from operations outside the U.S., with the majority of those sales denominated in currencies other than the U.S. dollar, especially the Euro and the Swedish Krona. Because much of our manufacturing and employee costs are outside the U.S., a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can impact our results and are quantified when significant in our discussion of our operations.

Economic Conditions in Strategic Markets

Our organic growth and profitability strategy focuses on five strategic markets: commercial marine, oil and gas, power generation, global navy and general industrial. Demand for our products depends on the level of new capital investment and planned maintenance by our customers. The level of capital expenditures depends, in turn, on the general economic conditions within that market as well as access to capital at reasonable cost. While demand within each of these strategic markets can be cyclical, the diversity of these markets may limit the impact of a downturn in any one of these markets on our consolidated results.

Pricing

We believe our customers place a premium on quality, reliability, availability, design and application engineering support. Our highly engineered fluid handling products typically have higher margins than products with commodity-like qualities. However, we are sensitive to price movements in our raw materials supply base. Our largest material purchases are for components and raw materials consisting of steel, iron, copper and aluminum. Historically, we have been generally successful in passing raw material price increases on to our customers. While we seek to take actions to manage this risk, including commodity hedging where appropriate, such increased costs may adversely impact earnings.

Sales and Cost Mix

Our profit margins vary in relation to the relative mix of many factors, including the type of product, the geographic location in which the product is manufactured, the end market for which the product is designed, and the percentage of total revenue represented by aftermarket sales and services. Aftermarket business, including spare parts and other value added services, is generally a higher margin business and is a significant component of our profitability.

Strategic Acquisitions

We complement our organic growth with strategic acquisitions. Acquisitions can significantly affect our reported results and can complicate period to period comparisons of results. As a consequence, we report the change in our sales between periods both from existing and acquired businesses. We intend to continue to pursue acquisitions of complementary businesses that will broaden our product portfolio, expand our geographic footprint or enhance our position within our strategic markets.

On January 31, 2007, we completed the acquisition of Lubrication Systems Company of Texas (“LSC”), a manufacturer of fluid handling systems, including oil mist lubrication and oil purification systems. LSC strengthens our presence in the oil and gas end market, particularly in the downstream refinery segment, broadens our overall lubrication portfolio, and presents the opportunity to expand its product application to other markets.

On November 29, 2007, we acquired Fairmount Automation, Inc. (“Fairmount”), an original equipment manufacturer of mission critical programmable automation controllers in fluid handling applications primarily for the U.S. Navy. In addition to strengthening our existing position with the U.S. Navy, we intend to leverage Fairmount’s experienced engineering talent and technology expertise to develop a portfolio of fluid handling solutions with diagnostic and prognostic capabilities for industrial applications.

On August 31, 2009, we completed the acquisition of PD-Technik Ingenieurbüro GmbH (“PD-Technik”), a provider of marine aftermarket related products and services located in Hamburg, Germany. The acquisition of PD-Technik supports our marine aftermarket growth initiatives, broadening our served market as well as service capabilities.

Restructuring and Other Related Charges

We initiated a series of restructuring actions during 2009 to better position the Company’s cost structure for future periods. As a result, the Company recorded pre-tax restructuring and other related costs of $18.2 million for the year ended December 31, 2009. As of December 31, 2009, we have reduced our company-wide workforce by 328 associates from December 31, 2008. Additionally, during 2009, approximately 630 associates participated in a German government-sponsored furlough program in which the government pays the wage-related costs for the portion of the work week the associate is not working. Our agreement with the German works council allowing participation in the furlough program ends in February 2011. During 2009, we closed a repair facility in Aberdeen, NC and a production facility in Sanford, NC and moved the operations to two of our other facilities. We realized savings of approximately $17 million in 2009 from our restructuring activities implemented in 2009 and expect annualized savings of approximately $29 million in 2010. We continue to monitor our order rates and will adjust our manufacturing capacity and cost structure as demand warrants.

IPO-related Costs

Results for the year ended December 31, 2008 include $57.0 million of nonrecurring costs associated with our IPO during the second quarter. This amount includes $10.0 million of share-based compensation and $27.8 million of special cash bonuses paid under previously adopted executive compensation plans as well as $2.8 million of employer payroll taxes and other related costs. It also includes $11.8 million to reimburse the selling stockholders for the underwriting discount on the shares sold by them as well as the write-off of $4.6 million of deferred loan costs associated with the early termination of a credit facility.

Legacy Legal Adjustment

Selling, general and administrative expenses for the year ended December 31, 2008 include a $4.1 million increase to legal reserves related to a non-asbestos legal matter that arose from the sale and subsequent repair of a product by a division of a subsidiary that was divested prior to our acquisition of the subsidiary. This legacy legal case was settled during the third quarter of 2008.

Asbestos Liability and Defense Income

Our financial results have been, and will likely in the future be, affected by our asbestos liabilities and the availability of insurance to cover these liabilities and defense costs related to asbestos personal injury litigation against two of our subsidiaries, as well as costs arising from our legal action against our insurers. Assessing asbestos liabilities and insurance assets requires judgments concerning matters such as the uncertainty of litigation, anticipated outcome of settlements, the number and cost of pending and future claims, the outcome of legal action against our insurance carriers, and their continued solvency. For a further discussion of these estimates and how they may affect our future results, see “—Critical Accounting Estimates—Asbestos Liabilities and Insurance Assets.”

Asbestos liability and defense income is comprised of projected indemnity cost, changes in the projected asbestos liability, changes in the probable insurance recovery of the projected asbestos-related liability, changes in the probable recovery of asbestos liability and defense costs paid in prior periods, and actual defense costs expensed in the period.

The table below presents asbestos liability and defense income for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009			2008			2007

Asbestos liability and defense (income)	$	(2.2	)	$	(4.8	)	$	(63.9	)

Asbestos liability and defense income was $2.2 million for the year ended December 31, 2009 compared to $4.8 million for the year ended December 31, 2008. The decrease in asbestos liability and defense income relates primarily to the favorable effect of one-time items in 2008 exceeding the favorable net effect of one-time items in 2009. One-time items in 2008 included a $7.0 million gain resulting from resolution of a coverage dispute with a primary insurer concerning certain pre-1966 insurance policies, as well as a $2.3 million gain from a change in estimate of our future asset recovery percentage for one subsidiary. One-time adjustments in 2009 include a $19.4 million gain as a result of favorable court rulings in October and December 2009 concerning allocation methodology offset by an $11.6 million charge to increase the Company’s asbestos-related liabilities as a result of an analysis of claims data.

Asbestos liability and defense income was $4.8 million for the year ended December 31, 2008 compared to $63.9 million for the year ended December 31, 2007. The decrease in asbestos liability and defense income relates primarily to income recognized in the year ended December 31, 2007 based upon a reevaluation of our insurance asset from an expected recovery percentage of 75% to 87.5% for one of our subsidiaries and from recording a receivable from insurers for past costs paid by us. We were able to reevaluate the insurance asset in 2007 because of a series of favorable court rulings which determined the proper insurance allocation methodology, interpreted policy provisions related to deductibles and number of occurrences, and that New Jersey state law applied.

Asbestos Coverage Litigation Expense

Asbestos coverage litigation expenses include legal costs related to the actions against two of our subsidiaries respective insurers and a former parent company of one of the subsidiaries.

The table below presents coverage litigation expenses for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009		2008		2007

Asbestos coverage litigation expenses	$	11.7	$	17.2	$	13.6

Legal costs related to the subsidiaries’ action against their asbestos insurers were $11.7 million for the year ended December 31, 2009 compared to $17.2 million for the year ended December 31, 2008. Legal costs for the year ended December 31, 2008 were higher than 2009 and 2007 primarily due to trial preparation in the fourth quarter of 2008 by one of our subsidiaries against a number of its insurers and former parent. The trial had been expected to commence in the first half of 2009, but did not begin until January 19, 2010.

Seasonality

We experience seasonality in our fluid handling business. As our customers seek to fully utilize capital spending budgets before the end of the year, historically our shipments have peaked during the fourth quarter; however, the global economic downturn has disrupted this pattern. Also, our European operations typically experience a slowdown during the July and August holiday season.

Sales and Orders

Our sales, orders and backlog are affected by many factors including but not limited to acquisitions, fluctuating foreign exchange rates, and growth (decline) in our existing businesses which may be driven by market conditions and other factors. To facilitate the comparison between reporting periods, we disclose the impact of each of these three factors to the extent they impact the periods presented. The impact of foreign currency translation is the difference between sales from existing businesses valued at current year foreign exchange rates and the same sales valued at prior year foreign exchange rates. Growth due to acquisitions includes incremental sales due to an acquisition during the period or incremental sales due to reporting a full year’s sales for an acquisition that occurred in the prior year. Sales growth (decline) from existing businesses excludes both the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth (decline) due to factors such as price, mix and volume.

Orders and order backlog are highly indicative of our future revenue and thus key measures of anticipated performance. Orders consist of contracts for products or services from our customers, net of cancellations, during a period. Order backlog consists of unfilled orders at the end of a period. The components of order and backlog growth (decline) are presented on the same basis as sales growth (decline).

The following tables present components of our sales and order growth (decline), as well as, sales by fluid handling product for the periods indicated:

													Backlog at
(Amounts in millions)	Sales						Orders (1)						Period End (1)
(Amounts in millions)	$			%			$			%			$			%

Year ended December 31, 2007	$	506.3					$	589.0					$	302.8

Components of Change:
Existing Businesses		70.2			13.9	%		46.8			7.9	%		57.9			19.1	%
Acquisitions		5.5			1.1	%		11.7			2.0	%		15.2			5.0	%
Foreign Currency Translation		22.9			4.5	%		34.6			5.9	%		(26.9	)		(8.9	)%
Total		98.6			19.5	%		93.1			15.8	%		46.2			15.3	%

Year ended December 31, 2008	$	604.9					$	682.1					$	349.0

Components of Change:
Existing Businesses		(48.8	)		(8.1	)%		(198.0	)		(29.0	)%		(66.8	)		(19.1	)%
Acquisitions		1.0			0.2	%		1.4			0.2	%		0.7			0.2	%
Foreign Currency Translation		(32.1	)		(5.3	)%		(23.1	)		(3.4	)%		8.0			2.3	%
Total		(79.9	)		(13.2	)%		(219.7	)		(32.2	)%		(58.1	)		(16.6	)%

Year ended December 31, 2009	$	525.0					$	462.4					$	290.9

(1)

At December 31, 2009, the Company standardized its definition of an order among its businesses, as well as, the methodology for calculating the currency impact on backlog. Orders and backlog are presented in accordance with the revised methodology for all periods presented. As a result, orders for the years ended December 31, 2008 and 2007 increased by $12.9 million, or 1.9% and $7.5 million, or 1.3%, respectively. Backlog for the years ended December 31, 2008 and 2007 increased by $11.6 million, or 3.4% and $10.0 million, or 3.4%, respectively. Applying the revised methodology, orders and backlog for 2009 increased by $7.7 million, or 1.7% and $21.7 million, or 8.1%, respectively, compared to the previous methodology.

	Year ended December 31,
(Amounts in millions)	2009		2008		2007

Net Sales by Product:
Pumps, including aftermarket parts and service	$	443.1	$	529.3	$	441.7
Systems, including installation service		69.3		58.2		48.4
Valves		10.1		10.1		9.5
Other		2.5		7.3		6.7
Total net sales	$	525.0	$	604.9	$	506.3

As detailed above, sales from existing businesses declined 8.1% for the year ended December 31, 2009 over the year ended December 31, 2008. This decrease was primarily due to a significant decline in sales volume in the general industrial end market resulting from the global economic downturn, partially offset by a sales volume increase in the global navy end market. Foreign currency translation negatively impacted sales and orders for the year ended December 31, 2009, primarily due to the strengthening of the U.S. dollar against the Euro.

Orders, net of cancellations, from existing businesses for the year ended December 31, 2009 were down 29.0% from the prior year, primarily due to a significant decline in demand in the commercial marine, oil and gas, general industrial and power generation end markets. We experienced commercial marine order cancellations of approximately $22 million during the year ended December 31, 2009, as a result of the economic downturn. Backlog as of December 31, 2009, of $290.9 million decreased $58.1 million, or 16.6%, reflecting the decline in orders during the year.

Sales growth from existing business increased 13.9% for the year ended December 31, 2008 over the year ended December 31, 2007. This increase was primarily attributable to increased volume and demand in the power generation, commercial marine, and general industrial end markets. Acquisition growth of 1.1% for the year was due to the acquisitions of LSC on January 31, 2007 and Fairmount on November 29, 2007. Foreign currency translation increased sales and orders by 4.5% and 5.9%, respectively. These increases were primarily due to the weakening of the U.S. dollar against the Euro throughout most of 2008. During the fourth quarter of 2008, the U.S. dollar appreciated sharply against both the Euro and the Swedish Krona, which had a negative effect on our sales and order growth.

Order growth from existing businesses was strong in most of our strategic end markets (most notably in the oil and gas and global navy end markets), up 7.9% in 2008. Commercial marine orders increased approximately 1%, net of cancellations of approximately $19 million. Our backlog of orders at December 31, 2008 was $349.0 million compared to $302.8 million at December 31, 2007. During 2008, backlog from existing businesses increased $57.9 million or 19.1%, on a currency-adjusted basis.

Gross Profit

The following table presents our gross profit and gross profit margin figures for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009			2008			2007

Gross profit	$	185.8		$	217.2		$	175.6
Gross profit margin		35.4	%		35.9	%		34.7	%

Gross profit decreased $31.4 million for the year ended December 31, 2009. Gross profit from existing businesses decreased $19.8 million, with an additional $11.7 million negative impact of foreign exchange rates. Gross profit margin declined a modest 50 basis points in 2009 despite a substantial decrease in production volume which caused lower absorption of fixed manufacturing costs. Significant restructuring program cost savings as well as favorable pricing and product mix in the commercial marine and general industrial end markets for the most part successfully mitigated the negative effect of volume on our gross margin.

Gross profit of $217.2 million for the year ended December 31, 2008 increased $41.6 million, or 23.7%, from $175.6 million in 2007. Of the $41.6 million increase, $31.6 million was attributable to growth from existing businesses, $2.4 million was due to the acquisitions of LSC on January 31, 2007 and Fairmount on November 29, 2007 and $7.6 million was due to the positive impact of foreign exchange rates. Gross profit margin increased to 35.9% for the year ended December 31, 2008 from 34.7% for the year ended December 31, 2007. The margin improvement for the year ended December 31, 2008 was primarily driven by favorable pricing and cost control in the commercial marine and oil and gas markets.

Selling, General and Administrative Expenses

The following table presents our selling, general and administrative (SG&A) expenses for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009 Restated			2008 Restated			2007 Restated

SG&A expenses	$	112.5		$	124.1		$	97.4
SG&A expenses as a percentage of sales		21.4	%		20.5	%		19.2	%

Selling, general and administrative expenses decreased $11.6 million to $112.5 million for the year ended December 31, 2009. Excluding the $6.1 million favorable impact of foreign exchange rates, SG&A declined $5.5 million from 2008, primarily due to reductions in selling and commission expenses of $2.2 million and restructuring savings of $2.5 million. An additional $2.0 million of professional fees and other costs associated with becoming a public company and $2.6 million of pension and other postretirement benefit costs were incurred in 2009, but were offset by lower legacy legal expenses and favorable changes in the fair value of commodity and foreign currency derivatives.

Selling, general and administrative expenses increased $26.7 million to $124.1 million for the year ended December 31, 2008 from $97.4 million for the year ended December 31, 2007. The increase was primarily related to $3.8 million negative impact of foreign exchange rates, $4.1 million reserve increase for a legacy legal matter, $4.2 million for audit and professional fees and other costs associated with becoming a public company, and $2.1 million from the acquisitions of Fairmount and LSC. The remaining increase was primarily due to higher selling expenses, insurance proceeds recognized in 2007 of $2.2 million related to a product liability matter, and a gain recognized in 2007 of $1.1 million from the sale of investment securities.

Operating Income

The table below presents operating income data for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009 Restated			2008 Restated			2007 Restated

Operating income	$	39.6		$	17.8		$	124.3
Operating margin		7.5	%		2.9	%		24.6	%

Operating income for the year ended December 31, 2009 increased $21.8 million from the prior year. The increase was primarily due to the absence of $57.0 million of initial public offering-related costs incurred in 2008, partially offset by $18.2 million of restructuring costs incurred in 2009 as well as a $5.5 million negative impact of foreign exchange rates. Excluding these impacts, operating income was $11.5 million lower than the prior year, primarily due to lower sales volume from existing businesses, partially offset by lower asbestos-related expenses and selling, general and administrative expenses.

Operating income for the year ended December 31, 2008 decreased $106.5 million from the year ended December 31, 2007. This decrease was primarily due to a $62.7 million decrease in asbestos-related income, IPO-related costs of $57.0 million, $4.2 million of professional and other costs associated with becoming a public company, $4.1 million related to a reserve increase for a legacy legal matter, and the absence of $2.2 million of income recognized in the prior year period related to a product liability matter, partially offset by $23.4 million of increased operational performance in our existing business units primarily caused by increased sales volume and a $3.3 million favorable impact from foreign exchange rates.

Interest Expense

For a description of our outstanding indebtedness, please refer to “—Liquidity and Capital Resources” below.

Interest expense of $7.2 million for the year ended December 31, 2009 declined $4.6 million from the prior year, primarily due to lower debt levels during 2009 compared to 2008 as a result of debt repayments of $105.4 million from a portion of the IPO proceeds in the second quarter of 2008. A decrease in the weighted-average effective interest rate on our variable rate borrowings that are not hedged, from 6.3% in 2008 to 5.6% in 2009 contributed approximately $0.7 million to the reduction in interest expense.

Interest expense of $11.8 million for the year ended December 31, 2008 declined $7.4 million from the prior year, primarily due to lower debt levels resulting from the debt repayments of $105.4 million with a portion of the IPO proceeds on May 13, 2008. A decrease in the weighted-average interest rate on our variable rate borrowings from 7.4% in 2007 to 6.3% in 2008 contributed approximately $1.5 million to the reduction in interest expense.

Provision for Income Taxes

The effective income tax rate for the year ended December 31, 2009 was 26.6% as compared to an effective tax rate of 91.1% for the year ended December 31, 2008. Our effective tax rate for the year ended December 31, 2009 was lower than the U.S. federal statutory rate primarily due to international tax rates which are lower than the U.S. tax rate, including the impact of the reduction in 2009 of the Swedish tax rate from 28% to 26.3 % that is applied to our Swedish operations and a net decrease to our valuation allowance and unrecognized tax benefit liability.

The effective income tax rate for the year ended December 31, 2008 was 91.1% as compared to an effective tax rate of 37.5% for the year ended December 31, 2007. Our effective tax rate for the year ended December 31, 2008 was higher than the U.S. federal statutory rate primarily due to an $11.8 million payment to reimburse certain selling shareholders for underwriters discounts that are not deductible for tax purposes and a $3.0 million net increase in valuation allowance, offset in part by an expected lower overall rate on normal operations due to reductions in German corporate tax rates in 2008, other international tax rates that are lower than the U.S. tax rate, changes in overall profitability and state tax benefits.

Liquidity and Capital Resources

Overview

Historically, we have financed our capital and working capital requirements through a combination of cash flows from operating activities and borrowings under our credit facility. We expect that our primary ongoing requirements for cash will be for working capital, funding for potential acquisitions, capital expenditures, asbestos-related outflows and pension plan funding. If additional funds are needed for strategic acquisitions or other corporate purposes, we believe we could raise additional funds in the form of debt or equity.

Borrowings

On May 13, 2008, coinciding with the closing of the IPO, we terminated our existing credit facility. There were no material early termination penalties incurred as a result of the termination. Deferred loan costs of $4.6 million were written off in connection with this termination. On the same day, we entered into a new credit agreement (the “Credit Agreement”). The Credit Agreement, led by Banc of America Securities LLC and administered by Bank of America, is a senior secured structure with a $150.0 million revolver and a Term A Note of $100.0 million.

The Term A Note bears interest at LIBOR plus a margin ranging from 2.25% to 2.75% determined by the total leverage ratio calculated at quarter end. At December 31, 2009, the interest rate was 2.48% inclusive of a 2.25% margin. The Term A Note, as entered into on May 13, 2008, has $1.25 million due on a quarterly basis on the last day of each March, June, September and December beginning June 30, 2008 and ending March 31, 2010, $2.5 million due on a quarterly basis on the last day of each March, June, September and December beginning June 30, 2010 and ending March 31, 2013, and one installment of $60.0 million payable on May 13, 2013. On December 31, 2009, there was $91.3 million outstanding on the Term A Note.

The $150.0 million revolver contains a $50.0 million letter of credit sub-facility, a $25.0 million swing line loan sub-facility and a €100.0 million sub-facility. At December 31, 2009, the annual commitment fee on the revolver was 0.4% and there was $14.4 million outstanding on the letter of credit sub-facility, leaving approximately $136 million available under our revolver loan.

On June 24, 2008, we entered into an interest rate swap with an aggregate notional value of $75.0 million whereby we exchanged our LIBOR-based variable rate interest for a fixed rate of 4.1375%. The notional value decreases to $50.0 million and then $25.0 million on June 30, 2010 and June 30, 2011, respectively and expires on June 29, 2012. The fair value of the swap agreement, based on third-party quotes, was a liability of $3.0 million at December 31, 2009. The swap agreement has been designated as a cash flow hedge, and therefore changes in its fair value are recorded as an adjustment to other comprehensive income.

Substantially all assets and stock of the Company’s domestic subsidiaries and 65% of the shares of certain European subsidiaries are pledged as collateral against borrowings under the Credit Agreement. Certain European assets are pledged against borrowings directly made to our European subsidiary. The Credit Agreement contains customary covenants limiting the Company’s ability to, among other things, pay cash dividends, incur debt or liens, redeem or repurchase Company stock, enter into transactions with affiliates, make investments, merge or consolidate with others or dispose of assets. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain a total leverage ratio of not more than 3.25 to 1.0 and a fixed charge coverage ratio of not less than 1.50 to 1.0, measured at the end of each quarter. If the Company does not comply with the various covenants under the Credit Agreement and related agreements, the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term A Note and revolver. The Company believes it is in compliance with all such covenants as of December 31, 2009 and expects to be in compliance for the next 12 months.

As of December 31, 2009, we had approximately $136 million available on our $150 million revolving credit line. Present drawings under the credit line are letters of credit securing various obligations related to our business. The revolving credit line is provided by a consortium of financial institutions with varying commitment levels as show below (in millions):

	Amount

Bank of America	$	32.4
RBS Citizens		14.4
TD BankNorth		14.4
Wells Fargo		14.4
SunTrust Bank		14.4
Landesbank Baden-Wuerttemberg		10.5
DnB Nor Bank		10.5
HSBC		10.5
KeyBank		10.5
Carolina First Corp		6.0
UBS		6.0
Lehman Brothers(1)		6.0

Total	$	150.0

(1)	The bankruptcy of Lehman Brothers resulted in their default under the terms of the revolver and it is doubtful that we would be able to draw on Lehman Brothers’ commitment of $6.0 million.

Comparative Cash Flows

The table below presents selected cash flow data for the periods indicated:

	Year ended December 31,
(Amounts in millions)	2009			2008			2007

Net cash provided by (used in) operating activities	$	38.3		$	(33.0	)	$	74.5
Purchases of fixed assets		(11.0	)		(18.6	)		(13.7	)
Net cash paid for acquisitions		(1.3	)		(0.4	)		(33.0	)
Other sources, net		0.3			(0.1	)		0.2

Net cash used in investing activities	$	(12.0	)	$	(19.1	)	$	(46.5	)
Proceeds and repayments of borrowings, net		(5.0	)		(110.3	)		14.7
Net proceeds from IPO		-			193.0			-
Dividends paid to preferred shareholders		-			(38.5	)		-
Repurchases of common stock		-			(5.7	)		-
Payments made for loan costs		-			(3.3	)		(1.4	)
Payment of deferred stock issuance costs		-			-			(1.2	)
Other uses, net		(0.4	)		(0.4	)		(0.4	)

Net cash (used in) provided by financing activities	$	(5.4	)	$	34.8		$	11.7

Cash flows from operating activities can fluctuate significantly from period to period as working capital needs, the timing of payments for items such as asbestos-related cash flows, pension funding decisions and other items impact reported cash flows.

Net cash provided by (used in) operating activities was $38.3 million, $(33.0) million and $74.5 million for the years ended December 31, 2009, 2008 and 2007, respectively. The two most significant items causing the variability in these reported amounts were asbestos-related cash flows (including the disposition of claims, defense costs, insurer reimbursements and settlements and legal expenses related to litigation against our insurers) and IPO-related costs in 2008. For the years ended December 31, 2009, 2008 and 2007, net cash paid (received) for asbestos liabilities, net of insurance settlements received, was $19.7 million, $21.8 million and $(22.5) million, respectively. For the year ended December 31, 2008, cash paid for IPO-related costs were $42.4 million. Additionally, in the year ended December 31, 2008, cash paid for legacy legal settlements were $11.7 million. Excluding the effect of asbestos-related cash flows, IPO-related costs, and legacy legal settlements, net cash provided by operating activities would have been $57.9 million, $42.9 million and $52.0 million for the years ended December 31, 2009, 2008 and 2007, respectively.

Other changes in operating cash flow items are discussed below.

Funding requirements of our defined benefit plans, including both pensions and other post-employment benefits, can vary significantly among periods due to changes in the fair value of plan assets and actuarial assumptions. For the years ended December 31, 2009, 2008 and 2007, cash contributions for defined benefit plans were $8.3 million, $6.4 million, and $8.7 million, respectively.

In 2009, $7.9 million of cash payments were made related to the Company’s restructuring initiatives.

Changes in working capital also affected the operating cash flows for the years presented. We define working capital as trade receivables plus inventories less accounts payable.

Working capital, excluding the effects of acquisitions and foreign currency translation, decreased $10.3 million from December 31, 2008 to December 31, 2009 and increased $30.5 million from December 31, 2007 to December 31, 2008. These changes were primarily due to changes in inventory levels and trade receivables due to variations in sales volume.

Investing activities consist primarily of purchases of fixed assets and cash paid for acquisitions.

In all years presented, capital expenditures were invested in new and replacement machinery, equipment and information technology. We generally target capital expenditures at approximately 2.0% to 2.5% of revenues.

In August 2009, we acquired PD-Technik for $1.3 million, net of cash acquired in the transaction.

In November 2007, we acquired Fairmount for a purchase price of $3.3 million, net of cash acquired. Purchase price adjustments of $0.4 million each in 2009 and 2008 increased the purchase price to $4.1 million, net of cash acquired.

In January 2007, we acquired LSC for a purchase price of $29.7 million, net of cash acquired.

Financing cash flows consist primarily of borrowings and repayments of indebtedness, payment of dividends to shareholders and redemptions of stock.

During 2009, we repaid $5.0 million of long-term borrowings.

In the fourth quarter of 2008, we purchased 795,000 shares of our common stock for approximately $5.7 million. We did not purchase any shares in 2009.

Our IPO proceeds in May 2008 were $193.0 million after deducting estimated accounting, legal and other expenses of $5.9 million. We used these proceeds to: (i) repay approximately $105.4 million of indebtedness outstanding under our credit facility, (ii) pay dividends to existing preferred stockholders of record immediately prior to the consummation of the IPO in the amount of $38.5 million, (iii) pay $11.8 million to the selling stockholders in the IPO as reimbursement for the underwriting discount incurred on the shares sold by them, and (iv) pay special bonuses of approximately $27.8 million to certain of our executives under previously adopted executive compensation plans. The remainder of the net proceeds was applied to working capital.

We paid approximately $3.3 million in deferred loan costs related to our new credit facility entered into May 13, 2008.

In November 2007, $10.0 million cash received from settlements with our asbestos insurers was used to pay down the revolver. In addition, the Term C was paid down by €7.0 million.

During 2007, we paid deferred stock issuance costs of $1.2 million for costs incurred related to our IPO in May 2008.

On January 3, 2007, we amended the credit facility to increase borrowings under the Term B loan by $55.0 million. Approximately $28.5 million of the proceeds were subsequently used to fund the acquisition of LSC, $24.5 million of the proceeds were used to pay down our revolver debt, and the remaining proceeds were used for other general corporate purposes.

Contractual Obligations

We are party to numerous contracts and arrangements that obligate us to make cash payments in future years. These contracts include financing arrangements such as debt agreements and leases, as well as contracts for the purchase of goods and services. The following table is a summary of our contractual obligations as of December 31, 2009 (in millions):

	Total		Less than One Year		1-3 Years		3-5 Years		More Than 5 Years

Debt & Leases:
Term Loan A	$	91.3	$	8.8	$	20.0	$	62.5		-
Interest Payments on Long-Term Debt (1)		10.9		4.7		5.6		0.6		-
Capital Leases & Other Debt		0.2		0.2		-		-		-
Operating Leases		9.8		3.9		4.1		1.6		0.2
Purchase Obligations (2)		25.3		24.6		0.6		-		0.1
Total	$	137.5	$	42.2	$	30.3	$	64.7	$	0.3

(1)	Includes estimated interest rate swap payments. Variable interest payments are estimated using a static rate of 3.7%.

(2)	Amounts exclude open purchase orders for goods or services that are provided on demand, the timing of which is not certain.

We have cash funding requirements associated with our pension and other post-retirement benefit plans, which are estimated to be approximately $6.9 million for the year ending December 31, 2010. Other long-term liabilities, such as those for asbestos and other legal claims, employee benefit plan obligations, and deferred income taxes, are excluded from the above table since they are not contractually fixed as to timing and amount.

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that provide liquidity, capital resources, market or credit risk support that expose us to any liability that is not reflected in our consolidated financial statements other than outstanding letters of credit of $14.4 million at December 31, 2009 and future operating lease payments of $9.8 million.

On November 29, 2007, we acquired Fairmount, an original equipment manufacturer of mission critical programmable automation controllers in fluid handling applications primarily for the U.S. Navy, for $4.5 million plus contingent payments based on achievement of future revenue and earnings targets over the period ending December 31, 2010. Remaining contingent payments, if any, of up to $1.3 million could result if targets are achieved.

The Company and its subsidiaries have in the past divested certain of its businesses and assets. In connection with these divestitures, certain representations, warranties and indemnities were made to purchasers to cover various risks or unknown liabilities. We cannot estimate the potential liability, if any, that may result from such representations, warranties and indemnities because they relate to unknown and unexpected contingencies; however, the Company does not believe that any such liabilities will have a material adverse effect on our financial condition, results of operations or liquidity.

Critical Accounting Policies

The methods, estimates and judgments we use in applying our critical accounting policies have a significant impact on the results we report in our financial statements. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends, and information from other outside sources as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates and different assumptions or estimates about the future could change our reported results.

We believe the following accounting policies are the most critical in that they are important to the financial statements and they require the most difficult, subjective or complex judgments in the preparation of the financial statements. For a detailed discussion on the application of these and other accounting policies, see Note 3 to the Consolidated Financial Statements.

Asbestos Liabilities and Insurance Assets

Two of our subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of our subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy.

The subsidiaries settle asbestos claims for amounts management considers reasonable given the facts and circumstances of each claim. The annual average settlement payment per asbestos claimant has fluctuated during the past several years. Management expects such fluctuations to continue in the future based upon, among other things, the number and type of claims settled in a particular period and the jurisdictions in which such claims arise. To date, the majority of settled claims have been dismissed for no payment.

Claims activity related to asbestos is as follows (1):

	Year ended December 31,
	2009			2008			2007

Claims unresolved at the beginning of the period		35,357			37,554			50,020
Claims filed (2)		3,323			4,729			6,861
Claims resolved (3)		(13,385	)		(6,926	)		(19,327	)

Claims unresolved at the end of the period		25,295			35,357			37,554

Average cost of resolved claims (4)	$	11,106		$	5,378		$	5,232

(1)	Excludes claims filed by one legal firm that have been “administratively dismissed.”

(2)	Claims filed include all asbestos claims for which notification has been received or a file has been opened.

(3)	Claims resolved include asbestos claims that have been settled or dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

(4)	Average cost of settlement to resolve claims in whole dollars. These amounts exclude claims in Mississippi for which the majority of claims have historically been without merit and have been resolved for no payment. These amounts exclude any potential insurance recoveries.

We have projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is the standard approach used by most experts and has been accepted by numerous courts. This methodology is based upon risk equations, exposed population estimates, mortality rates, and other demographic statistics. In applying the Nicholson methodology for each subsidiary we performed: 1) an analysis of the estimated population likely to have been exposed or claim to have been exposed to products manufactured by the subsidiaries based upon national studies undertaken of the population of workers believed to have been exposed to asbestos; 2) the use of epidemiological and demographic studies to estimate the number of potentially exposed people that would be likely to develop asbestos-related diseases in each year; 3) an analysis of the subsidiaries’ recent claims history to estimate likely filing rates for these diseases; and 4) an analysis of the historical asbestos liability costs to develop average values, which vary by disease type, jurisdiction and the nature of claim, to determine an estimate of costs likely to be associated with currently pending and projected asbestos claims. Our projections, based upon the Nicholson methodology, estimate both claims and the estimated cash outflows related to the resolution of such claims for periods up to and including the endpoint of asbestos studies referred to in item 2) above. It is our policy to record a liability for asbestos-related liability costs for the longest period of time that we can reasonably estimate.

Projecting future asbestos-related liability costs is subject to numerous variables that are difficult to predict, including the number of claims that might be received, the type and severity of the disease alleged by each claimant, the latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the financial resources of other companies that are co-defendants in the claims, funds available in post-bankruptcy trusts, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards, including potential tort reform. Furthermore, any projections with respect to these variables are subject to even greater uncertainty as the projection period lengthens. These trend factors have both positive and negative effects on the dynamics of asbestos litigation in the tort system and the related best estimate of our asbestos liability, and these effects do not move in linear fashion but rather change over multiple year periods. Accordingly, we monitor these trend factors over time and periodically assesses whether an alternative forecast period is appropriate. Taking these factors into account and the inherent uncertainties, we believe that we can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as our best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, we do not believe the reasonably possible loss or range of reasonably possible loss is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to litigation against the subsidiaries’ insurers are expensed as incurred.

We assessed the subsidiaries’ existing insurance arrangements and agreements, determined the applicability of insurance coverage for existing and expected future claims, analyzed publicly available information bearing on the current creditworthiness and solvency of the various insurers, and employed such insurance allocation methodologies as we believed appropriate to ascertain the probable insurance recoveries for asbestos liabilities. The analysis took into account self-insurance reserves, policy exclusions, pending litigation, liability caps and gaps in coverage, allocation agreements, indemnity arrangements with third-parties, existing and potential insolvencies of insurers as well as how legal and defense costs will be covered under the insurance policies.

During the third quarter of 2009, an analysis of claims data including filing and dismissal rates, alleged disease mix, filing jurisdiction, as well as settlement values resulted in the determination that the Company should revise its rolling 15-year estimate of asbestos-related liability for pending and future claims. As a result, the Company recorded an $11.6 million pretax charge in the third quarter of 2009, which was comprised of an increase to its asbestos-related liabilities of $111.3 million offset by expected insurance recoveries of $99.7 million.

Each subsidiary has separate insurance coverage resulting from the independent corporate history of each entity. In our evaluation of the insurance asset, we used differing insurance allocation methodologies for each subsidiary based upon the state law that will or is likely to apply for that subsidiary.

For one of the subsidiaries, the Delaware Court of Chancery ruled on October 14, 2009, that asbestos-related costs should be allocated among excess insurers using an “all sums” allocation (which allows an insured to collect all sums paid in connection with a claim from any insurer whose policy is triggered, up to the policy’s applicable limits) and that the subsidiary has rights to excess insurance policies purchased by a former owner of the business. Based upon this ruling mandating an “all sums” allocation, as well as the language of the underlying insurance policies and the determination that defense costs are outside policy limits, the Company, as of October 2, 2009, increased its future expected recovery percentage from 67% to 90% of asbestos-related costs following the exhaustion in the future of its primary and umbrella layers of insurance and recorded a pretax gain of $17.3 million. The subsidiary expects to be responsible for approximately 10% of all future asbestos-related costs.

In November 2008, the subsidiary entered into a settlement agreement with the primary and umbrella carrier governing all aspects of the carrier’s past and future handling of the asbestos related bodily injury claims against the subsidiary. As a result of this agreement, during the third quarter of 2008, the Company increased its insurance asset by $7.0 million attributable to resolution of a dispute concerning certain pre-1966 insurance policies and recorded a corresponding pretax gain. The additional insurance will be allocated by the carrier to cover any gaps in coverage up to $7.0 million resulting from exhaustion of umbrella policies and/or the failure of any excess carrier to pay amounts incurred in connection with asbestos claims. The Company reimbursed the primary insurer for $7.6 million in deductibles and retrospective premiums in the fourth quarter of 2008 and has no further liability to the insurer under these provisions of the primary policies.

This subsidiary’s primary and umbrella insurance coverage was exhausted in the first quarter of 2010. No cost sharing or allocation agreement is currently in place with the Company’s excess insurers; however, certain excess insurers have stated that they will abide by the Delaware Chancery Court's recent coverage rulings, including its ruling that the subsidiary may seek insurance coverage from the Company's excess insurers on and “all sums” basis and that they will defend and/or indemnify the subsidiary against asbestos claims, subject to their reservation of rights.

In 2003, the other subsidiary brought legal action against a large number of its insurers and its former parent to resolve a variety of disputes concerning insurance for asbestos-related bodily injury claims asserted against it. Although none of these insurance companies contested coverage, they disputed the timing, reasonableness and allocation of payments. For this subsidiary it was determined by court ruling in the fourth quarter of 2007, that the allocation methodology mandated by the New Jersey courts will apply. Further court rulings in December of 2009, clarified the allocation calculation related to amounts currently due from insurers as well as amounts the Company expects to be reimbursed for asbestos-related costs incurred in future periods. As a result, in the fourth quarter of 2009, the Company increased its receivable for past costs by $11.9 million and decreased its insurance asset for future costs by $9.8 million and recorded a pretax gain of $2.1 million. The subsidiary expects to responsible for approximately 14% of all future asbestos-related costs.

The Company has established reserves of $443.8 million and $357.3 million as of December 31, 2009 and December 31, 2008, respectively, for the probable and reasonably estimable asbestos-related liability cost it believes the subsidiaries will pay through the next 15 years. It has also established recoverables of $389.4 million and $304.0 million as of December 31, 2009 and December 31, 2008, respectively, for the insurance recoveries that are deemed probable during the same time period. Net of these recoverables, the expected cash outlay on a non-discounted basis for asbestos-related bodily injury claims over the next 15 years was $54.3 million and $53.3 million as of December 31, 2009 and December 31, 2008, respectively. In addition, the Company has recorded a receivable for liability and defense costs previously paid in the amount of $45.9 million and $36.4 million as of December 31, 2009 and December 31, 2008, respectively, for which insurance recovery is deemed probable. The Company has recorded the reserves for the asbestos liabilities as “Accrued asbestos liability” and “Long-term asbestos liability” and the related insurance recoveries as “Asbestos insurance asset” and “Long-term asbestos insurance asset”. The receivable for previously paid liability and defense costs is recorded in “Asbestos insurance receivable” and “Long-term asbestos insurance receivable” in the accompanying consolidated balance sheets.

The income related to these liabilities and legal defense was $2.2 million, net of estimated insurance recoveries, for the year ended December 31, 2009 compared to $4.8 million and $63.9 million for the years ended December 31, 2008 and 2007, respectively. Legal costs related to the subsidiaries’ action against their asbestos insurers were $11.7 million for the year ended December 31, 2009 compared to $17.2 million and $13.6 million for the years ended December 31, 2008 and 2007, respectively.

Management’s analyses are based on currently known facts and a number of assumptions. However, projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect our financial condition, results of operations or cash flow.

Retirement Benefits

Pension obligations and other post-retirement benefits are actuarially determined and are affected by several assumptions, including the discount rate, assumed annual rates of return on plan assets, and per capita cost of covered health care benefits. Changes in discount rate and differences from actual results for each assumption will affect the amounts of pension expense and other post-retirement expense recognized in future periods. These assumptions may also have an effect on the amount and timing of future cash contributions.

Impairment of Goodwill and Indefinite-Lived Intangible Assets

Goodwill represents the costs in excess of the fair value of net assets acquired associated with our acquisitions.

We evaluate the recoverability of goodwill and indefinite-lived intangible assets annually on December 31 or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. Goodwill is considered to be impaired when the net book value of a reporting unit exceeds its estimated fair value.

In the evaluation of goodwill for impairment, we first compare the fair value of the reporting unit to its carrying value. If the carrying value of a reporting unit exceeds its fair value, the goodwill of that reporting unit is potentially impaired and step two of the impairment analysis is performed. In step two of the analysis, an impairment loss is recorded equal to the excess of the carrying value of the reporting unit’s goodwill over its implied fair value should such a circumstance arise.

We measure fair value of reporting units based on a present value of future discounted cash flows or a market valuation approach. The discounted cash flows model indicates the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flows model include: the weighted average cost of capital; long-term rate of growth and profitability of our business; and working capital effects. The market valuation approach indicates the fair value of the business based on a comparison of the Company against certain market information. Significant estimates in the market approach model include identifying appropriate market multiples and assessing earnings before interest, income taxes, depreciation and amortization (EBITDA) in estimating the fair value of the reporting units.

The analysis performed for each of the years ended December 31, 2009, 2008 and 2007 indicated no impairment to be present. However, actual results could differ from our estimates and projections, which would affect the assessment of impairment. As of December 31, 2009, we have goodwill of $163.4 million that is subject to at least annual review of impairment.

Income Taxes

We account for income taxes under the asset and liability method, which requires that deferred tax assets and liabilities be recognized using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. Deferred tax assets are reduced by a valuation allowance if it is more likely than not that some portion of the deferred tax asset will not be realized. In evaluating the need for a valuation allowance, we take into account various factors, including the expected level of future taxable income and available tax planning strategies. If actual results differ from the assumptions made in the evaluation of our valuation allowance, we record a change in valuation allowance through income tax expense in the period such determination is made.

During the year ending December 31, 2009, the valuation allowance decreased from $45.2 million to $45.1 million with the decrease recognized in income tax expense. The $0.1 million net decrease in 2009 was primarily attributable to a corresponding reduction in deferred tax assets due to the pension restatement, offset in part by an increase attributable to certain separate company losses we believe may not be realized. Consideration was given to U.S. tax planning strategies and future U.S. taxable income as to how much of the total U.S. deferred tax asset could be realized on a more likely than not basis. If economic conditions adversely affect our ability to generate future U.S. taxable income, additional valuation allowances may be needed.

The determination of our provision for income tax requires significant judgment, the use of estimates, and the interpretation and application of complex tax laws. Significant judgment is required in assessing the timing and amounts of deductible and taxable items. We establish reserves when, despite the belief that the tax return positions are fully supportable, we believe that certain positions may be successfully challenged. When facts and circumstances change, the reserves are adjusted through the provision for income taxes. Tax benefits are not recognized until minimum recognition thresholds are met as prescribed by applicable accounting standards.

Revenue Recognition

We recognize revenues and costs from product sales when all of the following criteria are met: persuasive evidence of an arrangement exists, the price is fixed or determinable, product delivery has occurred or services have been rendered, there are no further obligations to customers, and collectibility is probable. Product delivery occurs when title and risk of loss transfer to the customer. Our shipping terms vary based on the contract. If any significant obligations to the customer with respect to such sale remain to be fulfilled following shipment, typically involving obligations relating to installation and acceptance by the buyer, revenue recognition is deferred until such obligations have been fulfilled. Any customer allowances and discounts are recorded as a reduction in reported revenues at the time of sale because these allowances reflect a reduction in the purchase price for the products purchased. These allowances and discounts are estimated based on historical experience and known trends. Revenue related to service agreements is recognized as revenue over the term of the agreement.

For long-term contracts, revenue is generally recognized based on the percentage-of-completion method calculated on the units of delivery basis or the cost-to-cost basis. The percentage of completion method requires estimates of total expected contract revenue and costs. We follow this method when we can make reasonably dependable estimates of the revenue and cost applicable to various stages of the contract. Revisions in profit estimates are reflected in the period in which the facts that gave rise to the revision become known and have historically been insignificant. Percentage of completion revenue was approximately 2.2%, 0.9%, and 2.9% of consolidated revenues for the years ended December 31, 2009, 2008 and 2007, respectively. Service revenues are recognized as services are performed.

We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments. These allowances are based on recent trends of certain customers estimated to be a greater credit risk as well as general trends of the entire pool of customers. The allowance for doubtful accounts was $2.8 million and $2.5 million as of December 31, 2009 and 2008, respectively. If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.

The foregoing criteria are used for all classes of customers including original equipment manufacturers, distributors, government contractors and other end users.

Stock-Based Compensation

Pursuant to our 2008 omnibus incentive plan, our board of directors may make awards in the form of shares of restricted stock, stock options and restricted stock units (“RSUs”) and other stock-based awards. We measure and recognize the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award, with limited exceptions. That cost is recognized over the period during which an employee is required to provide service in exchange for the award—the requisite service period or vesting period. No compensation cost is recognized for equity instruments for which employees do not render the requisite service. We have equity incentive plans to encourage employees and non-employee directors to remain with us and to more closely align their interests with those of our shareholders.

For purposes of calculating stock-based compensation, the fair value of restricted stock or restricted stock units granted is equal to the market value of a share of common stock on the date of the grant. For grants that were awarded on May 7, 2008 in conjunction with our initial public offering, we used the initial public offering price as the fair value of the restricted stock and restricted stock units granted. For stock options, we estimate the fair value on the date of grant using the Black-Scholes option-pricing model. The determination of fair value using the Black-Scholes model requires a number of complex and subjective variables. One key input into the model is the fair value of our common stock on the date of grant, the initial public offering price in the case of stock options issued on May 7, 2008. Other key variables in the Black-Scholes option-pricing model include the expected volatility of our common stock price, the expected term of the award and the risk-free interest rate. In addition, we are required to estimate forfeitures of unvested awards when recognizing compensation expense. Significant assumptions used to calculate stock-based compensation during the years ended December 31, 2009 and 2008 were a stock price volatility of 32.5% and 32.4%, respectively, an expected option life of 4.5 years, a risk-free interest rate based on the 5-year treasury note yield on the date of grant ranging from 1.9% to 2.5% in 2009 and 2.5 % to 3.1% in 2008 and a 0% expected dividend yield.

Stock-based compensation expense recognized for the years ended December 31, 2009 and 2008 was $2.6 million and $11.3 million, respectively. No stock-based compensation expense was recognized for the year ended December 31, 2007. We cannot predict with certainty the impact of stock-compensation expense to be recognized in the future because the actual amount of stock-based compensation expense we record in any fiscal period will be dependent on a number of factors, including the number of shares subject to the stock awards issued, the fair value of our common stock at the time of issuance and the expected volatility of our stock price over time. However, based on awards we currently expect to make in 2010, stock-based compensation for the year ended December 31, 2010 is projected to be approximately $3.4 million.

Recent Pronouncements

See Note 4 to our Consolidated Financial Statements for a discussion of recently issued accounting pronouncements.

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk from changes in interest rates, foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities.

Information concerning market risk for the year ended December 31, 2009 is discussed below.

Interest Rate Risk

We are subject to exposure from changes in interest rates based on our financing activities. Under our credit facility, all of our borrowings at December 31, 2009 are variable rate facilities based on LIBOR or EURIBOR. In order to mitigate our interest rate risk, we periodically enter into interest rate swap or collar agreements. A hypothetical increase in the interest rate of 1.00% during 2009 on our variable rate debt that is not hedged would have increased our interest cost by approximately $0.2 million.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar and against the currencies of other countries in which we manufacture and sell products and services. During 2009, approximately 66% of our sales were derived from operations outside the U.S., with approximately 63% generated from our European operations. In particular, we have more sales in European currencies than we have expenses in those currencies. Therefore, when European currencies strengthen or weaken against the U.S. dollar, operating profits are increased or decreased, respectively. To assist with the matching of revenues and expenses and assets and liabilities in foreign currencies, we may periodically enter into derivative instruments such as cross currency swaps or forward contracts. To illustrate the potential impact of changes in foreign currency exchange rates, assuming a 10% increase in average foreign exchange rates compared to the U.S. dollar, 2009 income before income taxes would have increased by $3.1 million.

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. Commodity futures contracts are periodically used to manage such exposure. As of December 31, 2009, we had no open commodity futures contracts.

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

INDEX TO FINANCIAL STATEMENTS

		Page
Audited Financial Statements for the Years Ended December 31, 2009, 2008 and 2007:

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial Reporting		43

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm		45

Consolidated Statements of Operations		46

Consolidated Balance Sheets		47

Consolidated Statements of Shareholders’ Equity and Comprehensive Income (Loss)		48

Consolidated Statements of Cash Flows		49

Notes to Consolidated Financial Statements		50

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm,

on Internal Control Over Financial Reporting

The Board of Directors and Shareholders of Colfax Corporation

We have audited Colfax Corporation’s internal control over financial reporting as of December 31, 2009, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Colfax Corporation’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our report dated February 25, 2010, we expressed an unqualified opinion that the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2009, based on the COSO criteria. Management has subsequently determined that a deficiency in controls relating to the maintenance and review of pension plan participant data existed as of the previous assessment date, and has further concluded that such deficiency represented a material weakness as of December 31, 2009. As a result, management has revised its assessment, as presented in the accompanying Management’s Report on Internal Control over Financial Reporting, to conclude that the Company’s internal control over financial reporting was not effective as of December 31, 2009. Accordingly, our present opinion on the effectiveness of the Company’s internal control over financial reporting as of December 31, 2009, as expressed herein, is different from that expressed in our previous report.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The following material weakness has been identified and included in management’s assessment. Management has identified a material weakness in its internal controls related to the maintenance and review of pension plan participant data. This material weakness resulted in the restatement of the Company’s consolidated financial statements as of and for the years ended December 31, 2007, 2008 and 2009. We have also audited, in accordance with the standards of the Public Accounting Oversight Board (United States), the consolidated balance sheets of Colfax Corporation as of December 31, 2009 and 2008 and the related consolidated statements of income, shareholder’s equity (deficit) and cash flows for each of the three years in the period ending December 31, 2009. This material weakness was considered in determining the nature, timing, and extent of audit tests applied in our audit of the 2009 financial statements and this report does not affect our report dated February 25, 2010, except for the effects of the matters described in Note 2, as to which the date is December 13, 2010, on those financial statements (as restated).

In our opinion, because of the effect of the material weakness described above on the achievement of the objectives of the control criteria, Colfax Corporation has not maintained effective internal control over financial reporting as of December 31, 2009, based on the COSO criteria.

/s/ Ernst & Young LLP

Richmond, Virginia

February 25, 2010

except for the effects of the material weakness described in the sixth paragraph above, as to which the date is

December 13, 2010

Report of Ernst & Young LLP, Independent Registered Public Accounting Firm

The Board of Directors and Shareholders of Colfax Corporation

We have audited the accompanying consolidated balance sheets of Colfax Corporation as of December 31, 2009 and 2008, and the related consolidated statements of income, shareholders’ equity (deficit), and cash flows for each of the three years in the period ended December 31, 2009. Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Colfax Corporation at December 31, 2009 and 2008, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2009, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly in all material respects the information set forth therein.

As more fully discussed in Note 2, the Company has restated the accompanying consolidated financial statements and financial statement schedule for all periods presented to correct an error in accounting for certain of its defined benefit pension plans.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Colfax Corporation’s internal control over financial reporting as of December 31, 2009, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 25, 2010, except for the effects of the material weakness described in the sixth paragraph of that report, as to which the date is December 13, 2010, expressed an adverse opinion thereon.

/s/ Ernst & Young LLP

Richmond, Virginia

February 25, 2010

except for the effects of the matters described in Note 2, as to which the date is

December 13, 2010

COLFAX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

Dollars in thousands, except per share amounts

	Year ended December 31,
	2009			2008			2007
	Restated			Restated			Restated

Net sales	$	525,024		$	604,854		$	506,305
Cost of sales		339,237			387,667			330,714

Gross profit		185,787			217,187			175,591
Selling, general and administrative expenses		112,503			124,105			97,426
Restructuring and other related charges		18,175			-			-
Initial public offering related costs		-			57,017			-
Research and development expenses		5,930			5,856			4,162
Asbestos liability and defense income		(2,193	)		(4,771	)		(63,978	)
Asbestos coverage litigation expenses		11,742			17,162			13,632
Operating income		39,630			17,818			124,349
Interest expense		7,212			11,822			19,246

Income before income taxes		32,418			5,996			105,103
Provision for income taxes		8,621			5,465			39,457

Net income		23,797			531			65,646

Dividends on preferred stock		-			(3,492	)		(25,816	)

Net income (loss) available to common shareholders	$	23,797		$	(2,961	)	$	39,830

Net income (loss) per share—basic and diluted	$	0.55		$	(0.08	)	$	1.82

See accompanying notes to consolidated financial statements.

COLFAX CORPORATION

CONSOLIDATED BALANCE SHEETS

Dollars in thousands, except per share amounts

	December 31,
	2009			2008
	Restated			Restated
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	49,963		$	28,762
Trade receivables, less allowance for doubtful accounts of $2,837 and $2,486		88,493			101,064
Inventories, net		71,150			80,327
Deferred income taxes, net		7,114			6,489
Asbestos insurance asset		31,502			26,473
Asbestos insurance receivable		28,991			36,371
Prepaid expenses		11,109			9,632
Other current assets		2,426			5,901

Total current assets		290,748			295,019
Deferred income taxes, net		51,838			53,372
Property, plant and equipment, net		92,090			92,090
Goodwill		163,418			161,694
Intangible assets, net		11,952			13,516
Long-term asbestos insurance asset		357,947			277,542
Long-term asbestos insurance receivable		16,876			-
Deferred loan costs, pension and other assets		14,532			14,317
Total assets	$	999,401		$	907,550
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt and capital leases	$	8,969		$	5,420
Accounts payable		36,579			52,138
Accrued asbestos liability		34,866			28,574
Accrued payroll		17,756			19,162
Accrued taxes		2,154			11,457
Accrued termination benefits		9,473			-
Other accrued liabilities		34,402			37,535

Total current liabilities		144,199			154,286
Long-term debt, less current portion		82,516			91,701
Long-term asbestos liability		408,903			328,684
Pension and accrued post-retirement benefits		105,230			110,218
Deferred income tax liability		10,375			7,685
Other liabilities		31,353			33,601
Total liabilities		782,576			726,175
Shareholders’ equity:
Common stock: $0.001 par value; authorized 200,000,000; issued and outstanding 43,229,104 and 43,211,026		43			43
Additional paid-in capital		402,852			400,259
Retained deficit		(76,273	)		(100,070	)
Accumulated other comprehensive loss		(109,797	)		(118,857	)
Total shareholders’ equity		216,825			181,375
Total liabilities and shareholders' equity	$	999,401		$	907,550

See accompanying notes to consolidated financial statements.

COLFAX CORPORATION

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY AND

COMPREHENSIVE INCOME (LOSS)

Years ended December 31, 2009, 2008 and 2007

Dollars in thousands

	Preferred Stock			Common Stock			Additional Paid-In Capital			Retained Deficit (Restated)			Accumulated Other Comprehensive Loss (Restated)			Total (Restated)

Balance as previously reported at December 31, 2006	$	1		$	22		$	201,660		$	(141,561	)	$	(54,223	)	$	5,899
Cumulative adjustment for restatement (see Note 2)											11,365			1,751			13,116
Restated Balance at December 31, 2006		1			22			201,660			(130,196	)		(52,472	)		19,015
Comprehensive income:
Net income		-			-			-			65,646			-			65,646
Foreign currency translation, net of $265 tax expense		-			-			-			-			8,952			8,952
Changes in unrecognized pension and postretirement benefit costs, net of $4,158 tax expense		-			-			-			-			3,900			3,900
Amounts reclassified to net income:
Net realized investment gains, net of $409 tax benefit		-			-			-			-			(667	)		(667	)
Net pension and other postretirement benefit costs, net of $1,590 tax expense		-			-			-			-			2,149			2,149
Total comprehensive income		-			-			-			65,646			14,334			79,980
Adoption of new accounting standard (see Note 6)		-			-			-			(6,743	)		-			(6,743	)
Preferred dividends declared		-			-			-			(25,816	)		-			(25,816	)
Balance at December 31, 2007		1			22			201,660			(97,109	)		(38,138	)		66,436
Comprehensive income (loss):
Net income		-			-			-			531			-			531
Foreign currency translation, net of $-0- tax		-			-			-			-			(10,662	)		(10,662	)
Unrealized losses on hedging activities, net of $-0- tax		-			-			-			-			(5,815	)		(5,815	)
Changes in unrecognized pension and postretirement benefit costs, net of $1,731 tax benefit		-			-			-			-			(67,630	)		(67,630	)
Amounts reclassified to net income:
Losses on hedging activities, net of $-0- tax		-			-			-			-			766			766
Net pension and other postretirement benefit costs, net of $128 tax expense		-			-			-			-			2,622			2,622
Total comprehensive loss		-			-			-			531			(80,719	)		(80,188	)
Net proceeds from initial public offering and conversion of preferred stock		(1	)		22			192,999			-			-			193,020
Stock repurchase		-			(1	)		(5,730	)		-			-			(5,731	)
Stock-based compensation		-			-			11,330			-			-			11,330
Preferred dividends declared		-			-			-			(3,492	)		-			(3,492	)
Balance at December 31, 2008		-			43			400,259			(100,070	)		(118,857	)		181,375
Comprehensive income:
Net income		-			-			-			23,797			-			23,797
Foreign currency translation, net of $7 tax benefit		-			-			-			-			5,401			5,401
Unrealized gains on hedging activities, net of $-0- tax		-			-			-			-			(866	)		(866	)
Changes in unrecognized pension and postretirement benefit costs, net of $572 tax benefit		-			-			-			-			(910	)		(910	)
Amounts reclassified to net income:
Losses on hedging activities, net of $-0- tax		-			-			-			-			2,881			2,881
Net pension and other postretirement benefit costs, net of $1,438 tax expense		-			-			-			-			2,554			2,554
Total comprehensive income		-			-			-			23,797			9,060			32,857
Stock-based compensation		-			-			2,593			-			-			2,593
Balance at December 31, 2009	$	-		$	43		$	402,852		$	(76,273	)	$	(109,797	)	$	216,825

See accompanying notes to consolidated financial statements.

COLFAX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

Dollars in thousands

	Year ended December 31,
	2009			2008			2007
	Restated			Restated			Restated
Cash flows from operating activities:
Net income	$	23,797		$	531		$	65,646
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Depreciation, amortization and fixed asset impairment charges		15,074			14,788			15,239
Noncash stock-based compensation		2,593			11,330			-
Write off of deferred loan costs		-			4,614			-
Amortization of deferred loan costs		677			934			1,644
Loss (gain) on sale of fixed assets		(64	)		60			(35	)
Deferred income taxes		2,689			(13,330	)		22,496
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables		16,280			(20,612	)		(3,149	)
Inventories		10,763			(15,556	)		(2,279	)
Accounts payable and accrued liabilities, excluding asbestos related accrued expenses		(20,899	)		7,044			8,748
Other current assets		2,605			(3,285	)		(2,304	)
Change in asbestos liability and asbestos-related accrued expenses, net of asbestos insurance asset and receivable		(10,166	)		(9,457	)		(27,807	)
Changes in other operating assets and liabilities		(5,063	)		(10,042	)		(3,716	)

Net cash provided by (used in) operating activities		38,286			(32,981	)		74,483

Cash flows from investing activities:
Purchases of fixed assets		(11,006	)		(18,645	)		(13,671	)
Acquisitions, net of cash received		(1,260	)		(439	)		(32,987	)
Proceeds from sale of fixed assets		219			23			133
Net cash used in investing activities		(12,047	)		(19,061	)		(46,525	)

Cash flows from financing activities:
Borrowings under term credit facility		-			100,000			55,000
Payments under term credit facility		(5,000	)		(210,278	)		(11,791	)
Proceeds from borrowings on revolving credit facilities		-			28,185			58,000
Repayments of borrowings on revolving credit facilities		-			(28,158	)		(86,500	)
Payments on capital leases		(417	)		(309	)		(449	)
Payments for loan costs		-			(3,347	)		(1,368	)
Payment of deferred stock issuance costs		-			-			(1,155	)
Proceeds from the issuance of common stock, net of offering costs		-			193,020			-
Repurchases of common stock		-			(5,731	)		-
Dividends paid to preferred shareholders		-			(38,546	)		-
Net cash (used in) provided by financing activities		(5,417	)		34,836			11,737

Effect of exchange rates on cash		379			(2,125	)		790

Increase (decrease) in cash and cash equivalents		21,201			(19,331	)		40,485
Cash and cash equivalents, beginning of year		28,762			48,093			7,608
Cash and cash equivalents, end of year	$	49,963		$	28,762		$	48,093

Cash interest paid	$	6,615		$	9,970		$	16,978
Cash income taxes paid	$	16,596		$	18,534		$	12,931

See accompanying notes to consolidated financial statements.

COLFAX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

December 31, 2009, 2008 and 2007

Dollars in thousands, unless otherwise noted

1. Organization and Nature of Operations

Colfax Corporation (the “Company”, “Colfax”, “we”, “our” or “us”) is a global supplier of a broad range of fluid handling products, including pumps, fluid handling systems and controls, and specialty valves. We believe that we are a leading manufacturer of rotary positive displacement pumps, which include screw pumps, gear pumps and progressive cavity pumps. We have a global manufacturing footprint, with production facilities in Europe, North America and Asia, as well as worldwide sales and distribution channels. Our products serve a variety of applications in five strategic markets: commercial marine, oil and gas, power generation, global navy and general industrial. We design and engineer our products to high quality and reliability standards for use in critical fluid handling applications where performance is paramount. We also offer customized fluid handling solutions to meet individual customer needs based on our in-depth technical knowledge of the applications in which our products are used. Our products are marketed principally under the Allweiler, Fairmount, Houttuin, Imo, LSC, Portland Valve, Tushaco, Warren, and Zenith brand names. We believe that our brands are widely known and have a premium position in our industry. Allweiler, Houttuin, Imo and Warren are among the oldest and most recognized brands in the fluid handling industry, with Allweiler dating back to 1860.

2. Restatement

On October 19, 2010, the Audit Committee of the Company’s Board of Directors concluded, based upon the recommendation of the Company’s management, that the Company should restate these financial statements to correct an overstatement of its pension liability. The Company has restated all periods in the accompanying consolidated financial statements.

This amendment also contains two immaterial balance sheet reclassification corrections at December 31, 2009 to reclassify a portion of the asbestos insurance asset from long term to current and to reflect certain property previously recorded in other assets as property, plant and equipment.

The following tables set forth the effects of the restatement on affected line items within the Company’s previously reported financial statements. The income tax effects of the restatement include the effects of reductions to the valuation allowance for deferred tax assets as a result of the reduction in grross deferred tax assets (See Note 6, Income Taxes):

CONSOLIDATED STATEMENTS OF OPERATIONS

	Year Ended
	December 31, 2009
	As
	Previously					As
	Reported		Adjustment			Restated
Selling, general and administrative expenses	$	113,674	$	(1,171	)	$	112,503
Operating income		38,459		1,171			39,630
Income before income taxes		31,247		1,171			32,418
Provision for income taxes		9,525		(904	)		8,621
Net income		21,722		2,075			23,797
Net income available to common shareholders		21,722		2,075			23,797
Net income per share—basic and diluted	$	0.50	$	0.05		$	0.55

	Year Ended
	December 31, 2008
	As
	Previously						As
	Reported			Adjustment			Restated
Selling, general and administrative expenses	$	125,234		$	(1,129	)	$	124,105
Operating income		16,689			1,129			17,818
Income before income taxes		4,867			1,129			5,996
Provision for income taxes		5,438			27			5,465
Net (loss) income		(571	)		1,102			531
Net (loss) income available to common shareholders		(4,063	)		1,102			(2,961	)
Net (loss) income per share—basic and diluted	$	(0.11	)	$	0.03		$	(0.08	)

	Year Ended
	December 31, 2007
	As
	Previously					As
	Reported		Adjustment			Restated
Selling, general and administrative expenses	$	98,500	$	(1,074	)	$	97,426
Operating income		123,275		1,074			124,349
Income before income taxes		104,029		1,074			105,103
Provision for income taxes		39,147		310			39,457
Net income		64,882		764			65,646
Net income available to common shareholders		39,066		764			39,830
Net income per share—basic and diluted	$	1.79	$	0.03		$	1.82

CONSOLIDATED BALANCE SHEETS

	December 31, 2009									December 31, 2008
	As									As
	Previously			Adjustment and			As			Previously						As
	Reported			Reclassifications			Restated			Reported			Adjustment			Restated
Deferred income taxes, net	$	6,823		$	291		$	7,114		$	6,327		$	162		$	6,489
Asbestos insurance asset		30,606			896			31,502			26,473			-			26,473
Total current assets		289,561			1,187			290,748			294,857			162			295,019
Deferred income taxes, net		52,023			(185	)		51,838			53,428			(56	)		53,372
Property, plant and equipment, net		90,434			1,656			92,090			92,090			-			92,090
Goodwill		167,254			(3,836	)		163,418			165,530			(3,836	)		161,694
Long-term asbestos insurance asset		358,843			(896	)		357,947			277,542			-			277,542
Deferred loan costs, pension and other assets		16,188			(1,656	)		14,532			16,113			(1,796	)		14,317
Total assets		1,003,131			(3,730	)		999,401			913,076			(5,526	)		907,550

Pension and accrued post-retirement benefits		126,953			(21,723	)		105,230			130,188			(19,970	)		110,218
Total liabilities		804,299			(21,723	)		782,576			746,145			(19,970	)		726,175
Retained deficit		(91,579	)		15,306			(76,273	)		(113,301	)		13,231			(100,070	)
Accumulated other comprehensive loss		(112,484	)		2,687			(109,797	)		(120,070	)		1,213			(118,857	)
Total shareholders’ equity		198,832			17,993			216,825			166,931			14,444			181,375
Total liabilities and shareholders' equity	$	1,003,131		$	(3,730	)	$	999,401		$	913,076		$	(5,526	)	$	907,550

The cumulative adjustment to retained deficit as of January 1, 2008 was a decrease of $12.1 million.

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Year Ended
	December 31, 2009
	As
	Previously						As
	Reported			Adjustment			Restated
Cash flows from operating activities:
Net income	$	21,722		$	2,075		$	23,797
Deferred income taxes		3,593			(904	)		2,689
Accounts payable and accrued liabilities, excluding asbestos		(20,899	)		-			(20,899	)
Changes in other operating assets and liabilities		(3,892	)		(1,171	)		(5,063	)
Net cash provided by (used in) operating activities		38,386			-			38,386

	Year Ended
	December 31, 2008
	As
	Previously						As
	Reported			Adjustment			Restated
Cash flows from operating activities:
Net income	$	(571	)	$	1,102		$	531
Deferred income taxes		(13,357	)		27			(13,330	)
Accounts payable and accrued liabilities, excluding asbestos		7,020			24			7,044
Changes in other operating assets and liabilities		(8,889	)		(1,153	)		(10,042	)
Net cash provided by (used in) operating activities		(32,981	)		-			(32,981	)

	Year Ended
	December 31, 2007
	As
	Previously						As
	Reported			Adjustment			Restated
Cash flows from operating activities:
Net income	$	64,882		$	764		$	65,646
Deferred income taxes		22,186			310			22,496
Accounts payable and accrued liabilities, excluding asbestos		8,772			(24	)		8,748
Changes in other operating assets and liabilities		(2,666	)		(1,050	)		(3,716	)
Net cash provided by (used in) operating activities		74,483			-			74,483

CONSOLIDATED COMPREHENSIVE INCOME (LOSS)

	As
	Previously						As
	Reported			Adjustment			Restated

Year ended December 31, 2007	$	14,829		$	(495	)	$	14,334

Year ended December 31, 2008	$	(80,676	)	$	(43	)	$	(80,719	)

Year ended December 31, 2009	$	7,586		$	1,474		$	9,060

3. Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its subsidiaries. The Company owns 44% of the common shares of Sistemas Centrales de Lubricación S.A. de C.V., a Mexican company and 28% of the common shares of Allweiler Al-Farid Pumps Company (S.A.E.), an Egyptian Corporation. These investments are recorded in these financial statements using the equity method of accounting. Accordingly, $6.6 million and $5.4 million are recorded in other assets on the consolidated balance sheets at December 31, 2009 and 2008, respectively. The Company records its share of these investments’ net earnings, based on its economic ownership percentage. Accordingly, $1.5 million of earnings from equity investments were included as a reduction of selling, general and administrative expenses on the consolidated statements of operations for each of the three years ended December 31, 2009, 2008 and 2007, respectively. All significant intercompany accounts and transactions have been eliminated.

Revenue Recognition

The Company generally recognizes revenues and costs from product sales when all of the following criteria are met: persuasive evidence of an arrangement exists, the price is fixed and determinable, product delivery has occurred or services have been rendered, there are no further obligations to customers, and collectibility is probable. Product delivery occurs when title and risk of loss transfer to the customer. The Company’s shipping terms vary based on the contract. If any significant obligations to the customer with respect to such sale remain to be fulfilled following shipments, typically involving obligations relating to installation and acceptance by the buyer, revenue recognition is deferred until such obligations have been fulfilled. Any customer allowances and discounts are recorded as a reduction in reported revenues at the time of sale because these allowances reflect a reduction in the sales price for the products sold. These allowances and discounts are estimated based on historical experience and known trends. Revenue related to service agreements is recognized as revenue over the term of the agreement.

In some cases, customer contracts may include multiple deliverables for product shipments and installation or maintenance labor. The cost of the products is generally quoted separately from the service costs, and the services that are provided are available from other vendors. Revenues from product shipments on this type of contract are recognized when title and risk of loss transfer to the customer, and the service revenue components are recognized as services are performed.

For long-term contracts, revenue is generally recognized based on the percentage-of-completion method calculated on the units of delivery basis or the cost-to-cost basis. Percentage of completion revenue was approximately 2.2%, 0.9%, and 2.9% of consolidated revenues for the years ended December 31, 2009, 2008 and 2007, respectively. For long-term contracts in which reasonable estimates cannot be made, the Company uses the completed contract method.

Amounts billed for shipping and handling are recorded as revenue. Shipping and handling expenses are recorded as cost of sales. Progress billings are generally shown as a reduction of inventory unless such billings are in excess of accumulated costs, in which case such balances are included in accrued liabilities. The Company accrues for bad debts, as a component of selling, general, and administrative expenses, based upon estimates of amounts deemed uncollectible and a specific review of significant delinquent accounts factoring in current and expected economic conditions. Product return reserves are accrued at the time of sale based on historical rates, and are recorded as a reduction to net sales.

Taxes Collected from Customers and Remitted to Governmental Authorities

The Company collects various taxes and fees as an agent in connection with the sale of products and remits these amounts to the respective taxing authorities. These taxes and fees have been presented on a net basis in the consolidated statements of operations and are recorded as a liability until remitted to the respective taxing authority.

Research and Development

Research and development costs are expensed as incurred.

Advertising

Advertising costs of $0.5 million, $0.9 million, and $0.6 million for years ending December 31, 2009, 2008 and 2007, respectively, are expensed as incurred and have been included in selling, general and administrative expenses.

Cash and Cash Equivalents

Cash and cash equivalents include all financial instruments purchased with an initial maturity of three months or less.

Trade Receivables

Receivables are presented net of allowances for doubtful accounts. The Company records the allowance for doubtful accounts based on its best estimate of probable losses incurred in the collection of accounts receivable. Estimated losses are based on historical collection experience, and are reviewed periodically by management.

Inventories

Inventories include the costs of material, labor and overhead. Inventories are stated at the lower of cost or market. Cost is primarily determined using the first-in, first-out method. The Company periodically reviews its quantities of inventories on hand and compares these amounts to the expected usage of each particular product. The Company records as a charge to cost of sales any amounts required to reduce the carrying value of inventories to net realizable value.

Property, Plant and Equipment

Property, plant and equipment are stated at historical cost, which includes the fair values of such assets acquired. Depreciation of property, plant and equipment is provided for on a straight-line basis over estimated useful lives ranging from three to 40 years. Assets recorded under capital leases are amortized over the shorter of their estimated useful lives or the lease terms. The estimated useful lives or lease terms of assets range from three to 40 years. Repairs and maintenance expenditures are expensed as incurred unless the repair extends the useful life of the asset.

Impairment of Goodwill and Indefinite-Lived Intangible Assets

Goodwill represents the costs in excess of the fair value of net assets acquired associated with acquisitions by the Company.

The Company evaluates the recoverability of goodwill and indefinite-lived intangible assets annually on December 31 or more frequently if an event occurs or circumstances change in the interim that would more likely than not reduce the fair value of the asset below its carrying amount. Goodwill is considered to be impaired when the net book value of a reporting unit exceeds its estimated fair value.

In the evaluation of goodwill for impairment, the Company first compares the fair value of the reporting unit to its carrying value. If the carrying value of a reporting unit exceeds its fair value, the goodwill of that reporting unit is potentially impaired and step two of the impairment analysis is performed. In step two of the analysis, an impairment loss is recorded equal to the excess of the carrying value of the reporting unit’s goodwill over its implied fair value should such a circumstance arise.

The Company measures fair value of reporting units based on a present value of future discounted cash flows or a market valuation approach. The discounted cash flows model indicates the fair value of the reporting units based on the present value of the cash flows that the reporting units are expected to generate in the future. Significant estimates in the discounted cash flows model include: the weighted average cost of capital; long-term rate of growth and profitability of our business; and working capital effects. The market valuation approach indicates the fair value of the business based on a comparison of the Company against certain market information. Significant estimates in the market approach model include identifying appropriate market multiples and assessing earnings before interest, income taxes, depreciation and amortization (EBITDA) in estimating the fair value of the reporting units.

The analysis performed for each of the years ended December 31, 2009, 2008 and 2007 indicated no impairment to be present.

Impairment of Long-Lived Assets Other than Goodwill and Indefinite-Lived Intangible Assets

Intangibles primarily represent acquired customer relationships, acquired order backlog, acquired technology, software license agreements and patents. Acquired order backlog is amortized in the same period the corresponding revenue is recognized. A portion of the Company’s acquired customer relationships is being amortized over seven years based on the present value of the future cash flows expected to be generated from the acquired customers. All other intangibles are being amortized on a straight-line basis over their estimated useful lives, generally ranging from three to 15 years.

The Company assesses its long-lived assets other than goodwill and indefinite-lived intangible assets for impairment whenever facts and circumstances indicate that the carrying amounts may not be fully recoverable. To analyze recoverability, the Company projects undiscounted net future cash flows over the remaining lives of such assets. If these projected cash flows are less than the carrying amounts, an impairment loss would be recognized, resulting in a write-down of the assets with a corresponding charge to earnings. The impairment loss is measured based upon the difference between the carrying amounts and the fair values of the assets. Assets to be disposed of are reported at the lower of the carrying amounts or fair value less cost to sell. Management determines fair value using the discounted cash flow method or other accepted valuation techniques. The Company recorded asset impairment losses totaling $0.6 million in 2009 in connection with the closure of two facilities. No such impairments were recorded in 2008 or 2007.

Derivatives

The Company periodically enters into foreign currency, interest rate swap, and commodity derivative contracts. The Company uses interest rate swaps to manage exposure to interest rate fluctuations. Foreign currency contracts are used to manage exchange rate fluctuations and generally hedge transactions between the Euro and the U.S. dollar. Commodity futures contracts are used to manage costs of raw materials used in the Company’s production processes.

The Company enters into such contracts with financial institutions of good standing, and the total credit exposure related to non-performance by those institutions is not material to the operations of the Company. The Company does not enter into contracts for trading purposes.

We designate a portion of our derivative instruments as cash flow hedges for accounting purposes. For all derivatives designated as hedges, we formally document the relationship between the hedging instrument and the hedged item, as well as the risk management objective and the strategy for using the hedging instrument. We assess whether the hedging relationship between the derivative and the hedged item is highly effective at offsetting changes in the cash flows both at inception of the hedging relationship and on an ongoing basis. Any change in the fair value of the derivative that is not effective at offsetting changes in the cash flows or fair values of the hedged item is recognized currently in earnings.

Interest rate swaps and other derivative contracts are recognized on the balance sheet as assets and liabilities, measured at fair value on a recurring basis using significant observable inputs, which is Level 2 as defined in the fair value hierarchy. For transactions in which we are hedging the variability of cash flows, changes in the fair value of the derivative are reported in accumulated other comprehensive income until earnings are affected by the hedged item. Changes in the fair value of derivatives not designated as hedges are recognized currently in earnings.

Self-Insurance

We are self-insured for a portion of our product liability, workers’ compensation, general liability, medical coverage and certain other liability exposures. The Company accrues loss reserves up to the retention amounts when such amounts are reasonably estimable and probable. The accompanying consolidated balance sheets include estimated amounts for claims exposure based on experience factors and management estimates for known and anticipated claims as follows:

	December 31,
	2009		2008

Medical insurance	$	697	$	563
Workers' compensation		189		173

Total self-insurance reserves	$	886	$	736

Warranty Costs

Estimated expenses related to product warranties are accrued at the time products are sold to customers and recorded as part of cost of sales. Estimates are established using historical information as to the nature, frequency, and average costs of warranty claims.

Warranty activity for the years ended December 31, 2009 and 2008 consisted of the following:

	2009			2008

Warranty liability at beginning of the year	$	3,108		$	2,971
Accrued warranty expense, net of adjustments		860			801
Changes in estimates related to pre-existing warranties		(552	)		374
Cost of warranty service work performed		(646	)		(869	)
Foreign exchange translation effect		82			(169	)

Warranty liability at end of the year	$	2,852		$	3,108

Income Taxes

Income taxes for the Company are accounted for under the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is generally recognized in income in the period that includes the enactment date.

Valuation allowances are recorded if it is more likely than not that some portion of the deferred tax asset will not be realized. In evaluating the need for a valuation allowance, we take into account various factors, including the expected level of future taxable income and available tax planning strategies. If actual results differ from the assumptions made in the evaluation of our valuation allowance, we record a change in valuation allowance through income tax expense or other comprehensive income in the period such determination is made.

Foreign Currency Exchange Gains and Losses

The Company’s financial statements are presented in U.S. dollars. The functional currencies of the Company’s operating subsidiaries are the local currencies of the countries in which each subsidiary is located. Assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the balance sheet date. Revenues and expenses are translated at average rates of exchange in effect during the year. The amounts recorded in each year are net of income taxes to the extent the underlying equity balances in the entities are not deemed to be permanently reinvested.

Transactions in foreign currencies are translated at the exchange rate in effect at the date of each transaction. Differences in exchange rates during the period between the date a transaction denominated in a foreign currency is consummated and the date on which it is either settled or translated for inclusion in the consolidated balance sheets are recognized in the consolidated statements of operations for that period. The foreign currency transaction gain (loss) in income was $(1.4) million, $0.3 million, and $1.0 million for the years ended December 31, 2009, 2008 and 2007, respectively.

Debt Issuance Costs

Costs directly related to the placement of debt are capitalized and amortized using the straight-line method, which approximates the effective interest method over the term of the related obligation. Amounts written off due to early extinguishment of debt are charged to earnings. Cost and accumulated amortization related to debt issuance costs amounted to approximately $3.4 million and $1.1 million, respectively, as of December 31, 2009 and $3.3 million and $0.4 million, respectively, as of December 31, 2008.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses for the periods presented. Actual results could differ from those estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform to current year presentations.

4. Recent Accounting Pronouncements

In October 2009, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2009-13, Multiple-Deliverable Revenue Arrangements—a consensus of the FASB Emerging Issues Task Force. ASU No. 2009-13 addresses the unit of accounting for arrangements involving multiple deliverables and how arrangement consideration should be allocated to the separate units of accounting. The Company will be required to adopt the provisions of ASU No. 2009-13 prospectively beginning January 1, 2011. Earlier retrospective application is permitted. The Company is evaluating the effects of implementing the provisions of this new guidance.

5. Acquisitions

The following acquisitions were accounted for using the purchase method of accounting and, accordingly, the accompanying financial statements include the financial position and the results of operations from the dates of acquisition.

On January 31, 2007, the Company purchased all of the outstanding stock of Lubrication Systems Company of Texas (LSC), a manufacturer of fluid handling systems, including oil mist lubrication systems and lube oil purification systems, for $29.8 million. As a result of the acquisition of LSC, intangible assets of $22.6 million were recorded. The purchase of LSC complements the Company’s existing line of fluid handling products.

On November 29, 2007, the Company acquired Fairmount Automation, Inc. (Fairmount), an original equipment manufacturer of mission critical programmable automation controllers in fluid handling applications primarily for the U.S. Navy, for $4.5 million plus contingent payments based on achievement of future revenue and earnings targets over the period ending December 31, 2010. In the fourth quarters of 2009 and 2008, the first two targets were achieved, resulting in payments of $0.4 million in each period, which were recorded as goodwill. Remaining contingent payments, if any, of up to $1.3 million will also be recorded as additional goodwill. In addition to strengthening its existing position with the U.S. Navy, the Company is leveraging Fairmount’s experienced engineering talent and technology expertise to develop a portfolio of fluid handling solutions with diagnostic and prognostic capabilities for use in industrial applications.

On August 31, 2009, we completed the acquisition of PD-Technik Ingenieurbüro GmbH (“PD-Technik”), a provider of marine aftermarket related products and services located in Hamburg, Germany, for $1.3 million, net of cash acquired in the transaction.

Purchase price allocations are based on fair value of the acquired assets and liabilities. This information is obtained mainly through due diligence and other information from the sellers, as well as tangible and intangible asset appraisals. The allocations for our significant acquisitions, Fairmount and LSC, are as follows:

	Fairmount		LSC

Cash	$	1,155	$	74
Accounts receivable		243		5,809
Inventories		469		4,248
Prepaid expenses and other current assets		77		301
Property, plant and equipment		109		428
Goodwill		3,028		15,065
Trade name		90		870
Developed technology		860		2,770
Backlog of open orders		-		552
Customer relationships		990		3,330
Other long-term assets		-		1,381
Total assets acquired	$	7,021	$	34,828
Accounts payable and accrued liabilities assumed	$	1,698	$	5,078

Developed technology is being amortized over a term of 6 to 15 years. Backlog of open orders is amortized over a term of approximately one year. Customer relationships are being amortized over periods of 7 to 10 years. The weighted average amortization period for intangibles subject to amortization is approximately six years.

Goodwill deductible for income tax purposes due to the Fairmount and LSC acquisitions is $2.8 million and $14.4 million, respectively.

The unaudited pro forma information below gives effect to these acquisitions as if they had occurred at the beginning of the period. The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have occurred had the acquisitions been consummated as of that time.

	Pro Forma
	Year ended
	December 31,
	2007 Restated

Net sales	$	510,021
Net income		65,521

Earnings per common share - basic and diluted	$	1.81

6. Income Taxes

Income before income taxes and the components of the provision for income taxes were as follows:

	Year ended December 31,
	2009 Restated			2008 Restated			2007 Restated

Income (loss) before income tax expense:
Domestic	$	698		$	(54,303	)	$	60,993
Foreign		31,720			60,299			44,110

	$	32,418		$	5,996		$	105,103
Provision for income taxes:
Current income tax expense (benefit):
Federal	$	(1,323	)	$	(1,145	)	$	444
State		344			239			199
Foreign		6,911			19,701			16,318

		5,932			18,795			16,961
Deferred income tax expense (benefit):
Domestic		2,241			(12,607	)		24,567
Foreign		448			(723	)		(2,071	)

		2,689			(13,330	)		22,496
	$	8,621		$	5,465		$	39,457

U.S. income taxes at the statutory rate reconciled to the overall U.S. and foreign provision for income taxes were as follows:

	Year ended December 31,
	2009 Restated			2008 Restated			2007 Restated

Tax at U.S. federal income tax rate	$	11,346		$	2,099		$	36,786
State taxes		34			(1,500	)		2,131
Effect of international tax rates		(2,260	)		(3,342	)		(2,230	)
Payment of non-deductible underwriting fee		-			4,483			-
Changes in valuation and tax reserves		(710	)		2,903			755
Inclusion of foreign earnings		-			-			1,565
Other		211			822			450

Provision for income taxes	$	8,621		$	5,465		$	39,457

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the deferred tax assets and liabilities were as follows:

	December 31,
	2009						2008
	Restated						Restated
	Current			Long-Term			Current			Long-Term

Deferred tax assets:
Post-retirement benefit obligations	$	1,003		$	23,262		$	602		$	25,632
Expenses not currently deductible		9,552			30,200			7,536			30,017
Net operating loss carryover		-			42,268			-			42,770
Tax credit carryover		-			5,560			-			7,518
Other		-			837			-			1,094

Total deferred tax assets		10,555			102,127			8,138			107,031
Valuation allowance for deferred tax assets		(2,649	)		(42,404	)		(1,649	)		(43,556	)

Net deferred tax assets		7,906			59,723			6,489			63,475

Net tax liabilities:
Tax over book depreciation		-			10,578			-			10,809
Other		1,074			7,680			-			6,979

Total deferred tax liabilities		1,074			18,258			-			17,788

Net deferred tax assets	$	6,832		$	41,465		$	6,489		$	45,687

For purposes of the balance sheet presentation, the Company nets current and non-current tax assets and liabilities within each taxing jurisdiction. The above table is presented prior to the netting of the current and non-current deferred tax items. The Company evaluates the recoverability of its net deferred tax assets on a jurisdictional basis by considering whether net deferred tax assets will be realized on a more likely than not basis. To the extent a portion or all of the applicable deferred tax assets do not meet the more likely than not threshold, a valuation allowance is recorded. During the year ending December 31, 2009, the valuation allowance decreased from $45.2 million to $45.1 million with the decrease recognized in income tax expense. The $0.1 million net decrease in 2009 was primarily attributable to a corresponding reduction in deferred tax assets due to the pension restatement, offset in part by an increase attributable to certain separate company losses the company believes may not be realized. Consideration was given to U.S. tax planning strategies and future U.S. taxable income as to how much of the relevant deferred tax asset could be realized on a more likely than not basis.

The Company has U.S. net operating loss carryforwards of approximately $109.6 million expiring in years 2021 through 2028, and minimum tax credits of approximately $1.9 million that may be carried forward indefinitely. Tax credit carryforwards include foreign tax credits that have been offset by a valuation allowance. We experienced an “ownership change” within the meaning of Section 382 of the Internal Revenue Code of 1986, as amended, as a result of the IPO. The Company’s ability to use these various carryforwards existing at the time of the ownership change to offset any taxable income generated in taxable periods after the ownership change may be limited under Section 382 and other federal tax provisions.

For the years ended December 31, 2009, 2008 and 2007, the Company intends that all undistributed earnings of its controlled international subsidiaries will be reinvested and no tax expense has been recognized under the applicable accounting standard, for these reinvested earnings. The amount of unremitted earnings from these international subsidiaries, subject to local statutory restrictions, as of December 31, 2009 is approximately $128.2 million. It is not reasonably determinable as to the amount of deferred tax liability that would need to be provided if such earnings were not reinvested.

The Company adopted an accounting standard which created a single model to address accounting for uncertainty in tax positions. This accounting standard applies to all tax positions and requires a recognition threshold and measurement of a tax position taken or expected to be taken in a tax return. This standard also provides guidance on classification, interest and penalties, accounting in interim periods and transition, and significantly expanded income tax disclosure requirements. As a result of the implementation of this accounting standard, the Company increased its net liability for unrecognized tax benefits by $6.7 million with a corresponding charge to beginning retained earnings as of January 1, 2007.

A reconciliation of the beginning and ending amount of gross unrecognized tax benefits is as follows:

Balance at December 31, 2007	$	10,299

Additions for tax positions in prior periods		886
Additions for tax positions in current period		886
Reductions for tax positions in prior periods		(1,658	)
Foreign exchange impact / other		(312	)

Balance at December 31, 2008	$	10,101

Additions for tax positions in prior periods		73
Additions for tax positions in current period		308
Reductions for tax positions in prior periods		(1,896	)
Foreign exchange impact / other		160

Balance at December 31, 2009	$	8,746

The Company’s unrecognized tax benefits as of December 31, 2009 and 2008 totaled $9.3 million and $11.1 million inclusive of $0.5 million and $1.0 million of interest, respectively. These amounts were offset in part by tax benefits of approximately $0.7 million and $1.4 million for the years ended December 31, 2009 and 2008, respectively. The net liabilities for uncertain tax positions for the years ended December 31, 2009 and 2008 were $8.6 million and $9.7 million, respectively, and if recognized, would favorably impact the effective tax rate.

The Company records interest and penalties on uncertain tax positions for post-adoption periods as a component of income tax expense. The interest and penalty expense recorded in income tax expense attributed to uncertain tax positions for the years ending December 31, 2009, 2008 and 2007 was $0.2 million, $0.2 million and $0.3 million, respectively.

The Company is subject to income tax in the U.S., state, and international locations. The Company’s significant operations outside the U.S. are located in Germany and Sweden. In Sweden, tax years 2004 to 2009 and in Germany, tax years 2003 and 2006 to 2008 remain subject to examination. In the U.S., tax years 2005 and beyond generally remain open for examination by U.S. and state tax authorities as well as tax years ending in 1997, 1998, 2000 and 2003 that have U.S. tax attributes available that have been carried forward to open tax years or are available to be carried forward to future tax years.

Due to the difficulty in predicting with reasonable certainty when tax audits will be fully resolved and closed, the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next 12 months is difficult to ascertain. Currently, we estimate it is reasonably possible the expiration of various statutes of limitations and resolution of tax audits may reduce our tax expense in the next 12 months ranging from zero to $1.3 million.

7. Restructuring and Other Related Charges

The Company has initiated a series of restructuring actions during 2009 in response to current and expected future economic conditions. As a result, the Company recorded pre-tax restructuring and related costs of $18.2 million during the year ended December 31, 2009. As of December 31, 2009, we have reduced our company-wide workforce by 328 associates from December 31, 2008. Additionally, during 2009, approximately 630 associates participated in a German government-sponsored furlough program in which the government pays the wage-related costs for the portion of the work week the associate is not working. Payroll taxes and other employee benefits related to employees’ furlough time are included in restructuring costs. Our agreement with the German works council allowing participation in the furlough program ends February 2011. Future restructuring costs that may be incurred cannot be reasonably estimated as of the date these financial statements are filed.

During the second quarter of 2009, we closed a repair facility in Aberdeen, NC. Further, during the fourth quarter of 2009, we closed a manufacturing facility in Sanford, NC and moved its production to the Company’s facilities in Monroe, NC and Columbia, KY. We recorded non-cash impairment charges of $0.6 million to reduce the carrying value of the real estate and equipment at these facilities to their estimated fair values.

We recognize the cost of involuntary termination benefits at the communication date or ratably over any remaining expected future service period. Voluntary termination benefits are recognized as a liability and a loss when employees accept the offer and the amount can be reasonably estimated. We record asset impairment charges to reduce the carrying amount of long-lived assets that will be sold or disposed of to their estimated fair values. Fair values are estimated using observable inputs including third party appraisals and quoted market prices.

A summary of restructuring activity for the year ended December 31, 2009 is shown below.

			Year Ended December 31, 2009
	Restructuring							Foreign			Restructuring
	Liability at							Currency			Liability at
	Dec. 31, 2008		Provisions		Payments			Translation			Dec. 31, 2009
Restructuring Charges:
Termination benefits (1)	$	-	$	15,218	$	(5,545	)	$	(200	)	$	9,473
Furlough charges (2)		-		1,187		(1,273	)		86			-
Facility closure charges (3)		-		1,122		(1,122	)		-			-
Total Restructuring Charges	$	-		17,527	$	(7,940	)	$	(114	)	$	9,473

Other Related Charges:
Asset impairment charges (4)				648

Total Restructuring and Other Related Charges			$	18,175

(1)	Includes severance and other termination benefits such as outplacement services.

(2)	Includes payroll taxes and other employee benefits related to German employees’ furlough time.

(3)	Includes the cost of relocating and training associates and relocating equipment in connection with the closing of the Sanford, NC facility.

(4)	Includes asset impairment charges associated with the real estate and equipment at the Aberdeen, NC and Sanford, NC locations.

8. Earnings (Loss) Per Share

The following table presents the computation of basic and diluted earnings (loss) per share:

	Year ended December 31,
	2009 Restated		2008 Restated			2007 Restated
Numerator:
Net income	$	23,797	$	531		$	65,646
Dividends on preferred stock		-		(3,492	)		(25,816	)
Net income (loss) available to common shareholders	$	23,797	$	(2,961	)	$	39,830

Denominator:
Weighted-average shares of common stock outstanding - basic		43,222,616		36,240,157			21,885,929
Net income (loss) per share - basic	$	0.55	$	(0.08	)	$	1.82

Weighted-average shares of common stock outstanding - basic		43,222,616		36,240,157			21,885,929
Net effect of potentally dilutive securities (1)		103,088		-			-
Weighted-average shares of common stock outstanding - diluted		43,325,704		36,240,157			21,885,929
Net income (loss) per share - diluted	$	0.55	$	(0.08	)	$	1.82

(1) Potentially dilutive securities consist of options and restricted stock units.

In the years ended December 31, 2009 and 2008, respectively, approximately 0.6 million and 0.5 million potentially dilutive stock options, restricted stock units and deferred stock units were excluded from the calculation of diluted loss per share since their effect would have been anti-dilutive.

9. Inventories

Inventories consisted of the following:

	December 31,
	2009			2008

Raw materials	$	28,445		$	34,074
Work in process		32,888			33,691
Finished goods		21,013			21,600

		82,346			89,365
Less-Customer progress billings		(3,171	)		(2,115	)
Less-Allowance for excess, slow-moving and obsolete inventory		(8,025	)		(6,923	)

	$	71,150		$	80,327

10. Property, Plant and Equipment

Property, plant and equipment consisted of the following:

	Depreciable	December 31,
	Lives in Years	2009			2008

Land	-	$	16,618		$	16,593
Buildings and improvements	3 - 40		36,651			34,784
Machinery and equipment	3 - 15		119,727			114,857
Software	3 - 5		17,324			14,487

			190,320			180,721
Less-Accumulated depreciation			(98,230	)		(88,631	)

		$	92,090		$	92,090

Depreciation expense, including the amortization of assets recorded under capital leases, for the years ended December 31, 2009, 2008 and 2007, was approximately $11.8 million, $12.1 million and $11.8 million, respectively. These amounts include depreciation expense related to software for the years ended December 31, 2009, 2008 and 2007 of $1.7 million, $2.0 million and $2.6 million, respectively.

11. Goodwill and Intangible Assets

Changes in the carrying amount of goodwill during the years ended December 31, 2009 and 2008 are as follows:

	Goodwill Restated

Balance December 31, 2007	$	165,123

Contingent purchase price payment for Fairmount acquisition		439
Adjustments due to finalization of purchase price allocations		165
Impact of changes in foreign exchange rates		(4,033	)

Balance December 31, 2008		161,694

Contingent purchase price payment for Fairmount acquisition		418
Attributable to 2009 acquisition of PD-Technik		6
Impact of changes in foreign exchange rates		1,300

Balance December 31, 2009	$	163,418

Other intangible assets consisted of the following:

	December 31,
	2009					2008
	Gross Carrying Amount		Accumulated Amortization			Gross Carrying Amount		Accumulated Amortization

Acquired customer relationships	$	15,512	$	(8,989	)	$	14,450	$	(7,022	)
Trade names - indefinite life		2,062		-			2,040		-
Acquired developed technology		5,811		(2,444	)		5,808		(1,760	)
Other intangibles		146		(146	)		464		(464	)

	$	23,531	$	(11,579	)	$	22,762	$	(9,246	)

In connection with the acquisition of PD-Technik in 2009, customer relationship intangibles of $0.9 million were acquired and are being amortized over a period of six years.

Amortization expense for the years ended December 31, 2009, 2008 and 2007 was approximately $2.6 million, $2.7 million and $3.4 million, respectively. Amortization expense for the next five fiscal years is expected to be: 2010—$2.5 million, 2011—$2.5 million, 2012—$2.2 million, 2013—$1.0 million, and 2014—$0.7 million.

12. Retirement and Benefit Plans

The Company sponsors various defined benefit plans, defined contribution plans and other post-retirement benefits plans, including health and life insurance, for certain eligible employees or former employees. We use December 31 as the measurement date for all of our employee benefit plans.

The following table summarizes the changes in our pension and other post-retirement benefit plan obligations and plan assets and includes a statement of the plans’ funded status:

							Other
	Pension Benefits						Post-retirement Benefits
Year ended December 31,	2009 Restated			2008 Restated			2009			2008

Change in benefit obligation:
Projected benefit obligation at beginning of year	$	295,165		$	303,654		$	10,370		$	7,304
Service cost		1,381			1,160			-			-
Interest cost		17,577			17,429			525			501
Plan amendments		-			-			-			2,359
Actuarial loss		10,662			3,740			772			901
Acquisitions		72			-			-			-
Settlement/curtailment		-			-			-			-
Foreign exchange effect		2,958			(7,844	)		-			-
Benefits paid		(21,244	)		(22,974	)		(808	)		(695	)

Projected benefit obligation at end of year	$	306,571		$	295,165		$	10,859		$	10,370

Accumulated benefit obligation at end of year	$	303,598		$	290,007		$	-		$	-

Change in plan assets:
Fair value of plan assets at beginning of year	$	192,859		$	257,036		$	-		$	-
Actual return on plan assets		29,193			(42,694	)		-			-
Employer contribution		7,517			5,695			808			695
Acquisitions		60			-			-			-
Foreign exchange effect		1,536			(4,204	)		-			-
Benefits paid		(21,244	)		(22,974	)		(808	)		(695	)

Fair value of plan assets at end of year	$	209,921		$	192,859		$	-		$	-

Funded status at end of year	$	(96,650	)	$	(102,306	)	$	(10,859	)	$	(10,370	)

Amounts recognized in the balance sheet at December 31:
Non-current assets	$	244		$	132		$	-		$	-
Current liabilities		(1,114	)		(1,153	)		(1,409	)		(1,437	)
Non-current liabilities		(95,780	)		(101,285	)		(9,450	)		(8,933	)

Total	$	(96,650	)	$	(102,306	)	$	(10,859	)	$	(10,370	)

The accumulated benefit obligation and fair value of plan assets for the pension plans with accumulated benefit obligations in excess of plan assets were $301.2 million and $207.2 million, respectively, as of December 31, 2009 and $288.1 million and $190.7 million, respectively, as of December 31, 2008.

The projected benefit obligation and fair value of plan assets for the pension plans with projected benefit obligations in excess of plan assets were $304.1 million and $207.2 million, respectively, as of December 31, 2009 and $293.1 million and $190.7 million, respectively, as of December 31, 2008.

The following table summarizes the changes in our foreign pension plans’ obligations and plan assets, included in the previous disclosure, and includes a statement of the foreign plans’ funded status:

	Foreign Pension Benefits
Year ended December 31,	2009			2008

Change in benefit obligation:
Projected benefit obligation at beginning of year	$	82,253		$	83,649
Service cost		1,381			1,160
Interest cost		4,668			4,364
Actuarial (gain) loss		(5,947	)		5,786
Acquisitions		72			-
Foreign exchange effect		2,958			(7,844	)
Benefits paid		(4,425	)		(4,862	)

Projected benefit obligation at end of year	$	80,960		$	82,253

Accumulated benefit obligation at end of year	$	77,988		$	77,097

Change in plan assets
Fair value of plan assets at beginning of year	$	23,219		$	28,918
Actual return on plan assets		1,390			69
Employer contribution		3,061			3,298
Acquisitions		60			-
Foreign exchange effect		1,536			(4,204	)
Benefits paid		(4,425	)		(4,862	)

Fair value of plan assets at end of year	$	24,841		$	23,219

Funded status at end of year	$	(56,119	)	$	(59,034	)

Expected contributions to the pension plans for 2010 are $5.5 million. The following benefit payments are expected to be paid during the years ending December 31:

					Other
	Pension Benefits				Post-retirement
	All Plans		Foreign Plans		Benefits
	Restated

2010	$	22,203	$	4,664	$	1,409
2011		23,308		4,760		843
2012		22,290		4,793		850
2013		22,219		4,858		840
2014		22,281		4,969		817
Years 2015-2019		109,186		24,652		3,689

The Company’s primary investment objective for its pension plan assets is to provide a source of retirement income for the plans’ participants and beneficiaries. The assets are invested with the goal of preserving principal while providing a reasonable real rate of return over the long term. Diversification of assets is achieved through strategic allocations to various asset classes. Actual allocations to each asset class vary due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions, and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced as required, as frequently as on a quarterly basis in some instances. The following are the actual and target allocation percentages for the Company’s pension plan assets:

	Actual Allocation
	December 31,						Target
	2009			2008			Allocation

United States Plans:
Equity securities:
U.S.		39	%		36	%		34% - 42	%
International		12			12			10% - 14	%
Fixed income securities		34			37			27% - 43	%
Hedge fund		15			15			13% - 17	%

Foreign Plans:
Large cap equity securities		15			19			0% - 20	%
Fixed income securities		83			80			80% - 100	%
Cash and cash equivalents		2			1			0% - 5	%

The following table presents the Company’s pension plan assets using the fair value hierarchy as of December 31, 2009. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant observable inputs, and Level 3 includes fair values estimated using significant unobservable inputs.

	Total		Level 1		Level 2		Level 3

United States Plans:
Cash and cash equivalents	$	1,180	$	1,180	$	-	$	-
Equity mutual funds:
U.S. large cap		56,400		56,400		-		-
U.S. small / mid-cap		15,992		15,992		-		-
Foreign		22,548		22,548		-		-
Fixed income mutual funds:
U.S.		50,805		50,805		-		-
Foreign		11,386		11,386		-		-
Hedge fund		26,769		-		-		26,769

Foreign Plans:
Cash and cash equivalents		568		568		-		-
Large cap equity securities		3,688		3,688		-		-
Fixed income securities		20,585		-		20,585		-

	$	209,921	$	162,567	$	20,585	$	26,769

Fixed income securities held by the foreign plans are valued using quotes from independent pricing vendors based on recent trading activity and other relevant information, including market interest rate curves, referenced credit spreads and estimated prepayment rates. The hedge fund investment is valued at the net asset value of units held by the plans at year end.

The table below presents a summary of the changes in the fair value of the Level 3 assets held during the year ended December 31, 2009.

Balance at January 1, 2009	$	25,983
Unrealized gains		786

Balance at December 31, 2009	$	26,769

The components of net periodic cost and other comprehensive (income) loss were as follows:

	Pension Benefits									Other Post-retirement Benefits
	2009 Restated			2008 Restated			2007 Restated			2009			2008			2007

Components of net periodic benefit cost:
Service cost	$	1,381		$	1,160		$	1,170		$	-		$	-		$	-
Interest cost		17,577			17,429			16,954			525			501			445
Amortization		3,639			2,523			3,606			353			227			133
Expected return on plan assets		(19,570	)		(20,509	)		(19,667	)		-			-			-

Net periodic benefit cost	$	3,027		$	603		$	2,063		$	878		$	728		$	578

Change in plan assets and benefit obligations recognized in other comprehensive (income) loss:
Current year net actuarial loss (gain)		710			66,101			(8,225	)		772			901			167
Prior service cost		-			-			-			-			2,359			-
Less amounts included in net periodic cost:											-
Amortization of net loss		(3,639	)		(2,523	)		(3,606	)		(104	)		(165	)		(133	)
Amortization of prior service cost		-			-			-			(249	)		(62	)		-

Total recognized in other comprehensive (income) loss	$	(2,929	)	$	63,578		$	(11,831	)	$	419		$	3,033		$	34

The components of net periodic cost and other comprehensive (income) loss for our foreign pension plans, included within the previous disclosure, were as follows:

	Foreign Pension Benefits
	2009			2008			2007

Components of net periodic benefit cost:
Service cost	$	1,381		$	1,160		$	1,170
Interest cost		4,668			4,364			3,738
Recognized net actuarial loss		808			348			718
Expected return on plan assets		(1,204	)		(1,456	)		(1,538	)

Net periodic benefit cost	$	5,653		$	4,416		$	4,088

Change in plan assets and benefit obligations recognized in other comprehensive loss (income):
Current year net actuarial (gain) loss		(6,464	)		6,339			(4,202	)
Less amounts included in net periodic cost:
Amortization of net loss		(808	)		(348	)		(718	)

Total recognized in other comprehensive loss (income)	$	(7,272	)	$	5,991		$	(4,920	)

The components of accumulated other comprehensive income that have not been recognized as components of net periodic cost are as follows:

					Other
	Pension Benefits				Post-retirement Benefits
At December 31,	2009 Restated		2008 Restated		2009		2008

Net actuarial loss	$	141,614	$	144,543	$	3,337	$	2,669
Prior service cost		-		-		2,048		2,297

Total	$	141,614	$	144,543	$	5,385	$	4,966

The components of accumulated other comprehensive income that are expected to be recognized in net periodic cost during the year ended December 31, 2010 are as follows:

	Pension		Other
	Benefits		Post-retirement
	Restated		Benefits

Net actuarial loss	$	4,565	$	248
Prior service cost		-		233

Total	$	4,565	$	481

The key economic assumptions used in the measurement of the Company’s benefit obligations at December 31, 2009 and 2008 are as follows:

	Pension Benefits						Other Post-retirement Benefits
	2009			2008			2009			2008

Weighted-average discount rate:
For all plans		5.7	%		6.1	%		5.6	%		6.0	%
For all foreign plans		5.6	%		5.8	%		-			-

Weighted-average rate of increase in compensation levels for active foreign plans		2.0	%		2.1	%		-			-

The key economic assumptions used in the computation of net periodic benefit cost for the years ended December 31, 2009, 2008 and 2007 are as follows:

	Pension Benefits									Other Post-retirement Benefits
	2009			2008			2007			2009			2008			2007

Weighted-average discount rate:
For all plans		6.1	%		6.0	%		5.9	%		6.0	%		6.3	%		6.0	%
For all foreign plans		5.8	%		4.7	%		5.4	%		-			-			-

Weighted-average expected return on plan assets:
For all plans		8.3	%		8.3	%		8.4	%		-			-			-
For all foreign plans		5.0	%		5.1	%		5.5	%		-			-			-

Weighted-average rate of increase in compensation levels for active foreign plans		2.1	%		2.2	%		2.6	%		-			-			-

In determining discount rates, the Company utilizes the single discount rate equivalent to discounting the expected future cash flows from each plan using the yields at each duration from a published yield curve as of the measurement date.

For measurement purposes, an annual rate of increase in the per capita cost of covered health care benefits of approximately 7.0% was assumed. The rate was assumed to decrease gradually to 5.0% by 2014 and remain at that level thereafter for benefits covered under the plans.

The expected long-term rate of return on plan assets was based on the Company’s investment policy target allocation of the asset portfolio between various asset classes and the expected real returns of each asset class over various periods of time that are consistent with the long-term nature of the underlying obligations of these plans.

Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plan. A one-percentage point change in assumed health care cost trend rates would have the following pre-tax effects:

	1 Percentage Point Increase		1 Percentage Point Decrease

Effect on total service and interest cost components for 2009	$	44	$	(35	)
Effect on post-retirement benefit obligation at December 31, 2009		1,201		(945	)

The Company maintains defined contribution plans covering substantially all of their non-union domestic employees, as well as certain union domestic employees. Under the terms of the plans, eligible employees may generally contribute from 1% to 50% of their compensation on a pre-tax basis. The Company’s contributions are based on 50% of the first 6% of each participant’s pre-tax contribution. Additionally, the Company makes a unilateral contribution of 3% of all employees’ salary (including non-contributing participants) to the defined contribution plans. The Company’s expense for 2009, 2008 and 2007 was $2.4 million, $2.2 million and $2.0 million, respectively, related to these plans.

13. Debt

Long-term debt consisted of the following:

	December 31,
	2009			2008
Term A notes (senior bank debt)	$	91,250		$	96,250
Capital leases and other		235			871

Total debt		91,485			97,121

Less-current portion Term A		(8,750	)		(5,000	)
Less-current portion capital leases and other		(219	)		(420	)

	$	82,516		$	91,701

On May 13, 2008, coinciding with the closing of the IPO, the Company terminated its existing credit facility. There were no material early termination penalties incurred as a result of the termination. Deferred loan costs of $4.6 million were written off in connection with this termination. On the same day, the Company entered into a new credit agreement (the Credit Agreement). The Credit Agreement, led by Banc of America Securities LLC and administered by Bank of America, is a senior secured structure with a $150.0 million revolver and a Term A Note of $100.0 million.

The Term A Note bears interest at LIBOR plus a margin ranging from 2.25% to 2.75% determined by the total leverage ratio calculated at quarter end. At December 31, 2009, the interest rate was 2.48% inclusive of 2.25% margin. The Term A Note, as entered into on May 13, 2008, has $1.25 million due on a quarterly basis on the last day of each March, June, September and December beginning with June 30, 2008 and ending March 31, 2010, $2.5 million due on a quarterly basis on the last day of each March, June, September and December beginning with June 30, 2010 and ending March 31, 2013, and one installment of $60.0 million payable on May 13, 2013.

The $150.0 million revolver contains a $50.0 million letter of credit sub-facility, a $25.0 million swing line loan sub-facility and a €100.0 million sub-facility. The annual commitment fee on the revolver ranges from 0.4% to 0.5% determined by the total leverage ratio calculated at quarter end. At December 31, 2009, the commitment fee was 0.4% and there was $14.4 million outstanding on the letter of credit sub-facility, leaving approximately $136 million available under the revolver loan. The bankruptcy of Lehman Brothers, one of the financial institutions in the consortium that provided the Company’s revolving credit line, resulted in their default under the terms of the revolver and it is doubtful that we would be able to draw on their commitment of $6.0 million. At December 31, 2008, the commitment fee was 0.4% and there was $16.7 million outstanding on the letter of credit sub-facility, leaving approximately $130 million available under the revolver loan.

Substantially all assets and stock of the Company’s domestic subsidiaries and 65% of the shares of certain European subsidiaries are pledged as collateral against borrowings under the Credit Agreement. Certain European assets are pledged against borrowings directly made to our European subsidiary. The Credit Agreement contains customary covenants limiting the Company’s ability to, among other things, pay cash dividends, incur debt or liens, redeem or repurchase Company stock, enter into transactions with affiliates, make investments, merge or consolidate with others or dispose of assets. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain a total leverage ratio of not more than 3.25 to 1.0 and a fixed charge coverage ratio of not less than 1.50 to 1.0, measured at the end of each quarter. If the Company does not comply with the various covenants under the Credit Agreement and related agreements, the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term A Note and revolver and foreclose on the collateral. The Company is in compliance with all such covenants as of December 31, 2009.

The future aggregate annual maturities of long-term debt and annual principal payments for capital leases at December 31, 2009 are:

	Term Debt		Capital Leases & Other		Total

2010	$	8,750	$	219	$	8,969
2011		10,000		7		10,007
2012		10,000		9		10,009
2013		62,500		-		62,500
2014		-		-		-

Total	$	91,250	$	235	$	91,485

14. Shareholders’ Equity

Preferred Stock

On May 13, 2008, pursuant to the amended articles of incorporation, the Company’s preferred stock was automatically converted into shares of common stock upon the closing of the IPO, determined by dividing the original issue price of the preferred shares by the issue price of the common shares at the offering date.

The holders of the Company’s preferred stock were entitled to receive dividends in preference to any dividend on the common stock at the rate of LIBOR plus 2.50% per annum, when and if declared by the Company’s board of directors. Preferred dividends of $3.5 million, $12.2 million and $13.7 million were declared on May 12, 2008, December 31, 2007, and May 15, 2007, respectively. These amounts were paid immediately prior to the consummation of the Company’s IPO on May 13, 2008. The holders of the preferred stock did not have voting rights except in certain corporate matters involving the priority and payment rights of such shares.

Stock Split

On April 21, 2008, the Company’s board of directors approved a restatement of capital accounts of the Company through an amendment of the Company’s certificate of incorporation to provide for a stock split to convert each share of common stock issued and outstanding into 13,436.22841 shares of common stock. The consolidated financial statements give retroactive effect as though the stock split occurred for all periods presented.

Issuance of Common Stock

On May 13, 2008, the Company completed its IPO of 21,562,500 shares of common stock at a per share price of $18.00. Of the 21,562,500 shares sold in the offering, 11,852,232 shares were sold by the Company and 9,710,268 shares were sold by certain selling stockholders. The Company received net proceeds of approximately $193.0 million, net of the underwriter’s discount of $14.4 million and offering-related costs of $5.9 million.

Results for the year ended December 31, 2008, include $57.0 million of nonrecurring costs associated with the IPO, including $10.0 million of share-based compensation and $27.8 million of special cash bonuses paid under previously adopted executive compensation plans, as well as $2.8 million of employer payroll taxes and other related costs. It also included $11.8 million to reimburse the selling stockholders for the underwriting discount on the shares sold by them and the write off of $4.6 million of deferred loan costs associated with the early termination of a credit facility.

In 2009, 18,078 shares of common stock were issued in connection with employee share-based payment arrangements that vested during the year.

Repurchases of Common Stock

On November 5, 2008, the Company’s board of directors authorized the repurchase of up to $20 million (up to $10 million per year in 2008 and 2009) of the Company’s common stock from time to time on the open market or in privately negotiated transactions. The repurchase program was conducted pursuant to SEC Rule 10b5-1. The timing and amount of any shares repurchased was determined by the Company’s management based on its evaluation of market conditions and other factors. In the fourth quarter of 2008, the Company purchased 795,000 shares of its common stock for approximately $5.7 million. There were no repurchases in 2009.

Dividend Restrictions

The Company’s Credit Agreement limits the amount of cash dividends and common stock repurchases the Company may make to a total of $10 million annually.

Accumulated Other Comprehensive Income

The components of accumulated other comprehensive income (loss) are as follows:

	December 31,
	2009 Restated			2008 Restated

Foreign currency translation adjustment	$	14,188		$	8,787
Unrealized losses on hedging activities		(3,035	)		(5,050	)
Net unrecognized pension and other post-retirement benefit costs		(120,950	)		(122,594	)

Total accumulated other comprehensive loss	$	(109,797	)	$	(118,857	)

Share-Based Payments

2008 Omnibus Incentive Plan

The Company adopted the Colfax Corporation 2008 Omnibus Incentive Plan (the 2008 Plan) on April 21, 2008. The 2008 Plan provides the compensation committee of the board of directors discretion in creating employee equity incentives. Awards under the 2008 Plan may be made in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance shares, performance units, and other stock-based awards.

The Company measures and recognizes compensation expense relating to share-based payments based on the fair value of the instruments issued. Stock-based compensation expense is recognized as a component of “Selling, general and administrative expenses” in the accompanying consolidated statements of operations as payroll costs of the employees receiving the awards are recorded in the same line item. In the years ended December 31, 2009 and 2008, $2.6 million and $1.3 million, respectively, of compensation cost and deferred tax benefits of approximately $0.9 million and $0.4 million, respectively, were recognized. At December 31, 2009, the Company had $4.5 million of unrecognized compensation expense related to stock-based awards that will be recognized over a weighted-average period of approximately 2.3 years. At December 31, 2009, the Company had issued stock-based awards that are described below.

Stock Options

Under the 2008 Plan, the Company may grant options to purchase common stock, with a maximum term of 10 years at a purchase price equal to the market value of the common stock on the date of grant. Or, in the case of an incentive stock option granted to a 10% stockholder, the Company may grant options to purchase common stock with a maximum term of 5 years, at a purchase price equal to 110% of the market value of the common stock on the date of grant. One-third of the options granted pursuant to the 2008 Plan vest on each anniversary of the grant date and the options expire in seven years.

Stock-based compensation expense for stock option awards was based on the grant-date fair value using the Black-Scholes option pricing model. We recognize compensation expense for stock option awards on a ratable basis over the requisite service period of the entire award. The following table shows the weighted-average assumptions we used to calculate fair value of stock option awards using the Black-Scholes option pricing model, as well as the weighted-average fair value of options granted during the years ended December 31, 2009 and 2008.

	Years Ended December 31,
	2009			2008
Weighted-average assumptions used in Black-Scholes model:
Expected period that options will be outstanding (in years)		4.50			4.50
Interest rate (based on U.S. Treasury yields at time of grant)		1.87	%		3.08	%
Volatility		32.50	%		32.35	%
Dividend yield		-			-
Weighted-average fair value of options granted	$	2.24		$	5.75

Expected volatility is estimated based on the historical volatility of comparable public companies. The Company uses historical data to estimate employee termination within the valuation model. Separate groups of employees that have similar historical exercise behavior are considered separately for valuation purposes. Since the Company has limited option exercise history, it has elected to estimate the expected life of an award based upon the SEC-approved “simplified method” noted under the provisions of Staff Accounting Bulletin No. 107 with the continued use of this method extended under the provisions of Staff Accounting Bulletin No. 110.

Stock option activity for the years ended December 31, 2009 and 2008 is as follows:

	Shares			Weighted- Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
						(Years)
Outstanding at January 1, 2008		-		$	-
Granted		531,999			17.94
Exercised		-			-
Forfeited		(17,008	)		18.00
Outstanding at December 31, 2008		514,991		$	17.93

Granted		844,165			7.44
Exercised		-			-
Forfeited		(91,523	)		11.70
Outstanding at December 31, 2009		1,267,633		$	11.40		5.88	$	3,655
Vested and expected to vest at December 31, 2009		1,150,635		$	11.16		5.90	$	3,439
Exercisable at December 31, 2009		159,883		$	17.93		5.36	$	8

The aggregate intrinsic value is based on the difference between the Company’s closing stock price at the balance sheet date and the exercise price of the stock option, multiplied by the number of in-the-money options. The amount of intrinsic value will change based on the fair value of the Company’s stock.

The aggregate fair value of options that vested in 2009 was $0.9 million.

Performance-Based Awards

Under the 2008 Plan, the compensation committee may award performance-based restricted stock and restricted stock units whose vesting is contingent upon meeting various performance goals. The vesting of the stock units is determined based on whether the Company achieves the applicable performance criterion established by the compensation committee of the board of directors. If the performance criteria are satisfied, the units are subject to additional time vesting requirements, by which units will vest fully in two equal installments on the fourth and fifth anniversary of the grant date, provided the individual remains an employee during this period.

The fair value of each grant of performance-based restricted stock or restricted stock units is equal to the market value of a share of common stock on the date of grant and the compensation expense is recognized when it is expected that the performance goals will be achieved. The performance criterion for the performance-based restricted stock units (PRSUs) granted in 2008 was achieved; however, the performance criterion for those granted in 2009 was not achieved and accordingly, no compensation expense for the 2009 grants was recognized.

Other Restricted Stock and Restricted Stock Units

Under the 2008 Plan, the compensation committee may award non-performance based restricted stock and restricted stock units (RSUs) to selected executives, key employees and outside directors. The compensation committee determines the terms and conditions of each award including the restriction period and other criteria applicable to the awards.

The employee RSUs vest either 100% at the 1st anniversary of the grant date or 50% at the 1st anniversary and 50% at the 2nd anniversary of the grant date. The majority of the director RSUs granted to date vest in three equal installments on each anniversary of the grant date over a 3-year period. Directors can also elect to defer their annual board fees into RSUs with immediate vesting. Delivery of the shares underlying these director restricted stock units is deferred until termination of the director’s service on the Company’s board. The fair value of each restricted stock unit is equal to the market value of a share of common stock on the date of grant.

The following table summarizes the Company’s PRSU and RSU and activity for 2009 and 2008:

	PRSUs					RSUs
Nonvested shares	Shares			Weighted- Average Grant Date Fair Value		Shares			Weighted- Average Grant Date Fair Value
Nonvested at January 1, 2008		-			-		-			-
Granted		125,041			17.89		73,305			18.00
Vested		-			-		-			-
Forfeited		(694	)		18.00		(1,116	)		18.00
Nonvested at December 31, 2008		124,347		$	17.89		72,189		$	18.00
Granted		337,716			7.44		69,610			8.35
Vested		-			-		(48,871	)		15.72
Forfeited		(31,566	)		10.69		-			-
Nonvested at December 31, 2009		430,497		$	10.22		92,928		$	11.97

2001 Plan and 2006 Plan

In 2001 and 2006, the board of directors implemented long-term cash incentive plans as a means to motivate senior management or those most responsible for the overall growth and direction of the Company. Certain executive officers participated in the Colfax Corporation 2001 Employee Appreciation Rights Plan (the 2001 Plan) or the 2006 Executive Stock Rights Plan (the 2006 Plan).

Generally, each of these plans provided the applicable officers with the opportunity to receive a certain percentage, in cash (or, with respect to the 2001 Plan only, in equity, at the determination of the Board of Directors), of the increase in value of the Company from the date of grant of the award until the date of the liquidity event.

The 2001 Plan rights fully vested on the third anniversary of the grant date. The 2006 Plan rights vested if a liquidity event occurred prior to the expiration of the term of the plan. Amounts were only payable upon the occurrence of a liquidity event. The Board determined that the IPO qualified as a liquidity event for both plans. In conjunction with the IPO, the participants received a total of 557,597 shares of common stock and approximately $27.8 million in cash payments under the 2001 Plan and 2006 Plan and thereafter both plans terminated. In the year ended December 31, 2008, the Company recognized $10.0 million of stock-based compensation expense associated with the 557,597 shares of common stock awarded and a related tax benefit of approximately $3.8 million.

15. Financial Instruments

The carrying values of financial instruments, including accounts receivable, accounts payable and other accrued liabilities, approximate their fair values due to their short-term maturities. The estimated fair value of the Company’s long-term debt of $88.6 million and $92.3 million at December 31, 2009 and 2008, respectively, was based on current interest rates for similar types of borrowings. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

A summary of the Company’s assets and liabilities that are measured at fair value on a recurring basis for each fair value hierarchy level for the periods presented follows:

	Total		Level 1		Level 2		Level 3
As of December 31, 2009

Assets:
Cash equivalents	$	33,846	$	33,846	$	-	$	-

Liabilities:
Derivatives	$	3,156	$	-	$	3,156	$	-

As of December 31, 2008

Assets:
Cash equivalents	$	17,965	$	17,965	$	-	$	-
Derivatives		1,651		-		1,651		-
	$	19,616	$	17,965	$	1,651	$	-

Liabilities:
Derivatives	$	7,070	$	-	$	7,070	$	-

The Company’s cash equivalents consist of investments in interest-bearing deposit accounts and money market mutual funds which are valued based on quoted market prices. The fair value of these investments approximate cost due to their short-term maturities and the high credit quality of the issuers of the underlying securities. Interest rate swaps are valued based on forward curves observable in the market. Other derivative contracts are measured using broker quotations or observable market transactions in either listed or over-the-counter markets. There were no changes during the periods presented in the Company’s valuation techniques used to measure asset and liability fair values on a recurring basis.

On June 24, 2008, the Company entered into an interest rate swap with an aggregate notional value of $75 million whereby it exchanged its LIBOR-based variable rate interest for a fixed rate of 4.1375%. The notional value decreases to $50 million and then $25 million on June 30, 2010 and June 30, 2011, respectively, and expires on June 29, 2012. The fair value of the swap agreement, based on third-party quotes, was a liability of $3.0 million and $5.0 million at December 31, 2009 and 2008, respectively, which are recorded in “Other long term liabilities” on the consolidated balance sheet. The swap agreement has been designated as a cash flow hedge, and therefore changes in its fair value are recorded as an adjustment to other comprehensive income. There has been no ineffectiveness related to this arrangement since its inception. During the years ended December 31, 2009 and 2008, $2.9 million and $0.8 million, respectively, of losses on the swap were reclassified from AOCI to interest expense. At December 31, 2009, the Company expects to reclassify $2.3 million of net losses on the interest rate swap from accumulated other comprehensive income to earnings during the next twelve months.

Also on June 24, 2008, the Company entered into a cross currency swap denominated in Euro with an aggregate notional value of $27.3 million. The notional value decreased ratably each month over the term of the agreement and expired on March 31, 2009. The fair value of the swap agreement, based on third-party quotes, was an asset of $1.0 million at December 31, 2008. The swap agreement was designated as a cash flow hedge, and therefore changes in its fair value were recorded as an adjustment to other comprehensive income. There was no ineffectiveness related to this arrangement.

As of December 31, 2009, the Company had no open commodity futures contracts. As of December 31, 2008, the Company had copper and nickel futures contracts with notional values of $3.6 million. The fair value of the contracts, based on third-party quotes, was a liability of $2.1 million as of December 31, 2008, and is recorded in “Other accrued liabilities” on the accompanying consolidated balance sheets. The Company did not electe hedge accounting for these contracts, and therefore changes in their fair value were recognized in earnings. For the years ended December 31, 2009, 2008 and 2007, the consolidated statements of operations include $2.0 million, $(1.7) million and $(0.1) million, respectively, of unrealized gains (losses) as a result of changes in the fair value of these contracts. Realized gains (losses) on these contracts of $(1.0) million, $(0.4) million and $0.1 million were recognized in the years ended December 31, 2009, 2008, and 2007, respectively.

As of December 31, 2009 and 2008, the Company had foreign currency contracts with notional values of $10.5 million and $16.5 million, respectively. The fair values of the contracts was a liability of $0.1 million at December 31, 2009 and an asset of $0.7 million at December 31, 2008, and are recorded in “Other accrued liabilities” and in “Other current assets”, respectively, on the consolidated balance sheets. The Company has not elected hedge accounting for these contracts; therefore, changes in the fair value are recognized as a component of selling, general and administrative expense. For the years ended December 31, 2009, 2008 and 2007, the consolidated statements of operations include $(0.7) million, $0.3 million and $0.2 million, respectively, of unrealized gains (losses) as a result of changes in the fair value of these contracts. Realized gains (losses) on these contracts of $0.9 million, $(0.3) million and $0.5 million were recognized in the years ended December 31, 2009, 2008, and 2007, respectively.

On July 1, 2005, the Company entered into an interest rate collar with an aggregate notional value of $90 million, whereby the Company exchanged its LIBOR based variable rate interest for a ceiling of 4.75% and a floor of approximately 3.40%. The LIBOR-based interest can vary between the ceiling and floor based on market conditions. The Company did not elect hedge accounting for the collar agreement, and therefore changes in the fair value were recognized in income as a component of interest expense. The collar agreement expired on July 1, 2008.

16. Concentration of Credit Risk

In addition to interest rate swaps, financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable.

The Company performs credit evaluations of its customers prior to delivery or commencement of services and normally does not require collateral. Letters of credit are occasionally required for international customers when the Company deems necessary. The Company maintains an allowance for potential credit losses and losses have historically been within management’s expectations.

The Company may be exposed to credit-related losses in the event of non-performance by counterparties to financial instruments. Counterparties to the Company’s financial instruments represent, in general, international financial institutions or well-established financial institutions.

No one customer accounted for 10% or more of the Company’s sales in 2009, 2008 or 2007 or accounts receivable at December 31, 2009 or 2008.

17. Related Party Transactions

During 2008 and 2007, the Company paid a management fee of $0.5 million, and $1.0 million, respectively, to Colfax Towers, a party related by common ownership, recorded in selling, general and administrative expenses. This arrangement was discontinued following the Company’s IPO in May 2008.

18. Operations by Geographical Area

The Company’s operations have been aggregated into a single reportable operating segment for the design, production and distribution of fluid handling products. The operations of the Company on a geographic basis are as follows:

	Year ended December 31,
	2009		2008		2007
Net sales by origin:
United States	$	177,373	$	189,924	$	173,713
Foreign locations:
Germany		180,917		239,723		190,693
Other		166,734		175,207		141,899
Total foreign locations		347,651		414,930		332,592

Total net sales	$	525,024	$	604,854	$	506,305

Net sales by product:
Pumps, including aftermarket parts and service	$	443,073	$	529,300	$	441,692
Systems, including installation service		69,339		58,231		48,355
Valves		10,081		10,094		9,537
Other		2,531		7,229		6,721

Total net sales	$	525,024	$	604,854	$	506,305

	December 31,
	2009		2008
Long-lived assets:
United States	$	24,785	$	26,257
Foreign locations:
Germany		48,232		48,598
Other		19,073		17,235
Total foreign locations		67,305		65,833

Total long-lived assets	$	92,090	$	92,090

19. Commitments and Contingencies

Asbestos Liabilities and Insurance Assets

Two of our subsidiaries are each one of many defendants in a large number of lawsuits that claim personal injury as a result of exposure to asbestos from products manufactured with components that are alleged to have contained asbestos. Such components were acquired from third-party suppliers, and were not manufactured by any of our subsidiaries nor were the subsidiaries producers or direct suppliers of asbestos. The manufactured products that are alleged to have contained asbestos generally were provided to meet the specifications of the subsidiaries’ customers, including the U.S. Navy.

Of the 25,295 pending claims, approximately 4,400 of such claims have been brought in various federal and state courts in Mississippi; approximately 3,100 of such claims have been brought in the Supreme Court of New York County, New York; approximately 200 of such claims have been brought in the Superior Court, Middlesex County, New Jersey; and approximately 1,000 claims have been filed in state courts in Michigan and the U.S. District Court, Eastern and Western Districts of Michigan. The remaining pending claims have been filed in state and federal courts in Alabama, California, Kentucky, Louisiana, Pennsylvania, Rhode Island, Texas, Virginia, the U.S. Virgin Islands and Washington.

Claims activity related to asbestos is as follows (1):

	Year ended December 31,
	2009			2008			2007

Claims unresolved at the beginning of the period		35,357			37,554			50,020
Claims filed (2)		3,323			4,729			6,861
Claims resolved (3)		(13,385	)		(6,926	)		(19,327	)

Claims unresolved at the end of the period		25,295			35,357			37,554

Average cost of resolved claims (4)	$	11,106		$	5,378		$	5,232

(1)	Excludes claims filed by one legal firm that have been “administratively dismissed.”

(2)	Claims filed include all asbestos claims for which notification has been received or a file has been opened.

(3)	Claims resolved include asbestos claims that have been settled or dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

(4)	Average cost of settlement to resolve claims in whole dollars. These amounts exclude claims in Mississippi for which the majority of claims have historically been without merit and have been resolved for no payment. These amounts exclude any potential insurance recoveries.

The Company has projected each subsidiary’s future asbestos-related liability costs with regard to pending and future unasserted claims based upon the Nicholson methodology. The Nicholson methodology is the standard approach used by most experts and has been accepted by numerous courts. It is the Company’s policy to record a liability for asbestos-related liability costs for the longest period of time that it can reasonably estimate.

The Company believes that it can reasonably estimate the asbestos-related liability for pending and future claims that will be resolved in the next 15 years and has recorded that liability as its best estimate. While it is reasonably possible that the subsidiaries will incur costs after this period, the Company does not believe the reasonably possible loss or range of reasonably possible loss is estimable at the current time. Accordingly, no accrual has been recorded for any costs which may be paid after the next 15 years. Defense costs associated with asbestos-related liabilities as well as costs incurred related to litigation against the subsidiaries’ insurers are expensed as incurred.

Each subsidiary has separate, substantial insurance coverage resulting from the independent corporate history of each entity. In its evaluation of the insurance asset, in addition to the criteria listed above, the Company used differing insurance allocation methodologies for each subsidiary based upon the applicable law pertaining to the affected subsidiary.

For one of the subsidiaries, on October 14, 2009, the Delaware Court of Chancery ruled that asbestos-related costs should be allocated among excess insurers using an “all sums” allocation (which allows an insured to collect all sums paid in connection with a claim from any insurer whose policy is triggered, up to the policy’s applicable limits) and that the subsidiary has rights to excess insurance policies purchased by a former owner of the business. Based upon this ruling mandating an “all sums” allocation, as well as the language of the underlying insurance policies and the determination that defense costs are outside policy limits, the Company as of October 2, 2009, increased its future expected recovery percentage from 67% to 90% of asbestos-related costs following the exhaustion in the future of its primary and umbrella layers of insurance and recorded a pretax gain of $17.3 million. The subsidiary expects to be responsible for approximately 10% of all future asbestos-related costs.

Presently, this subsidiary is having all of its liability and defense costs covered in full by its primary and umbrella insurance carrier; however, this coverage is expected to exhaust in the first quarter of 2010. No cost sharing or allocation agreement is currently in place with the Company’s excess insurers; however, certain excess insurers have stated that they will abide by the Delaware Chancery Court's recent coverage rulings, including its ruling that the subsidiary may seek insurance coverage from the Company's excess insurers on and “all sums” basis and that they will defend and/or indemnify the subsidiary against asbestos claims, subject to their reservation of rights.

In 2003, the other subsidiary brought legal action against a large number of its insurers and its former parent to resolve a variety of disputes concerning insurance for asbestos-related bodily injury claims asserted against it. Although none of these insurance companies contested coverage, they disputed the timing, reasonableness and allocation of payments. For this subsidiary, it was determined by court ruling in the fourth quarter of 2007, that the allocation methodology mandated by the New Jersey courts will apply. Further court rulings in December of 2009, clarified the allocation calculation related to amounts currently due from insurers as well as amounts the Company expects to be reimbursed for asbestos-related costs incurred in future periods. As a result, in the fourth quarter of 2009, the Company increased its receivable for past costs by $11.9 million and decreased its insurance asset for future costs by $9.8 million and recorded a pretax gain of $2.1 million. The subsidiary expects to responsible for approximately 14% of all future asbestos-related costs.

General Litigation

On June 3, 1997, one of our subsidiaries was served with a complaint in a case brought by Litton Industries, Inc. (“Litton”) in the Superior Court of New Jersey which alleges damages in excess of $10.0 million incurred as a result of losses under a government contract bid transferred in connection with the sale of its former Electro-Optical Systems business. In the third quarter of 2004, this case was tried and the jury rendered a verdict of $2.1 million for the plaintiffs. After appeals by both parties, the Supreme Court of New Jersey upheld the plaintiffs’ right to a refund of their attorney’s fees and costs of trial, but remanded the issue to the trial court to reconsider the amount of fees using a proportionality analysis of the relationship between the fee requested and the damages recovered. The date for the new trial on additional claims allowed by the Appellate Division of the New Jersey Superior Court and the recalculation of attorney’s fees has not been set. The subsidiary intends to continue to defend this matter vigorously. At December 31, 2009, the Company’s consolidated balance sheet includes a liability, reflected in “Other liabilities”, related to this matter of $9.5 million.

In April 1999, the Company’s Imo Industries subsidiary resolved through a settlement the matter of Young v. Imo Industries Inc. that was pending in the United States District Court for the District of Massachusetts. This matter had been brought on behalf of a class of retirees of one of the subsidiary’s divisions relating to retiree health care obligations. On June 15, 2005, a motion was filed seeking an order that certain of the features of the plan as implemented by the Company were in violation of the settlement agreement. On December 16, 2008, the parties executed a Memorandum of Understanding, memorializing the principal terms of a new settlement agreement that resolved the litigation in its entirety. A final settlement agreement was executed by the parties and approved by the court in the fourth quarter of 2009. At December 31, 2009, the Company’s consolidated balance reflected an accumulated post retirement benefit obligation of $2.4 million related to this matter, of which $0.6 million was paid in January 2010.

The Company is also involved in various other pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings are expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate reserves to cover potential liabilities. Any costs that management estimates may be paid related to these proceedings or claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adversely to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

Guarantees

At December 31, 2009, there were $14.4 million of letters of credit outstanding. Additionally, at December 31, 2009, we had issued $12.9 million of bank guarantees securing primarily customer prepayments, performance, and product warranties in our European and Asian operations.

Minimum Lease Obligations

The Company has the following minimum rental obligations under non-cancelable operating leases for certain property, plant and equipment. The remaining lease terms range from 1 to 5 years.

Year ended December 31,

2010	$	3,873
2011		2,428
2012		1,719
2013		1,087
2014		519
Thereafter		240

Total	$	9,866

Net rental expense under operating leases was approximately $4.8 million, $5.1 million, and $4.6 million in 2009, 2008 and 2007, respectively.

20. Quarterly Results for 2009 and 2008 (Unaudited)

The summarized interim financial data presented below for 2009 and 2008 gives effect to the restatement of the Company’s consolidated financial statements as discussed in Note 2.

	First Quarter							Second Quarter
	As							As
	Previously					As		Previously					As
	Reported		Adjustment			Restated		Reported		Adjustment			Restated
2009
Net sales	$	136,323				$	136,323	$	129,185				$	129,185
Cost of sales		88,308					88,308		84,630					84,630
Gross profit		48,015					48,015		44,555					44,555
Selling, general and administrative expenses		30,187		(322	)		29,865		28,586		(193	)		28,393
Restructuring and other related charges		-					-		486		-			486
Research and development expenses		1,407					1,407		1,680					1,680
Asbestos liability and defense costs		1,645					1,645		1,482					1,482
Asbestos coverage litigation expenses		2,966					2,966		4,027					4,027
Operating income		11,810		322			12,132		8,294		193			8,487
Interest expense		1,846					1,846		1,786					1,786
Income before income taxes		9,964		322			10,286		6,508		193			6,701
Provision for income taxes		3,103		118			3,221		2,142		83			2,225
Net income available to common shareholders	$	6,861	$	204		$	7,065	$	4,366	$	110		$	4,476

Net income per share—basic and diluted	$	0.16	$	-		$	0.16	$	0.10	$	-		$	0.10

	Third Quarter									Fourth Quarter
	As									As
	Previously						As			Previously						As
	Reported			Adjustment			Restated			Reported			Adjustment			Restated
2009
Net sales	$	128,545					$	128,545		$	130,971					$	130,971
Cost of sales		82,339						82,339			83,960						83,960
Gross profit		46,206						46,206			47,011						47,011
Selling, general and administrative expenses		28,136			(258	)		27,878			27,426			(398	)		27,028
Restructuring and other related charges		9,608						9,608			7,420						7,420
Research and development expenses		1,523						1,523			1,320						1,320
Asbestos liability and defense income		(4,303	)					(4,303	)		(1,017	)					(1,017	)
Asbestos coverage litigation expenses		1,845						1,845			2,904						2,904
Operating income		9,397			258			9,655			8,958			398			9,356
Interest expense		1,834						1,834			1,746						1,746
Income before income taxes		7,563			258			7,821			7,212			398			7,610
Provision for income taxes		2,188			103			2,291			2,092			(1,208	)		884
Net income available to common shareholders	$	5,375		$	155		$	5,530		$	5,120		$	1,606		$	6,726

Net income per share—basic	$	0.12		$	0.01		$	0.13		$	0.12		$	0.04		$	0.16
Net income per share—diluted	$	0.12		$	0.01		$	0.13		$	0.12		$	0.04		$	0.15

	First Quarter							Second Quarter
	As							As
	Previously					As		Previously						As
	Reported		Adjustment			Restated		Reported			Adjustment			Restated
2008
Net sales	$	130,651				$	130,651	$	161,431					$	161,431
Cost of sales		82,473					82,473		104,654						104,654
Gross profit		48,178					48,178		56,777						56,777
Selling, general and administrative expenses		28,507		(330	)		28,177		35,776			(331	)		35,445
Initial public offering related costs		-					-		57,017						57,017
Research and development expenses		1,381					1,381		1,571						1,571
Asbestos liability and defense costs (income)		278					278		(715	)					(715	)
Asbestos coverage litigation expenses		3,139					3,139		3,970						3,970
Operating income		14,873		330			15,203		(40,842	)		331			(40,511	)
Interest expense		4,497					4,497		3,236						3,236
Income before income taxes		10,376		330			10,706		(44,078	)		331			(43,747	)
Provision for income taxes		3,578		102			3,680		(12,679	)		88			(12,591	)
Net income (loss)		6,798		228			7,026		(31,399	)		243			(31,156	)
Dividends on preferred stock		-					-		(3,492	)					(3,492	)
Net income (loss) available to common shareholders	$	6,798	$	228		$	7,026	$	(34,891	)	$	243		$	(34,648	)

Net income (loss) per share—basic and diluted	$	0.31	$	0.01		$	0.32	$	(1.01	)	$	0.01		$	(1.00	)

	Third Quarter									Fourth Quarter
	As									As
	Previously						As			Previously					As
	Reported			Adjustment			Restated			Reported		Adjustment			Restated
2008
Net sales	$	153,461					$	153,461		$	159,311				$	159,311
Cost of sales		98,983						98,983			101,557					101,557
Gross profit		54,478						54,478			57,754					57,754
Selling, general and administrative expenses		33,233			(330	)		32,903			27,718		(138	)		27,580
Research and development expenses		1,478						1,478			1,426					1,426
Asbestos liability and defense (income) costs		(6,312	)					(6,312	)		1,978					1,978
Asbestos coverage litigation expenses		5,148						5,148			4,905					4,905
Operating income		20,931			330			21,261			21,727		138			21,865
Interest expense		1,951						1,951			2,138					2,138
Income before income taxes		18,980			330			19,310			19,589		138			19,727
Provision for income taxes		5,329			173			5,502			9,210		(336	)		8,874
Net income available to common shareholders	$	13,651		$	157		$	13,808		$	10,379	$	474		$	10,853

Net income per share—basic	$	0.31		$	-		$	0.31		$	0.24	$	0.01		$	0.25

(1)	Second quarter 2008 results include $57.0 million of non-recurring costs associated with our IPO.

21. Subsequent Event

The board of directors of the Company appointed Clay H. Kiefaber as the Company’s President and Chief Executive Officer effective January 9, 2010. Mr. Kiefaber succeeds John A. Young, who resigned as President and Chief Executive Officer and as a director of the Company, effective January 9, 2010.

In connection with Mr. Young’s resignation, the Company and Mr. Young entered into a separation agreement on January 9, 2010, which provided Mr. Young with certain termination benefits, including cash payments totaling $1.6 million, health coverage for a period of one year and accelerated vesting of share-based payments. In the first quarter of 2010, the Company expects to recognize restructuring and other related charges totaling $2.1 million for these benefits.

In connection with Mr. Kiefaber’s appointment, the board of directors approved a grant to him of 102,124 stock options and 40,850 performance restricted stock units, effective on January 11, 2010 (the “Grant Date”) pursuant to the terms of the 2008 Plan. The stock options vest in three equal annual installments beginning with the first anniversary of the Grant Date (subject to Mr. Kiefaber’s continued employment with the Company on each such anniversary) and will have a per share exercise price of $12.27, the closing price of the Company’s common stock on the Grant Date. The performance restricted stock units will be earned if the Company has cumulative adjusted earnings per share equal to at least 110% of the adjusted earnings per share for the 2009 fiscal year for any four consecutive fiscal quarters beginning with the first fiscal quarter of 2010 and ending with the last fiscal quarter of 2013, and, if earned, will vest in two equal installments upon the fourth and fifth anniversaries of the Grant Date, subject to Mr. Kiefaber’s continued employment with the Company on each such anniversary. The fair value of these awards totaled $1.1 million, which is expected to be recognized over a period of approximately 3.4 years.

ITEM 9.

CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None

ITEM 9A.

CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

In connection with this restatement on Form 10-K/A, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, the Company has re-evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this report. Management, in consultation with the Audit Committee, has concluded that the restatement errors, described in Note 2 to the Consolidated Financial Statements, constituted a material weakness in the Company’s internal control over financial reporting as of the date of the Original Form 10-K. As a result of the material weakness, management has concluded that the Company’s disclosure controls and procedures were not effective in providing reasonable assurance that the information required to be disclosed in this report has been recorded, processed, summarized and reported as of the end of the period covered by this report.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commissions rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

The financial statements for the period covered by this amended report were prepared with particular attention to the material weakness. Accordingly, management believes that the consolidated financial statements included in this Annual Report fairly present, in all material respects, our financial condition, results of operations and cash flows as of and for the periods presented.

The Company continually reviews its disclosure controls and procedures and makes changes, as necessary, to ensure the quality of its financial reporting. As detailed below, the Company has implemented certain additional controls that it believes will remediate the issues that arose with respect to the material weakness.

Changes in Internal Control Over Financial Reporting

Management and the Board of Directors are committed to the remediation of the material weakness set forth above as well as the continued improvement of the Company’s overall system of internal control over financial reporting. Subsequent to the period covered by this report, management has implemented measures to remediate the material weakness in internal control over financial reporting described above. Specifically, we have implemented procedures to enhance the maintenance and review of participant data for benefit plans. As part of the Company’s fiscal 2010 assessment of internal control over financial reporting, management will conduct sufficient testing and evaluation of the implemented controls to ascertain whether they are designed and operating effectively. Management believes the implemented controls will remediate the material weakness related to the maintenance and review of participant data for benefit plans discussed in Note 2 to the Consolidated Financial Statements.

Management’s Annual Report on Internal Control Over Financial Reporting

The management of Colfax Corporation is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. Internal control over financial reporting includes policies and procedures that:

(i)

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the company’s assets;

(ii)

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures are being made only in accordance with the authorization of management and directors of the company; and

(iii)

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with existing policies or procedures may deteriorate.

Under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, our management conducted an assessment of the effectiveness of internal control over financial reporting as of December 31, 2009 based on the criteria established in Internal Control – Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission. As a result of the material weakness discussed above, management has concluded that our internal control over financial reporting were not effective as of December 31, 2009.

Our independent registered public accounting firm is engaged to express an opinion on our internal control over financial reporting, as stated in their report which is included in Part II, Item 8 of this Form 10-K/A under the caption “Report of Ernst & Young LLP, Independent Registered Public Accounting Firm, on Internal Control Over Financial Reporting.”

ITEM 9B.

OTHER INFORMATION

None

PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Information relating to our Executive Officers is set forth in Part I of this Form 10-K/A under the caption “Executive Officers of the Registrant.” Additional information regarding our directors, audit committee and compliance with Section 16(a) of the Exchange Act is incorporated by reference to such information included in our proxy statement for our 2010 annual meeting to be filed with the SEC within 120 days after the end of the fiscal year covered by this Form 10-K (the “2010 Proxy Statement”) under the captions “Election of Directors”, “Board of Directors and its Committees – Audit Committee” and “Section 16(a) Beneficial Ownership Reporting Compliance”.

As part of our system of corporate governance, our board of directors has adopted a code of ethics that applies to all employees, including our principal executive officer and our principal financial officer and principal accounting officer. A copy of the code of ethics is available on our website at www.colfaxcorp.com. We intend to satisfy any disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or a waiver from, a provision of our code of ethics by posting such information on our website at the address above.

ITEM 11.

EXECUTIVE COMPENSATION

Information responsive to this item is incorporated by reference to such information included in our 2010 Proxy Statement under the captions “Executive Compensation”, “Director Compensation”, “Compensation Discussion and Analysis”, “Compensation Committee Report” and “Compensation Committee Interlocks and Insider Participation”,

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Information responsive to this item is incorporated by reference to such information included in our 2010 Proxy Statement under the captions “Beneficial Ownership of Our Common Stock” and “Equity Compensation Plan Information”.

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Information responsive to this item is incorporated by reference to such information included in our 2010 Proxy Statement under the captions “Certain Relationships and Related Person Transactions” and “Director Independence”.

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

Information responsive to this item is incorporated by reference to such information included in our 2010 Proxy Statement under the captions “Independent Registered Public Accountant Fees and Services” and “Audit Committee’s Pre-Approval Policies and Procedures”.

PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)	The following documents are filed as part of this report.

(1)

Financial Statements. The financial statements are set forth under “Item 8. Financial Statements and Supplementary Data” of this report on Form 10-K/A.

(2)

Schedules. An index of Exhibits and Schedules is on page 88 of this report. Schedules other than those listed below have been omitted from this Annual Report because they are not required, are not applicable or the required information is included in the financial statements or the notes thereto.

(b)	Exhibits. The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this report.

(c)	Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on December 13, 2010.

COLFAX CORPORATION

By:	/s/ CLAY H. KIEFABER
	Clay H. Kiefaber
	President and Chief Executive Officer

COLFAX CORPORATION

INDEX TO FINANCIAL STATEMENTS, SUPPLEMENTARY DATA AND FINANCIAL STATEMENT SCHEDULES

		Page Number in Form 10-K/A
Schedules:

Valuation and Qualifying Accounts		91

EXHIBIT INDEX

Exhibit Number		Description	Location*

3.1		Amended and Restated Certificate of Incorporation of Colfax Corporation	Incorporated by reference to Exhibit 3.1 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the Commission on May 13, 2008

3.2		Colfax Corporation Amended and Restated Bylaws	Incorporated by reference to Exhibit 3.2 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the Commission on May 13, 2008

4.1		Specimen Common Stock Certificate

10.1		Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	a	Form of Non-Qualified Stock Option Agreement for grants pursuant to the Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	b	Form of Performance Stock Unit Agreement for grants pursuant to the Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	c	Form of Outside Director Restricted Stock Unit Agreement for grants pursuant to the Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	d	Form of Outside Director Deferred Stock Unit Agreement for grants pursuant to the Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	e	Form of Outside Director Deferred Stock Unit Agreement for deferral of grants of restricted stock made pursuant to the Colfax Corporation 2008 Omnibus Incentive Plan**

10.1	f	Form of Outside Director Deferred Stock Unit Agreement for deferral of director fees**

10.2		Service Contract for Board Member, dated November 14, 2006, between the Company and Dr. Michael Matros**

10.3		Form of Indemnification Agreement entered into between the Company and each of its directors and officers**

10.4		Colfax Corporation Amended and Restated Excess Benefit Plan**

10.5		Retirement Plan for salaried U.S. Employees of Imo Industries, Inc. and Affiliates**

10.6		Colfax Corporation Excess Benefit Plan**

10.7		Allweiler AG Company Pension Plan**

10.8		Colfax Corporation Director Deferred Compensation Plan**

10.9		Employment Agreement between Colfax Corporation and Clay Kiefaber	Incorporated by reference to Exhibit 10.1 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the Commission on January 11, 2010

10.10	Employment Agreement between Colfax Corporation and John A. Young**

10.11	Employment Agreement between Colfax Corporation and Thomas M. O’Brien**

10.12	Employment Agreement between Colfax Corporation and Michael K. Dwyer**

10.13	Employment Agreement between Colfax Corporation and William E. Roller**	Incorporated by reference to Exhibit 10.1 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the Commission on May 8, 2009

10.14	Employment Agreement between Colfax Corporation and Mario E. DiDomenico**	Incorporated by reference to Exhibit 10.3 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the Commission on May 8, 2009

10.15	Employment Agreement between Colfax Corporation and G. Scott Faison**

10.16	Amendment to the Employment Agreement between Colfax Corporation and John A. Young**	Incorporated by reference to Exhibit 10.13 to Colfax Corporation’s Form 10-K (File No. 001-034045) as filed with the Commission on March 6, 2009

10.17	Amendment to the Employment Agreement between Colfax Corporation and Thomas B. O’Brien**	Incorporated by reference to Exhibit 10.14 to Colfax Corporation’s Form 10-K (File No. 001-034045) as filed with the Commission on March 6, 2009

10.18	Amendment to the Employment Agreement between Colfax Corporation and Michael K. Dwyer**	Incorporated by reference to Exhibit 10.15 to Colfax Corporation’s Form 10-K (File No. 001-034045) as filed with the Commission on March 6, 2009

10.19	Amendment to the Employment Agreement between Colfax Corporation and William E. Roller**	Incorporated by reference to Exhibit 10.2 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the Commission on May 8, 2009

10.20	Amendment to the Employment Agreement between Colfax Corporation and Mario E. DiDomenico**	Incorporated by reference to Exhibit 10.4 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the Commission on May 8, 2009

10.21	Amendment to the Employment Agreement between Colfax Corporation and G. Scott Faison**	Incorporated by reference to Exhibit 10.16 to Colfax Corporation’s Form 10-K (File No. 001-034045) as filed with the Commission on March 6, 2009

10.22	Separation Agreement between Colfax Corporation and John A. Young**	Incorporated by reference to Exhibit 10.2 to Colfax Corporation’s 8-K (File No. 001-34045) as filed with the Commission on January 11, 2010

10.23	Tax Equalization Program Amendment Letter between Colfax Corporation and Michael K. Dwyer**	Incorporated by reference to Exhibit 10.17 to Colfax Corporation’s Form 10-K (File No. 001-034045) as filed with the Commission on March 6, 2009

10.24	Colfax Corporation Annual Incentive Plan**	Incorporated by reference to Exhibit 10.1 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the Commission on August 4, 2009

10.25	Credit Agreement, dated May 13, 2008, by and among the Colfax Corporation, certain subsidiaries of Colfax Corporation identified therein and the lenders identified therein	Incorporated by reference to Exhibit 10.1 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the Commission on May 13, 2008

21.1	Subsidiaries of the registrant	Incorporated by reference to Exhibit 21.1 to Colfax Corporation’s Form 10-K (File No. 001-34045) as filed with the Commission on February 25, 2010

23.1	Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm	Filed herewith

31.1	Certification of Chief Executive Officer Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith

31.2	Certification of Chief Financial Officer Pursuant to Item 601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.	Filed herewith

32.1	Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed herewith

32.2	Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Filed herewith

*	Unless otherwise noted, all exhibits are incorporated by reference to the Company’s Registration Statement on Form S-1 (File No. 001-34045).

**	Indicates management contract or compensatory plan, contract or arrangement.

COLFAX CORPORATION AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(Dollars in thousands)

	Balance at Beginning of Period		Charged to Cost and Expenses (a)			Charged to Other Accounts			Write-offs, Write-downs & Deductions			Foreign Currency Translation			Balance at End of Period
Year Ended December 31, 2009
Allowance for doubtful accounts	$	2,486		405			-			(178	)		124		$	2,837
Allowance for excess, slow-moving and obsolete inventory	$	6,923		1,368			-			(413	)		147		$	8,025

Valuation allowance for deferred tax assets (as restated)	$	45,206		(82	)		-			-			(71	)	$	45,053

Year Ended December 31, 2008
Allowance for doubtful accounts	$	1,812		828			-			(33	)		(121	)	$	2,486
Allowance for excess, slow-moving and obsolete inventory	$	7,589		(334	)		-			(74	)		(258	)	$	6,923
Valuation allowance for deferred tax assets (as restated)	$	17,776		2,999			24,431	(b)		-			-		$	45,206

Year Ended December 31, 2007
Allowance for doubtful accounts	$	1,650		964			(10	) (c)		(909	)		117		$	1,812
Allowance for excess, slow-moving and obsolete inventory	$	6,412		1,735			144	(c)		(1,309	)		607		$	7,589

Valuation allowance for deferred tax assets (as restated)	$	17,884		(108	)		-			-			-		$	17,776

(a)	Net of recoveries.

(b)	Amounts charged to other comprehensive income.

(c)	Amounts related to businesses acquired and related adjustments.